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such as the post-translational modification of histone proteins. Histone acetylation plays a major role in
neuronal function, but our understanding of the upstream mechanisms that regulate recruitment of the
HDAC enzymes, and of the genes and proteins downstream of histone acetylation that support plasticity,
are poorly understood. In my thesis research I investigated the role of the SIN3A/HDAC complex, a
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and memory-related transcription factors, in hippocampal synaptic plasticity. In Chapter 1, I discussed the
mechanisms that support memory formation and the stabilization of synaptic potentiation, described the
mechanisms of post-translational histone modification, and reviewed the role of epigenetic histone
modification in memory and plasticity as well as in neuronal dysfunction. In Chapter 2, we demonstrated
that reducing levels of the co-repressor SIN3A enhanced long-term potentiation and long-term memory,
increased expression of Cdk5 and Homer1, and altered signaling through the Group I metabotropic
glutamate receptors. In the Appendix, I show additional data that demonstrates increased
mGluR5-mediated signaling in hippocampal neurons with loss of SIN3A. In Chapter 3, I found that
disrupting the function of the Nr4a family of nuclear receptor transcription factors impaired long-lasting
forms of synaptic potentiation and blocked the enhancement of plasticity by pharmacological HDAC
inhibition. In Chapter 4 I found that C-DIM compounds, activators of NR4A, enhanced hippocampal
potentiation in a manner sensitive to Nr4a disruption; we also found that CREB/CBP interaction regulates
activity-induced Nr4a2 promoter acetylation and gene expression. These findings improve our
understanding of the role of epigenetic histone modification in synaptic plasticity and memory, and
indicate that the NR4A nuclear receptors are exceptional downstream targets for the enhancement of
cognitive function and the amelioration of neuronal dysfunction.
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ABSTRACT
THE REGULATION OF HIPPOCAMPAL SYNAPTIC PLASTICITY BY UPSTREAM
AND DOWNSTREAM EFFECTORS OF HISTONE ACETYLATION
Morgan Stuart Bridi
Dr. Ted Abel

Long-lasting forms of hippocampal plasticity and hippocampus-dependent memory share a
requirement for gene expression. Activity-induced neuronal gene expression is regulated by
epigenetic mechanisms such as the post-translational modification of histone proteins. Histone
acetylation plays a major role in neuronal function, but our understanding of the upstream
mechanisms that regulate recruitment of the HDAC enzymes, and of the genes and proteins
downstream of histone acetylation that support plasticity, are poorly understood. In my thesis
research I investigated the role of the SIN3A/HDAC complex, a repressive histone-modifying
complex, and of the Nr4a nuclear receptors, which are acetylation-regulated and memory-related
transcription factors, in hippocampal synaptic plasticity. In Chapter 1, I discussed the
mechanisms that support memory formation and the stabilization of synaptic potentiation,
described the mechanisms of post-translational histone modification, and reviewed the role of
epigenetic histone modification in memory and plasticity as well as in neuronal dysfunction. In
Chapter 2, we demonstrated that reducing levels of the co-repressor SIN3A enhanced long-term
potentiation and long-term memory, increased expression of Cdk5 and Homer1, and altered
signaling through the Group I metabotropic glutamate receptors. In the Appendix, I show
additional data that demonstrates increased mGluR5-mediated signaling in hippocampal neurons
with loss of SIN3A. In Chapter 3, I found that disrupting the function of the Nr4a family of nuclear
receptor transcription factors impaired long-lasting forms of synaptic potentiation and blocked the
enhancement of plasticity by pharmacological HDAC inhibition. In Chapter 4 I found that C-DIM
compounds, activators of NR4A, enhanced hippocampal potentiation in a manner sensitive to

iv

Nr4a disruption; we also found that CREB/CBP interaction regulates activity-induced Nr4a2
promoter acetylation and gene expression. These findings improve our understanding of the role
of epigenetic histone modification in synaptic plasticity and memory, and indicate that the NR4A
nuclear receptors are exceptional downstream targets for the enhancement of cognitive function
and the amelioration of neuronal dysfunction.
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CHAPTER 1: An overview of epigenetic histone modification in long-term
memory and synaptic plasticity.
1.1. Overview
Understanding the cellular and molecular mechanisms by which the brain forms and
stores memories is a central goal of neuroscience research. The ability of an organism to learn
and adapt its behavior in response to changes in its environment is essential to the survival of
animals from sea slugs, to fruit flies, to rats, to cats, to humans. Although substantial progress
has been made in our understanding of neuronal function and the biochemical and cellular
processes involved in memory formation and neuronal plasticity, our knowledge is still far from
complete. In the hippocampus, the formation of long-term memory and the stabilization of longterm changes in synaptic strength both require gene transcription and de novo protein synthesis
(reviewed in Mayford, Siegelbaum, & Kandel, 2012). A relatively recent development in the field is
the understanding that epigenetic mechanisms are involved in the regulation of plasticity-related
neuronal gene expression. One such epigenetic mechanism, the post-translational modification of
histone proteins, has received much attention, and histone acetylation, an epigenetic mark
associated with active transcription, has been positively correlated with memory and plasticity
(reviewed in Peixoto & Abel, 2013). While it is now clear that these epigenetic processes are
major contributors to plastic processes in the hippocampus, many questions still remain.
My thesis research has focused on the mechanisms both upstream and downstream of
histone acetylation that regulate this particular epigenetic modification and mediate its effects on
hippocampus-dependent long-term memory and hippocampal synaptic plasticity. In this
introduction, I will review a number of topics that pertain to the research presented in subsequent
chapters. Here, I will provide an overview of the role of the hippocampus in memory, some
foundational concepts of learning, memory, and synaptic plasticity will be introduced, and
synaptic signaling pathways and important signal transduction molecules will be described. I will
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also review the concept of epigenetics and histone modification, the many ways in which histone
modification is involved in plastic processes and neuronal function, and how epigenetic histone
modification is itself regulated and ultimately exerts effects on neuronal function.

1.2. The Hippocampus is Critical for Memory Formation
Long-standing questions in the field of neuroscience are how memories are created, and
where they are stored in the brain. An early clue pointing us towards some answers came from
the case of Henry Molaison, known as patient H. M., who underwent a complete bilateral
hippocampal resection to treat his severe epileptic seizures. After his surgery, H.M. could still
recall memories formed earlier in his life – say, from his childhood – but was unable to form new
declarative memories – memories about specific facts and events (Scoviille and Milner, 1957).
The findings of Scoville and Milner provided some of the first evidence that the hippocampus, a
structure in the medial temporal lobe (Fig. 1.1A), was important for the formation of new
memories but not for their long-term storage, a finding supported by experimental lesioning of
hippocampi in rodents (Anagnostaras et al., 1999). Since the 1950s, behavioral work with animal
models – especially rodents – has expanded our understanding of the role of the hippocampal
formation in spatial and contextual memory, including the development of widely-used behavioral
paradigms such as the Morris water maze, contextual fear conditioning, and spatial object
recognition memory (Morris, 1984; Maren, 2001; Maren and Quirk, 2004).
The formation of hippocampus-dependent memory is a process involving three distinct
phases of acquisition, consolidation, and retrieval (McGaugh, 2000; Abel and Lattal, 2001) (Fig.
1.1B). Acquisition is the process of learning new information – the formation of new associations
between environmental events or behavioral outcomes. A newly-acquired association takes the
form of a short-term memory that exists in a highly labile state, vulnerable to modification or
disruption by new associations, by the disruption of critical biochemical pathways, and even by
neuronal activity. Consolidation is the process by which the vulnerable short-term memory is
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gradually converted into a long-term memory resistant to disruption. This process of consolidation
has been shown to include at least two distinct windows of time in which the memory is
susceptible to disruption of protein synthesis, gene expression, and various signaling molecules
(Barondes and Jarvik, 1964; Squire and Barondes, 1970; Abel et al., 1997; Meiri and Rosenblum,
1998; Pittenger and Kandel, 1998; Igaz et al., 2002). Retrieval is the final phase, when a stored
memory is accessed at some point in the future and used to inform behavior. Following retrieval,
the memory trace is temporarily returned to a labile state and is once again subject to
modification (Nader et al., 2000; Sara, 2000).

1.3. Synaptic Plasticity in the Hippocampus
Activity-driven, long-term synaptic plasticity is well-established as a cellular/physiological
correlate of memory formation and storage (Malenka and Bear, 2004; Citri and Malenka, 2008;
Mayford et al., 2012), but it has taken over a century of work to arrive at this point. Our current
thinking about synaptic plasticity has its genesis in work carried out around the turn of the 19
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century. The doctrine of the time held that the mature nervous system was fixed; any changes in
neuronal processes were viewed as aberrant, rather than part of normal neuronal function. This
paradigm was challenged by the observations of early neuroscientists such as Tanzi, William
James, Marinesco and his student Minea, Santiago Ramon y Cajal, and Ernesto Lugaro, who
contributed the term “neuronal plasticity” to the field (Stahnisch and Nitsch, 2002; Jones, 2004;
Berlucchi and Buchtel, 2009).
th

These ideas would be returned to prominence in the middle of the 20 century. Donald
O. Hebb, at McGill University, hypothesized that simultaneous activity between two connected
neurons would lead to strengthening of that connection and that such changes in neuronal
connectivity could be a mechanism of memory formation and storage (Hebb, 1949). As Hebb
postulated: “When an axon of cell A…excites cell B and repeatedly or persistently takes part in
firing it, some growth process or metabolic change takes place in one or both cells so that A’s
efficiency as one of the cells firing B is increased.” The concept that “neurons that fire together,
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wire together” is now a commonly-referenced aspect of so-called Hebbian plasticity. In the 1970s,
evidence of a synaptic mechanism fitting the Hebbian concept of plasticity was described in the
findings of Bliss and colleagues, at the University of Oslo (Bliss and Gardner-Medwin, 1973; Bliss
and Lomo, 1973), when they reported changes in hippocampal synaptic strength induced by
repetitive activity in a manner that was associative, input-specific, and long-lasting. Using
extracellular electrodes in both anesthetized and awake rabbits, they applied high-frequency
stimulation to perforant path axons (projecting from the entorhinal cortex) and recorded
responses from neurons of hippocampal area CA3. Repetitive high-frequency stimulation of this
pathway led to persistent strengthening of the CA3 synaptic response, which was termed “longterm potentiation,” or LTP (Bliss and Lomo, 1973; Douglas and Goddard, 1975).
In the subsequent decades, many forms of synaptic plasticity have been discovered
using a variety of in vivo and in vitro research paradigms. Multiple forms of synaptic potentiation
and depression have been investigated at the different synapses of the hippocampal formation, in
the amygdala, in different areas of the frontal cortex, in the striatum, and in the cerebellum
(Malenka and Bear, 2004). In addition to the rabbits used by Bliss and colleagues, and the mice
and rats commonly used today, long-term potentiation has been found at synapses in gerbils
(Tsubokawa et al., 1993), guinea pigs (Gustafsson and Wigström, 1986; Harris and Carl, 1986),
cats (Kimura et al., 1994), rhesus macaques (Huang et al., 2014), and humans (Chen et al.,
1996; Beck et al., 2000). The study of long-lasting, activity-dependent synaptic plasticity has been
best characterized at connections of the hippocampal trisynaptic circuit (see Fig. 1.1A), and in
the next portion of this chapter I will review some of the basic mechanisms known to be involved
in LTP at the CA3-CA1 Schaffer collateral synapses.

1.4. Mechanisms of Hippocampal Synaptic Long-Term Potentiation
Excitatory synaptic activity begins a series of intracellular signaling events that not only
have local effects at the activated synapse but also involve intracellular signaling cascades that
lead to protein synthesis, gene transcription, and the stabilization of long-term changes in
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synaptic strength. These biochemical events can help us divide synaptic long-term potentiation
into distinct but overlapping phases. Relatively “weak” stimulation (for example, a single 1 sec,
100 Hz tetanus) leads to short-lasting early LTP (E-LTP) that persists for only 1 to 2 hours after
LTP induction before synaptic strength returns to baseline levels. Such E-LTP requires the
activation of synaptic kinases and modification of proteins already present at the synapse, but
does not require gene expression of the production of new proteins (Huang and Kandel, 1994;
Tsien et al., 1996). A “strong” pattern of stimulation (such as application of four 100 Hz tetani)
leads to long-lasting late LTP (L-LTP) that can persist for many hours, and is distinct from shortterm E-LTP in its requirement for the activation of additional signaling cascades, gene
expression, and de novo protein synthesis (Huang and Kandel, 1994; Nguyen et al., 1994; Abel
et al., 1997; Nguyen and Kandel, 1997; Malenka and Bear, 2004) (Fig. 1.2).
The synaptic events that support long-term potentiation begin with the pre-synaptic
release of the excitatory neurotransmitter glutamate into the synaptic cleft and the activation of
+

postsynaptic glutamate receptors. Glutamate binding gates Na -permeable ionotropic 2-amino-32+

(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid (AMPA) receptors and Ca -permeable Nmethyl-D-aspartate (NMDA) receptors (Dingledine et al., 1999). Schaffer collateral LTP is NMDA
receptor-dependent (Collingridge et al., 1983; Kuenzi et al., 2000), and these receptors act as
coincidence detectors for pre-synaptic and post-synaptic activity. NMDA receptors are voltagedependent; at resting membrane potential, the channel pore is blocked by an Mg
prevents Ca

2+

2+

cation that

influx even in the presence of glutamate. Postsynaptic activity, which depolarizes

the membrane, must occur simultaneously with presynaptic glutamate release; co-occurrence of
2+

these events allows for the gating of NMDA receptors and a large Ca

influx into the

postsynaptic neuron, and this increase in intracellular calcium is necessary for triggering
mechanisms that support LTP (Luscher and Malenka, 2012).

1.4.1. Mechanisms of Transcription-Independent E-LTP. As mentioned above, short-lasting
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E-LTP does not require transcription or translation (Nguyen, Abel, & Kandel, 1994a), but it does
require activity-dependent kinase activation and the covalent modification of proteins already
present at the synapse. NMDA receptor-mediated calcium influx increases levels of intracellular
calcium, which activates calcium/calmodulin dependent kinase II (CaMKII) by facilitating
autophosphorylation of the kinase and allowing it to localize to the postsynaptic density
(Reymann et al., 1988; Malinow et al., 1989; Lisman et al., 2002). Active CaMKII facilitates the
insertion of AMPA receptors in the postsynaptic membrane, while its phosphorylation of the
GluR1 subunit of AMPA receptors modulates their gating and conductance in response to
glutamate binding (Benke et al., 1998; Bolton et al., 2000; Malinow and Malenka, 2002;
Collingridge et al., 2004; Oh et al., 2006; Lu et al., 2010; Kristensen et al., 2011). The increased
number and enhanced single-channel conductance of phosphorylated AMPA receptors
contributes to the overall potentiation of the AMPAR-mediated synaptic current that is seen in
LTP. The activity of synaptic protein phosphatases (such as PP1 and PP2) ultimately results in
the dephosphorylation and inactivation CaMKII, followed by the dephosphorylation of AMPA
receptors and their return to basal conductance states and removal from the synaptic membrane
(Soderling and Derkach, 2000).
1.4.2. Signaling Cascades Involved in Long-Lasting L-LTP. The activation of additional
signaling mechanisms is necessary for the maintenance of synaptic potentiation as seen in L-LTP
(Levenson et al., 2004; Malenka and Bear, 2004; Sweatt, 2004; Luscher and Malenka, 2012). An
increased level of presynaptic activity facilitates NMDA receptor activation and a larger
postsynaptic calcium influx. This activates adenylyl cyclase and the subsequent production of the
second messenger cyclic adenosine monophosphate (cAMP), both of which are required for LTP
(Matthies and Reymann, 1993). Protein kinase A (PKA), which is activated by cAMP, is also a
critical mediator of LTP with multiple roles in plasticity (Abel et al., 1997; Huang & Kandel, 1994).
A number of other kinases have been identified as important contributors to long-lasting LTP;
these include protein kinase C (PKC), SRC tyrosine kinases, CaMKIV, and extracellular-signal
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related kinase-mitogen-activated protein kinase (ERK/MAPK, or ERK) just to name a few (Bliss
and Collingridge, 1993; Malenka and Nicoll, 1999; Salter and Kalia, 2004; Sweatt, 2004).
ERK, PKA, and CaMKIV are all in some way involved in the initiation of the protein
synthesis and gene expression that are needed to maintain changes in synaptic strength
(Sacktor, 2008). Translation can occur locally at the synapse, through activation of the Mnk1
pathway by ERK (Kelleher et al., 2004). These kinases are also involved in signal transduction
from the synapse to the nucleus, where they work to phosphorylate and activate plasticityregulating transcription factors like Elk-1 and cAMP-response element binding protein (CREB)
(Impey et al., 1998; Davis et al., 2000; Panja et al., 2009). Long-term potentiation – as well as
long-term memory formation – is dependent on CRE-mediated transcription, and disruption of
CREB blocks the expression of Schaffer collateral LTP (Bourtchuladze et al., 1994).
Synaptic activity-induced transcriptional regulation is not as straightforward as the
activation of CREB or Elk1. Over the last decade-and-a-half, researchers have demonstrated that
epigenetic mechanisms are very involved in the control of activity-driven neuronal gene
expression. One class of epigenetic mechanism, the post-translational modification of histone
proteins, has been found to play an especially large role in the regulation of memory formation
and synaptic plasticity. The following sections will discuss the role of epigenetic histone
modification in the function and dysfunction of the central nervous system.

1.5. Post-translational Histone Modification: An Epigenetic Code
The term “epigenetics” was coined by Conrad Waddington, a developmental biologist,
who referred to an “epigenetic landscape” to explain the observation that cells sharing the same
origin and genotype display different phenotypes over the course of development (Waddington,
1942, 1957). This concept was updated in the decades to follow as our understanding of genetics
grew, and epigenetics came to refer to “potentially heritable changes in gene expression that do
not involve changes in DNA sequence” (Holliday and Pugh, 1975; Jaenisch and Bird, 2003).
Epigenetics was first conceived as a way to explain developmental phenomena, and indeed
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epigenetic modifications are heritable through cell division, influencing the transcriptome and
phenotype of subsequent generations of cells. Epigenetic changes are also mitotically stable,
enough to be heritable transgenerationally and passed on from parent to offspring and influence
behavioral and genetic phenotypes (Weaver et al., 2004, 2006). However, epigenetic
modifications are not limited to developmental contexts and it is now clear that such mechanisms
are at work even in terminally differentiated cells such as neurons. The modern understanding of
epigenetics reflects this, and we now define epigenetics as “the sum of the alterations to the
chromatin template that collectively establish and propagate different patterns of gene expression
and silencing from the same genome” (Allis et al., 2007).
Changes to the epigenome can be stable and long-lasting. They are also dynamic and
can be recruited in response to external stimuli in non-dividing cells, such as neurons (Borrelli et
al., 2008). Research into the various epigenetic systems at work in the central nervous system is
a burgeoning field, and investigators have begun to reveal essential roles for post-translational
histone modifications in a diverse array of neuronal systems. In this chapter, we explore some of
the implications of histone modifications in central nervous system function, as well as the
relationship between histone modifications and neuropsychiatric and neurological disorders.
1.5.1. The Histone Code: Complex and Combinatorial. Chromatin is the tightly packaged
complex of DNA and proteins that facilitates the proper organization, storage, and transcription of
the genome within the nucleus. The basic unit of chromatin is the nucleosome core particle, 147
base pairs of DNA wrapped around an octamer composed of two copies each of the canonical
core histone proteins H2A, H2B, H3, and H4 (Richmond et al., 1997). A number of posttranslational modifications can be made to the histones, altering the structure of nucleosomes
and chromatin and thereby potentially altering patterns of gene expression (Berger, 2007;
Kouzarides, 2007). The histone code hypothesis was first proposed by David Allis and
colleagues over a decade ago (Strahl and Allis, 2000). At its most basic, this idea was that
histone modifications act in combination to effect downstream changes in gene expression in
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response to external stimuli. The histone code has served the field well as a general hypothesis
and framework for experimental design. As our knowledge of chromatin biology has expanded
and matured, so too has the formulation of the histone code hypothesis changed to keep pace
with current research (Jenuwein and Allis, 2001; Borrelli et al., 2008; Lee et al., 2010). A more
current view of the histone code is that of an “epigenetic index” (Borrelli et al., 2008) in which the
different combinations of histone modifications correspond to particular transcriptional and
epigenetic states. This idea is taken further with the concept of a “histone language” (Lee et al.,
2010), in which the downstream effects of histone modifications are context-sensitive and
crosstalk between modifications influences the addition, removal, and ultimately the readout of
epigenetic histone marks.
There are at least 14 distinct modifications that have been identified in the literature,
occurring at over 100 sites on the N-terminal tails and the globular bodies of histone proteins (see
Fig. 1.3) (Martin and Zhang, 2007; Ruthenburg et al., 2007). Histone modifications regulate
various processes including activation or inactivation of transcription, DNA repair, replication, and
chromatin condensation (Kouzarides, 2007; Bannister and Kouzarides, 2011). Histone acetylation
occurs at lysine residues on all of the core histone proteins, and is usually associated with active
transcription (Hebbes and Thorne, 1988). Phosphorylation at serine, threonine, and tyrosine
residues is also correlated with actively-transcribed genes, and it is frequently found to co-occur
with histone acetylation, although some uncertainty surrounds the nature of this relationship
(Zippo et al., 2009; Berger, 2010). Histone methylation is a more complicated modification. Methyl
groups are added to both lysine and arginine residues. Lysine residues can be mono-, di-, or trimethylated, while arginine residues can only have one or two methyl groups added. Histone
methylation is an uncharged modification and is associated with both activation and inactivation
of transcription, depending on the site modified and the number of methyl groups added (Ng et
al., 2009).
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The other histone modifications are generally not as well-understood, especially as they
relate to brain function. Ubiquitination is a very large modification, associated with repression, and
it may interfere with histone acetylation. Sumoylation is related to ubiquitination, though it is a
smaller and antagonizes both acetylation and ubiqutination (Kouzarides, 2007; Bannister and
Kouzarides, 2011). Deimination, or citrullination, is the conversion of an arginine residue to
citrulline, which possibly interferes with transcriptional activation by arginine methylation (Cuthbert
et al., 2004; Wang et al., 2004), although this relationship may also go the other way (Raijmakers
et al., 2007). There are still other histone modifications: proprionylation, formylation, butyrylation,
ADP ribosylation, and proline isomerization have all been reported, but it is not yet known what
role they play in CNS function. Novel histone modifications and modification sites are still being
discovered. The addition of Beta-N-acetylglucosamine (O-GlcNAc) to serine and threonine on
histones H2A, H2B, and H4 was first described in 2010. Histone O-GlcNAcylation was found to
be responsive to heat shock and mitotic cell division, and may be involved in chromatin
remodeling (Sakabe et al., 2010). Crotonylation is a recently described modification, discovered
in 2011 (Tan et al., 2011). Histone crotonylation was observed at lysine residues and is
associated with the promoters of actively transcribed genes in male germ cells. The same study
that identified crotonylation also found another novel, as-yet-uncharacterized mark, histone
tyrosine hydroxylation (Tan et al., 2011). Clearly, future research is needed to define these
histone modifications and what roles they play in neurons.
A rough, back-of-the-envelope calculation can give us a feel for the complexity of the
histone code by estimating how many potential epigenetic states histone modification could
establish at the promoter of any particular gene. To begin, consider the number of modifications
that are possible on the nucleosome core proteins: approximately 100 modifications between
histones H3 and H4 and another 10 between histones H2A and H2B. If all the different
6

combinations are taken into account, this gives a possible 10 states. Some redundancy may be
involved, because not all modifications make unique contributions and not all possible
combinations are observed in vivo. In that case, we can trim the number down to a more
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conservative 10 possible combinations per gene. Multiply that figure by the approximately
30,000 genes identified in the human genome, and we could estimate that there are 30,000,000
possible histone modification states that could be established in the nucleus.
The potential number of epigenetic states created by histone modifications is large and
the crosstalk between histone modifications in complex, but the histone code seems to follow
particular rules that could make understanding it more tractable. Genome-wide studies in yeast,
Drosophila, and mammalian cells have mapped histone modifications and found that not all of the
possible histone modification patterns actually occur in vivo (Kurdistani et al., 2004; Schübeler et
al., 2004; Bernstein et al., 2005). Smaller-scale experiments have also found some of the
relationships and rules that dictate the histone code. For example, not all histone modifications
make unique contributions, and the addition of some histone modifications is dependent on
others. In yeast, mutagenesis studies of the lysine residues on the tail of histone H4 revealed two
apparently independent histone acetylation mechanisms (Dion et al., 2005). Acetylation on three
of the four H4 lysine residues (H4K5, H4K8, and H4K12) acted as a cumulative mark; the number
of acetylated lysines, but not the identity, led to higher levels of transcription of one set of genes.
On the other hand, H4K16 acetylation functioned separately, regulating an entirely different
transcriptional program than the other three acetyl marks.
Biochemical evidence indicates that causal relationships exist between histone
modifications, and that they are not made independently. Some evidence from yeast (Liu et al.,
2005) and Drosophila (Schübeler et al., 2004) indicates that only a limited number of histone
modification combinations may occur. Many histone-modifying enzymes occur together in large
regulatory complexes, which may facilitate the co-occurrence of some histone marks. The
interdependence of histone modifications could also result in them being “written” in a particular
order or as part of a group, leading to a characteristic pattern of modifications and transcriptional
outcomes. Epigenomic data from S. cerevisiae has been scrutinized for evidence of such
relationships, and multiple causal combinations of histone acetylation and histone methylation
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have been reported (Cui et al., 2011), specifically associated with both high and low levels of
transcription.

Interplay between histone modifications has also been implicated in memory

formation (Wood et al., 2006b). Investigators have observed that contextual fear conditioning
induces concurrent phosphorylation (at S10) and acetylation (K14) of histone H3 (Chwang et al.,
2006), a combination of modifications associated with transcriptional activation. There is some
evidence that histone acetylation and phosphorylation are coupled (Cheung et al., 2000), with
H3S10 phosphorylation acting to recruit an enzyme that is able to acetylate H3K14 (Brownell et
al., 1996; Lo et al., 2000). It is hypothesized that the combined phospho-acetylation of histone H3
could be part of a histone modification state that regulates the gene expression required for
memory formation (Chwang et al., 2006; Wood et al., 2006b). It is very likely that more of these
causal histone modification interactions are waiting to be discovered, both within and between
nucleosomes. These results should not be interpreted as a truly “simple” histone code, however.
The ultimate effects of a histone modification are dependent on time and context, as well as the
identity of the writers, erasers, and readers involved. Future studies must account for these
variables to fully understand the sometimes contradictory effects of histone crosstalk (Lee et al.,
2010).
1.5.2. Other Epigenetic Mechanisms. Epigenetic modifications extend beyond histone
modifications to include DNA methylation, chromatin remodeling and deposition of variant histone
proteins, RNA-mediated regulation, and even protein conformational changes (see Fig. 1.4). All
of these processes contribute to epigenetic regulation in mature eukaryotic cells, operating in
concert with post-translational histone modifications. There are well-documented links between
histone modification and DNA methylation, an epigenetic modification associated with
transcriptional silencing. Many of genes related to learning and plasticity have transcription start
sites that are located within CpG islands, the substrate for DNA methylation (Sultan and Day,
2011). Memory formation is accompanied by bidirectional changes in DNA methylation (Miller and
Sweatt, 2007). Inhibition of DNA methylation impairs memory, but these deficits can be
counteracted by inhibition of histone deacetylase enzymes, leading to histone hyperacetylation
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(Miller et al., 2008). Conversely, DNA methyltransferase inhibition in hippocampal slices blocks
histone acetylation following the induction of long-term potentiation(Miller et al., 2008). Work from
the lab of Michael Meaney at McGill University has demonstrated that maternal care influences
response to stress in offspring, and that such maternal behaviors are transmitted across
generations in female pups (Francis et al., 1999). The transmission of these behaviors and
manifestation of altered adult stress behavior have been attributed to epigenetic programming
due to the style of maternal care, and differences in DNA methylation and histone acetylation
have been observed at relevant genes in the hippocampus. The epigenetic changes are stable
enough to be passed to future generations, but still labile and responsive to pharmacological
manipulation in adulthood, as the differences in DNA methylation and stress response can be
reversed in by treatment with a drug that alters histone acetylation (Weaver et al., 2004, 2006).
These experiments provide evidence of the close relationships between histone modification and
other epigenetic mechanisms, and show that even extremely stable changes like CpG
methylation can be dynamically altered in adult neurons by intervention through histone-modifying
pathways.
Histone variants provide another means by which cells may alter their transcriptional
activity. In eukaryotes, histone H3 variants (differing only by a few amino acids) serve distinct
functions at certain developmental timepoints and at certain sites within chromosomes. In the
postmitotic cells of the central nervous system, the variant histone H3.3 is of particular interest
because it is deposited at nucleosomes independently of DNA replication (Ahmad and Henikoff,
2002). H3.3 tends to be found at active genes, both within the genes and after the transcription
end site (Henikoff, 2009; Goldberg et al., 2010), which may link it to control of activity-dependent
transcription in neurons. It is also enriched at transcription factor binding sites throughout the
genome (Henikoff, 2008). It is hypothesized that histone H3.3 may serve to define the boundary
of active transcription, possibly by limiting the spread of histone modifications via its replicationindependent deposition. At transcription factor binding elements this deposition could act to
maintain those sites in a more open state (Henikoff, 2008). Another variant histone, H2A.Z, has
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been linked to both activation and inactivation of transcription. Nucleosomes that contain both of
the variant histones H3.3 and H2A.Z are particularly unstable, which may be part of their utility;
the unstable H3.3/H2A.Z nucleosomes are enriched at transcriptionally active and highlyexpressed genes (Jin and Felsenfeld, 2007; Jin et al., 2009), and are observed at “nucleosomefree” regions of DNA. Easily displaced from the DNA by transcription factor binding, the
deposition and subsequent turnover of H3.3/H2A.Z nucleosomes could prevent more stable
nucleosomes from depositing while maintaining actively-transcribed DNA in an accessible,
relatively nucleosome-free state.
1.5.3. Summary. I have briefly reviewed the variety of histone modifications that could be acting
in the central nervous system, as well as some of the interacting mechanisms that contribute to
the epigenetic landscape. This information does not so much paint a picture of the current state of
knowledge as it does describe the possible future of research into the brain’s histone code. Most
of our epigenetic knowledge has been acquired from cultured eukaryotic cells, yeast, Drosophila,
and non-neuronal mammalian cells, rather than neurons. It is now understood that cells utilize
epigenetic mechanisms in their response to external stimuli. These mechanisms, especially
histone modification, can be rapidly made and are stable enough to mediate long-term changes in
the transcriptome. However, the histone language is complicated and dynamic, making it wellsuited to the needs of cells like neurons that must receive thousands of inputs. The complex
crosstalk of histone modifications at plasticity-related genes offers a system that can integrate
such input and produce the appropriate pattern of gene expression in response. Research into
the neural histone code has focused primarily on the best-characterized histone modifications
(acetylation, phosphorylation, and methylation), and accordingly this chapter will provide an
overview of many of the central nervous system functions that are influenced, controlled, or
regulated by this epigenetic language.
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1.6. The Histone Code in Learning, Memory, & Synaptic Plasticity.
Gene transcription and de novo protein synthesis are required for the formation of longlasting memories (Agranoff et al., 1967; Flood et al., 1973). These requirements are shared by
long-lasting forms of long-term potentiation, an activity-dependent change in synaptic strength
that is viewed as a cellular and molecular correlate of learning (Nguyen et al., 1994; Huang et al.,
1996). The histone code, posited to be an epigenetic network responsible for much of the
transcriptional flexibility demonstrated by our cells, sits poised to regulate both the long- and
short-term changes in chromatin environment and gene expression patterns that support memory
consolidation. Over the past decade, epigenetics research has shown us that chromatin
modifications are required for memory acquisition and synaptic plasticity in many areas of the
brain including the cortex, hippocampus, striatum, and amygdale (see Fig. 1.5). Only a few of
these histone marks have been studied in the context of memory formation; most of the work to
date has focused on histone tail acetylation, phosphorylation, and methylation. In the next section
these modifications and their involvement in memory and plasticity are our focus.
1.6.1. Histone Acetylation.

Histone acetylation is the best studied of the chromatin

modifications that have been linked learning and memory (Peixoto and Abel, 2013). This makes
sense, as histone acetylation is associated with active transcription (Hebbes and Thorne, 1988),
and the active transcription of a subset of genes is necessary for both memory formation and
long-term changes in synaptic plasticity (Tischmeyer and Grimm, 1999; Loebrich and Nedivi,
2009). Schmitt and Matthies (Schmitt and Matthies, 1979) were the first to demonstrate changes
in acetylation in the brain after learning. Using radiolabelled acetate, they showed that histone
acetylation after behavioral training was upregulated in the hippocampus, but downregulated in
other brain regions. It took a little over two decades for histone acetylation to get another look,
this time in the classic invertebrate model of learning Aplysia californica (Guan et al., 2002) where
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long-term facilitation of synaptic strength in response to administration of 5-HT increased the
acetylation of histone H3 and histone H4.
Over the past decade, histone acetylation has been repeatedly connected to learning and
plasticity in both invertebrate and mammalian model systems, and it is now known to be a vital
mechanism underlying both memory consolidation (Bourtchouladze et al., 2003; Alarcón et al.,
2004; Korzus et al., 2004; Levenson et al., 2004; Vecsey et al., 2007) and long-term potentiation
(Levenson et al., 2004; Vecsey et al., 2007). The changes in histone acetylation that accompany
learning occur rapidly, peaking at approximately 60 minutes post-training. However, these global
changes in histone acetylation are relatively transient and return to baseline levels by 24 hours
post-training (Levenson et al., 2004). The time course of these changes in histone acetylation
dovetails very well with their proposed role in transcription of memory-related genes, occurring on
the same timescale as the intial wave of transcription that facilitates memory consolidation and
LTP (Squire and Barondes, 1970; Tischmeyer and Grimm, 1999; Igaz et al., 2002; Duvarci et al.,
2008; Katche et al., 2010).
What are the specific histone acetylation marks that interact with the processes of
memory consolidation and plasticity? In Aplysia, long-term facilitation is associated with
acetylation of histone H3K14 and histone H4K8 (Guan et al., 2002). The findings in rodent
models are more varied. For example, contextual fear conditioning increases histone H3, but not
histone H4, acetylation in hippocampal area CA1, while latent inhibition training has the opposite
outcome (Levenson et al., 2004). Fear conditioning also increases the expression of homer1
mRNA in the hippocampus, which is accompanied by increased histone H3 acetylation at the
homer1 promoter with no change in acetylation of histone H4 (Mahan et al., 2012). A study on
aging and memory found that in young mice, fear conditioning increased acetylation at H3 (K9
and K14) and H4 (K5, K8, and K12), while old mice had memory impairments and were deficient
in H4K12 acetylation (Peleg et al., 2010). Morris water maze training increases acetylation of H3
(K9 and K14), H4 (K12), and H2B, but the acetylation of H3 was also found in a visual-platform
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version of this task, indicating that H3 acetylation could be involved in more passive spatial
learning (Bousiges et al., 2010); another study found that water maze training increases H3K18
acetylation (Engmann et al., 2011). Mice with a deletion of the histone deacetylase enzyme
HDAC2 had enhanced memory and synaptic plasticity, and increased H4K5 and H4K12
acetylation (Guan et al., 2009). In hippocampal slices, the induction of LTP by forskolin
stimulation increased H3K14 acetylation (Chwang et al., 2007). It is clear that different training
paradigms have revealed that specific patterns of histone acetylation are associated with specific
forms of memory and plasticity, but acetylation of histone H3 or histone H4 lysine residues are
the most commonly reported modifications.
Acetyl groups are added to histone tail lysine residues by the histone acetyltransferase
(HAT) enzymes. CREB-binding protein, CBP, is a transcriptional co-activator with intrinsic HAT
activity. CBP binds CREB, a transcription factor that is a well-known mediator of transcription of
memory-related genes (Pittenger et al., 2002; Sakamoto et al., 2011). Many groups have used
genetic tools to dissect out the role of CBP in memory, and we now understand that both the HAT
activity (Korzus et al., 2004) and CREB-binding activity (Wood et al., 2006a) of CBP are important
for long-term memory formation and late-phase LTP. HDAC inhibition can rescue memory deficits
in some strains of CBP mutant mice (Alarcón et al., 2004; Korzus et al., 2004), but the
enhancement of memory and plasticity by HDAC inhibition requires CREB and the interaction of
CBP with CREB (Vecsey et al., 2007; Haettig et al., 2011), which implicates CREB-mediated
genes as targets of regulation by histone modification in memory. The closely related HATs p300
and PCAF have also been implicated in learning and memory, though their precise roles and the
targets of their acetyltransferase activity seem to differ from those of CBP (Oliveira et al., 2007,
2011; Maurice et al., 2008; Duclot et al., 2010)
The histone deacetylase (HDAC) enzymes are responsible for the removal of acetyl
groups from histone tails, acting in opposition to the HATs. There are currently 18 identified
HDAC enzymes, divided into four different classes based on sequence and structure. In the
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mammalian CNS, the class I enzymes (HDAC1, HDAC2, HDAC3, and HDAC8) are the most
active in regulating memory formation, whereas others are involved in different plastic processes
such as stress, depression, and addiction (Ferland and Schrader, 2011). The supporting
evidence is both pharmacological and genetic. Overexpression of HDAC2 results in impaired
long-term memory and hippocampal LTP, while knocking it out has the inverse effect.
Overexpression of HDAC1 does not produce any differences in learning or plasticity, indicating
that HDAC2, but not HDAC1, is particularly important for memory (Guan et al., 2009). In mice,
conditional deletion of HDAC3 in the dorsal hippocampus enhances long-term contextual fear
memory (McQuown et al., 2011), an effect which is phenocopied by specific pharmacological
inhibition of HDAC3. Intrahippocampal infusion of the class I-specific HDAC inhibitor MS-275
enhances long-term memory for object location; MS-275 preferentially inhibits HDAC1 and
HDAC2 over HDAC3 and HDAC8, which supports the importance of HDAC2 in memory (Hawk et
al., 2011). The HDAC enzymes do not bind to DNA directly, but function as parts of large, multisubunit repressor complexes (Sengupta and Seto, 2004). HDAC1 and HDAC2 can be found as
part of the Sin3a, NurD, and Co-REST repressor complexes, while HDAC3 is found with the corepressors N-CoR and SMRT. Additionally, the Sin3a co-repressor complex interacts with both
SMRT and N-CoR, so HDAC2 and HDAC3 may be found at promoters together or separately,
adding another layer of complexity and specificity to the regulation of histone modification (Jones
et al., 2001). It still remains to be seen where and when the various co-repressor complexes are
localized, and exactly what recruits them. A large number of transcription-regulating factors have
been identified that could interact with and recruit repressive deacetylase activity, making the
puzzle of these upstream regulators of histone acetylation even more interesting and
complicated.
Small-molecule histone deacetylase inhibitors are now widely available, and have been
used in many experimental systems. These drugs belong to a variety of chemical families and
boast various degrees of specificity in which HDAC enzymes they target (Bolden et al., 2006).
The experiments performed in Aplysia found that treatment with trichostatin-A (TSA) enhanced
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long-term facilitation (Guan et al., 2002). In rodents, TSA and another HDAC inhibitor, sodium
butyrate (NaB), enhance LTP in ex vivo hippocampal slices (Levenson et al., 2004; Vecsey et al.,
2007) and memory formation in vivo following systemic administration (Levenson et al., 2004).
Infusion of TSA directly into the hippocampus also enhances contextual fear memory, but not
short-term memory or hippocampal-independent cued fear (Vecsey et al., 2007). The memoryenhancing effects of HDAC inhibitors are not limited to contextual and spatial memory, which tells
us that HDAC inhibition cab facilitate histone hyperacetylation in plastic processes outside of the
hippocampus. For example, the infusion of an HDAC inhibitor directly into the lateral amygdala
enhances the memory for the tone-footshock association of cued fear conditioning, and LTP at
amygdalar synapses is also enhanced by HDAC inhibition (Monsey et al., 2011).
Memory processes besides acquisition and consolidation are also influenced by histone
acetylation. Reconsolidation, the phenomenon of a consolidated memory becoming temporarily
labile when it is recalled, involves many of the same molecular mechanisms as the initial
consolidation, and extinction, which is the weakening of a previously-learned association, share
many behavioral and biochemical mechanisms with memory acquisition (Debiec et al., 2002;
Lattal et al., 2006; Alberini, 2008; Kaplan and Moore, 2011; Stafford and Lattal, 2011). The frontal
cortex plays a major part in extinction processes, and it has been reported that systemic
treatment with the HDAC inhibitor valproic acid (VPA) enhances extinction of conditioned fear by
increasing acetylation of bdnf promoter regions P1 and P4 (and thus increasing expression of
BDNF exon IV) in the prefrontal cortex (Bredy et al., 2007). Researchers also found that VPA
administration facilitates both the reconsolidation and the extinction of a conditioned fear memory,
depending upon the conditions of memory retrieval (Bredy and Barad, 2008). The hippocampus
also plays a role in extinction learning, demonstrated by the enhanced extinction of fear memory
that results from intrahippocampal injection of the HDAC inhibitor TSA before memory retrieval
(Lattal et al., 2007). The extinction of cued fear memory, which is amygdala-dependent, is also
enhanced by a single treatment with sodium butyrate (Itzhak et al., 2012).
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Although highly specific agents are currently under development and have seen some
limited experimental use (Simonini et al., 2006; Engmann et al., 2011; Hawk et al., 2011;
McQuown et al., 2011), most of the commonly-used HDAC inhibitors (TSA, VPA, SAHA, NaB)
affect a broad range of HDAC enzymes (Bolden et al., 2006). It cannot always be certain if the
effects of HDAC inhibition are attributable to altered acetylation of histone or non-histone proteins
(Yeh et al., 2004); these drugs are powerful tools in the investigator’s arsenal, but they tend to be
sledgehammers rather than fine scalpels. The use of HDAC inhibitors has provided powerful
evidence that histone acetylation plays a pivotal role in normal processes of memory and
plasticity. They have also shown us that HDAC enzymes are act to negatively regulate memory,
as learning and plasticity are both enhanced by their inhibition.
The multi-factor, multi-layered regulation of histone acetylation in molecular memory
processes does present difficulties for research, and great effort will be required to dissect the
mechanisms that enable the precise, opposing activites of HAT and HDAC complexes. This
complication does present a large number of potential targets for pharmacological and genetic
manipulation, waiting to be exploited by experimenters. Other histone-modifying enzymes,
involved in phosphorylation and methylation and implicated in memory, are being found to
interact with the HAT- and HDAC-containing complexes. Histone acetylation is important, but
when it comes to memory it is far from the only game in town. Investigation of the details of
histone acetylation, together with the combined action and cross-talk with complexed histone
methyltransferases and histone kinases, will provide avenues of investigation for years to come.
1.6.2. Histone Phosphorylation. Histone phosphorylation plays a role in the transcriptional
programs triggered by external stimuli (Crosio et al., 2000, 2003) in many cellular systems,
including the central nervous system. Like histone acetylation it has been associated with active
gene transcription, but histone phosphorylation is not yet as well-characterized. The enzymes
responsible for writing this mark are the histone kinases, which add phosphate groups to serine,
threonine, and tyrosine residues on histone tails, mostly on histone H3. Only 8 of these marks
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have been fully characterized in S. cerevisiae (Berger, 2010). While there are many kinases that
are capable of modifying histones, few of them have been linked to histone phosphorylation in
neurons (Bode and Dong, 2005; Zippo et al., 2007; Berger, 2010). Cell culture experiments
provided the initial clues that would connect histone phosphorylation with memory; in vitro, the
ERK/MAPK intracellular signaling cascade, which is essential for the formation of associative
memories (Atkins et al., 1998), has been placed upstream of histone H3 phosphorylation through
the phosphorylation and activation of the kinases MSK1 and MSK2 (Soloaga et al., 2003).
Investigators were interested in determining if histone phosphorylation, with its links to
the MAPK signaling pathway and transcriptional activation, is important for memory and synaptic
plasticity. Both in vivo and ex vivo experiments have found correlations between histone
phosphorylation and memory processes. In hippocampal slice preparations, pharmacological
activation of the ERK pathway through either of the kinases PKC or PKA significantly increases
both H3S10 phosphorylation and H3K14 acetylation, as well as concurrent H3 phosphoacetylation – a reminder of the combinatorial nature of the histone code (Chwang et al., 2006).
Moving in vivo, the same histone modifications, along with levels of phosphorylated, active ERK,
peaked at 60 minutes after contextual fear conditioning. This observation corresponds to the
observed peaks in histone acetylation and the initial wave of transcription that follows neuronal
activation or memory induction.
The ability to add and remove phosphate groups to histone proteins in neurons has so far
only been demonstrated for two enzymes, the kinase MSK1 (mitogen- and stress-activated
kinase 1) and the phosphatase PP1 (protein phosphatase 1). In mice, knockout of MSK1 impairs
memory for contextual fear and attenuates both the H3 acetylation and phosphorylation that are
usually found after learning (Chwang et al., 2007). MSK1 and histone phosphorylation are thus
connected to memory, but it should be kept in mind that MSK1, like many other histone-modifying
enzymes, also has non-histone targets in the nucleus such as CREB and NFκB (Arthur, 2008).
PP1 is known to dephosphorylate histone H3, and it is also known to interact with HDAC
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enzymes and to affect their activity (Brush et al., 2004). Overexpression of PP1 attenuates
H3K14 and H4K5 acetylation, whereas inhibition of nuclear PP1 also decreases HDAC activity,
increases H4K5 and H2B acetylation, and enhances object recognition memory (Koshibu et al.,
2009).
Although there is evidence for the co-dependence of acetylation and phosphorylation of
histone H3 (Cheung et al., 2000; Lo et al., 2000; Chwang et al., 2006), some conflicting reports
provide evidence that acetylation and phosphorylation are targeted to histone H3 through
independent mechanisms (Thomson et al., 2001), and the observed H3 phospho-acetylation
could be a matter of coincidence rather than coordinated action. Even with independent targeting
and writing mechanisms in some systems, phosphorylation may still be involved in crosstalk with
histone acetyl marks in the brain (Wood et al., 2006b; Banerjee and Chakravarti, 2011). On its
own or in combination with histone acetylation, histone phosphorylation merits further inquiry as
part of the histone code of the central nervous system.
1.6.3. Histone Methylation. Histone methylation is the third major histone modification implicated
in memory and CNS function, and it is potentially a much more complicated phenomenon due to
its diversity. Methylation of histone tails occurs at both lysine and arginine residues, and in three
different possible variations -- monomethylated, dimethylated, and trimethylated. These
combinations can have different effects on chromatin structure and transcriptional activity
(Berger, 2007; Kouzarides, 2007; Ng et al., 2009), and histone methylation is known to play both
repressive and facilitative roles in transcription (Berger, 2007). Methylation was once considered
to be a stable, maybe irreversible modification, and the rate of turnover for histone methyl marks
is much slower than that of histone acetylation (Ng et al., 2009). However, the discovery of
several enzymes that are able to reverse arginine and lysine methylation has revealed that
histone methylation is in fact dynamically regulated (Ng et al., 2009; Bannister and Kouzarides,
2011).
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Gupta and colleagues (Gupta et al., 2010) were the first to investigate the role of histone
methylation in hippocampus-dependent memory. They found that contextual fear conditioning
increased trimethylation of H3K4, a chromatin modification associated with active transcription.
This increase in permissive histone methylation was observed at the promoter regions of the
immediate-early gene zif268 and the neuronal growth factor bdnf, both of which have established
roles in memory formation (Loebrich and Nedivi, 2009). Much like the acetylation of histone H3,
which can occur in response to exposure to a novel environment (Bousiges et al., 2010),
behavioral training is not required for changes in histone methylation to occur. When Gupta et al.
placed mice in a novel context, H3K9 dimethylation was increased 60 minutes later independent
of footshock delivery, indicating the this change in methylation is involved spatial, not associative,
learning (Gupta et al., 2010). Interestingly, 24

hours after context exposure, when histone

acetylation induced by learning has been reduced to baseline levels, the dimethylation of H3K9
dipped to levels below those seen at baseline,the first report of a memory-related change in
histone modification persisting beyond the initial consolidation phase (Gupta et al., 2010).
Several of the enzymes that mediate histone methylation in the central nervous system
have been identified. Trimethylation of H3K4, an activating mark, is specifically handled by the
histone methyltransferase (HMT) enzyme MLL, and deletion of the Mll gene leads to deficits in
long-term memory for contextual fear (Gupta et al., 2010). The HMT enzyme Setdb1 (also known
as Eset) catalyzes the dimethylation of H3K9, and represses expression of the NMDA receptor
subunit NR2B (Jiang et al., 2010). The related enzymes GLP and G9a, which form a complex
together and catalyze the repressive di- and trimethylation of H3K9, have also been linked to
behavior and cognition (Ding et al., 2008). These HMTs are involved in repression of lineagespecific genes in the central nervous system, and postnatal knockdown of GLP in the forebrain
results in a number of behavioral abnormalities including memory deficits for cued and contextual
fear (Schaefer et al., 2009). Pharmacological inhibition of GLP/G9a in the entorhinal cortex
enhances both the consolidation and the extinction of fear memory, while the same manipulation
of GLP/G9a in hippocampal area CA1 impairs long-term contextual fear memory (Gupta-Agarwal
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et al., 2012). Corresponding effects on synaptic plasticity were observed ex vivo in brain slices.
Long-term LTP at the CA3-CA1 Schaffer collaterals was blocked by GLP/G9a inhibition, but at
the synapses of the temporoammonic pathway (from the entorhinal cortex to hippocampal CA1)
GLP/G9a inhibition had no effect on LTP (Gupta-Agarwal et al., 2012).
For some time, histone methylation was thought of as a more-or-less permanent histone
modification. That view has changed with the discovery of multiple histone demethylase (HDM)
enzymes in the past decade. HDM enzymes capable of targeting methylated lysine (KDM1/LSD1,
JMJD2) and arginine (JMJD6) at all methylation states have been identified (Ng et al., 2009;
Bannister and Kouzarides, 2011), but little is known of their role in the central nervous system.
Some interesting evidence has come from human genetic studies, however, where mutation in
the H3K4 demethylase KDM5 has been linked to an intellectual disability phenotype (SantosRebouças et al., 2011).
Some connections have been made between the roles of histone acetylation and
methylation in memory. Systemic administration of the HDAC inhibitor NaB before fear
conditioning enhances long-term memory and increases histone acetylation, and is accompanied
by a decrease in repressive H3K9 dimethylation (Gupta et al., 2010). Furthermore, memory
enhancement induced by GLP/G9a inhibition is not only accompanied by H3 methylation
changes, but also by increased H3K9 acetylation (Gupta-Agarwal et al., 2012). The activation and
repression complexes that regulate histone acetylation in plastic processes are also linked with
histone methylation enzymes, though these links have not been explored in memory-formation
experiments. The histone methyltransferase MLL associates with the histone acetyltransferase
CBP as well as HDAC1 and HDAC2 (Xia et al., 2003), while Setdb1 can interact with the corepressor complex mediated by Sin3a (Yang et al., 2003). The cross-talk and interdependence
between different histone modifications remains largely unexplored, and investigating these
relationships will prove crucial to our understanding of neuronal plasticity.
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1.7. The Histone Code in Neurological and Neuropsychiatric Disorders
The previous sections of this chapter illustrated the role of histone modifications in the
processes that underlie our ability to learn and adapt to our environments. Epigenetic
mechanisms enable neurons to tightly regulate gene expression, allowing the brain to respond to
external events, forming new associations and memories. These findings have prompted
speculation that we could enhance our cognitive abilities through careful pharmacological
manipulation of the writers, erasers, and readers of histone modifications. Conversely,
dysregulation of histone modifications contributes to many neurodevelopmental and psychiatric
disorders (see Fig. 1.6). Developmental disorders that result from mutation in the histonemodifying machinery are rare, but when they do occur they can lead to severe intellectual
disability. In other cases, changes in histone modifications may be connected with widespread
alterations in gene expression patterns that underlie serious, chronic behavioral and mood
disorders. In such instances, the pharmacological interventions described above may provide
therapeutic opportunities to ameliorate these conditions.
1.7.1. Rubinstein-Taybi Syndrome. Rubinstein-Taybi Syndrome, or RTS, is often referenced in
the histone acetylation literature. Named for the authors of the 1963 paper that first described this
syndrome (Rubinstein and Taybi, 1963), Rubinstein-Taybi is a developmental disorder that is
characterized by skeletal abnormalities, impaired growth, and intellectual disability (which, though
usually profound, can vary widely in its severity). Approximately 1 out of every 125,000 births is
affected by RTS. The genetic underpinnings of RTS are generally understood, based on evidence
gathered from human patients and studies of genetically-modified mouse models. Most instances
of RTS can be traced to dysfunction of the transcriptional co-activator and histone
acetyltransferase CBP (Petrij et al., 1995; Blough et al., 2000), attributable to a number of
mutations in the gene encoding the CBP protein (CREBBP in humans, cbp in rodents). More
recent data has also implicated similar mutations in the gene encoding p300 (a HAT closely
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related to CBP) as a cause of Rubinstein-Taybi syndrome (Roelfsema et al., 2005; Viosca et al.,
2010; Tsai et al., 2011).
Most of our knowledge of the molecular and genetic basis of RTS comes from research
performed in mouse models of the disease, and they tend to follow one of two distinct
approaches in studying the syndrome. The first is the haploinsufficiency model, in which two
functional copies of CREBBP are necessary for normal development and function (Petrij et al.,
1995). These studies have used null mutations of one copy of the cbp allele, either globally or in a
restricted fashion, to reduce the expression of CBP protein (Tanaka et al., 1997; Alarcón et al.,
2004). The other model typically proposes a dominant-negative effect of altered CBP protein
produced by CREBBP mutation (Parker et al., 1996; Oike et al., 1999). Experimenters have also
used a number of cbp mutant lines expressing truncated CBP protein (Oike et al., 1999;
Bourtchouladze et al., 2003) or proteins with point mutations disrupting transcription-factor
binding or enzymatic activity (Korzus et al., 2004; Wood et al., 2006a) to produce a dominantnegative CBP protein.
The first attempts at modeling RTS used global manipulation of cbp. Mice without a
functioning cbp allele died early during development (Tanaka et al., 2000). However,
+/-

heterozygous CBP

mutants with just one functional allele of cbp were viable. These mice

expressed CBP protein at levels half that of wild-type animals and displayed physiological
characteristics that resembled RTS in humans (Tanaka et al., 1997). Behavioral and
electrophysiological phenotyping of these CBP

+/-

mice did not occur until years later, when

Alarcón and colleagues (Alarcón et al., 2004) found that the reduction in CBP protein was
accompanied by impaired long-term memory for contextual fear and novel object recognition, but
not spatial navigation memory, as well as impairments in the late phase of hippocampal LTP.
Truncated and modified forms of CBP also produce deficits in long-term memory and
synaptic plasticity (Oike et al., 1999; Bourtchouladze et al., 2003; Korzus et al., 2004; Wood et al.,
2006a). A different line of CBP mutant mice, with one wild-type cbp allele and one producing a
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truncated CBP protein lacking the HAT domain and C-terminus, displayed long-term memory
deficits in cued fear conditioning and a step-through passive avoidance task (Oike et al., 1999).
The memory impairment caused by truncated CBP was not limited to fear memory, as later
experiments with the same truncated CBP mutants also found long-term memory deficits in novel
object recognition (Bourtchouladze et al., 2003). Transgenic expression of a similar truncated
CBP protein in forebrain neurons impaired LTP induced by pairing tetanic stimulation with D1
dopamine receptor activation. Expression of the CBP transgene also impaired spatial memory
and contextual, but not cued, fear memory (Wood et al., 2005).
These experiments revealed an important role for CBP in memory formation, but did not
demonstrate which of its functions were responsible for the memory deficits and RTS-like
symptoms. To specifically investigate the role of the HAT activity of CBP, experimenters
generated a line of mice expressing a dominant-negative CBP transgene carrying two point
mutations in the HAT domain that blocked the acetyltransferase activity of CBP but did not affect
any of its protein-protein interaction domains (Korzus et al., 2004). Disruption of the HAT activity
of CBP impaired long-term object and spatial memory, but not short-term memory (Korzus et al.,
2004). In addition to its HAT activity, CBP acts as co-activator of the transcription factor CREB,
binding to the KID domain of phosphorylated CREB via its KIX domain (Parker et al., 1996).
Mutation of the CBP KIX domain disrupts CREB binding but leaves the HAT activity of CBP intact
(Kasper et al., 2002), and this mutation impairs memory for contextual fear and novel object
recognition without affecting cued fear memory (Wood et al., 2006a). Thus there are at least two
distinct roles for CBP in memory, one depending on the CREB/CBP interaction and the other on
the enzymatic HAT activity of CBP (see Fig. 1.6B).
+/-

RTS-like symptoms can be linked with deficits in histone acetylation. Null-allele CBP

mice have significantly diminished histone H2B acetylation levels (Alarcón et al., 2004). More
recent studies have further characterized the acetylation deficits in CBP mutants, with reductions
in H3K14, H4K8, and H2BK12 observed following focal knockout of CBP in the hippocampus
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(Barrett et al., 2011). These particular H3 and H4 acetyl marks have established links to active
transcription (Pokholok et al., 2005) and memory (Bousiges et al., 2010; Peleg et al., 2010), and
evidence supports a similar role for acetylation of H2B (Myers et al., 2003). HDAC inhibitors can
rescue RTS-like phenotypes in some cbp mutant animals. This finding is encouraging for the
development of new pharmacological interventions (Alarcón et al., 2004; Korzus et al., 2004).
Further understanding of how dysregulation of histone acetylation leads to Rubinstein-Taybi will
provide opportunities to develop targeted therapies for the amelioration of this syndrome.
1.7.2. ATR-X Syndrome. While Rubinstein-Taybi syndrome disrupts histone acetylation, there
are disorders that arise from dysregulation of other histone modifications such as histone
methylation. The syndrome known as ATR-X (α-thalassemia/mental retardation, X-linked) is a
rare congenital neurodevelopmental disorder presenting with skeletal abnormalities, characteristic
facial features, small stature, foot, hand, and genital abnormalities, and severe intellectual and
verbal impairment (Gibbons et al., 1995; McPherson et al., 1995; Ausió et al., 2003). Being an Xlinked syndrome, ATR-X usually occurs in males.
The locus of the disorder on the X chromosome has been identified in the ATRX gene.
ATRX encodes the nuclear protein ATRX, (also known as X-linked helicase-2 or XH2) a member
of the SNF2 chromatin remodeling family (Gibbons et al., 2008). The ATRX protein C-terminus
contains an ATP-dependent chromatin-remodeling domain, while the N-terminus contains a plant
homeodomain (PHD)-like zinc-finger domain (known as the ADD or ADDATRX domain). These
PHD domains are known to bind to methylated histones, and facilitate interaction with methylated
histone H3 (Gibbons et al., 2008; Ng et al., 2009). ATRX is localized to pericentric
heterochromatin, where it interacts with the methyl-DNA binding protein MeCP2 and the protein
HP1α (Lechner et al., 2005), part of a repressor complex that includes the repressive histone
methyltransferase Setdb1 (Loyola et al., 2009).
ATR-X syndrome was only recently identified as a disorder stemming from disruption of a
histone modification mechanism. Mutations of the ATRX gene are responsible for ATR-X
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syndrome (Gibbons, 2006), and usually occur in two distinct regions of the gene. Missense
mutations in the C-terminal ATP-dependent chromatin remodeling domain disrupt the enzymatic
helicase remodeling action of ATRX, which can have a devastating effect on neuronal
development. While nearly half of ATR-X-associated missense mutations occur in the N-terminus
ADDATRX domain of ATRX, the function of this atypical PHD domain was unknown until very
recently (Gibbons et al., 2008; Dhayalan et al., 2011), when it was determined that the ADDATRX
domain acts as a histone H3-binding module and contains a structurally unique H3K9 trimethyl
binding pocket (Iwase et al., 2011). Binding of ADDATRX to histone H3 is promoted by
trimethylation of H3K9, a repressive chromatin mark, but inhibited by the simultaneous presence
of di- or trimethylated H3K4, a histone modification characteristic of active transcription (Dhayalan
et al., 2011; Iwase et al., 2011). This revealed that ATRX acts as a reader of the combined
methylation states of K4 and K9 on histone H3, preferentially binding to the repressive,
trimethylated H3K9 characteristic of heterochromatin in the absence of methylated H3K4.
The implications of these studies are important, because the cases of ATR-X syndrome
caused by mutation of the ADD domain have been reported to be more severe than those
attributed to missense mutation of the C-terminus helicase portion of the protein (Badens et al.,
2006; Gibbons et al., 2008; Dhayalan et al., 2011). A proposed model of ATR-X syndrome
focuses on the role of the ADDATRX domain in reading the methylation state of histone H3 (Iwase
et al., 2011). Researchers found that mutating the ADDATRX domain disrupts H3K9 binding,
prevents localization of ATRX to pericentric heterochromatin, and reduces ATRX protein stability
(Dhayalan et al., 2011; Iwase et al., 2011). The loss of ATRX at pericentric chromatin could result
in reduced disruption in heterochromatin structure and defects in chromosome segregation,
leading to the death of neural progenitor cells (Fig. 1.6A) (Iwase et al., 2011).
1.7.3. Addiction. Drug addiction – as opposed to drug use – is a chronic behavioral disorder in
which individuals exhibit pathological drug-seeking and drug-taking behavior despite the severe
negative outcomes of those behaviors (Hyman et al., 2006; Koob and Kreek, 2007). It is thought
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that there is some element of genetic predisposition in the development of addiction, but
environmental factors probably account for a large part of the susceptibility to addiction (Maze
and Nestler, 2011). The search to explain the biological mechanisms that underlie these factors is
a major endeavor in the biomedical research community.
The behavioral patterns that develop from drug addiction are very persistent and resistant
to extinction. These changes are thus hypothesized to be supported by drug-induced, long-term
alterations in gene expression, and epigenetic mechanisms may be involved in such stable
changes transcription. The brain regions involved in addiction include the reward pathways of the
nucleus accumbens, the limbic system, the hippocampus, and the prefrontal cortex. Drug
exposure induces neuronal plasticity, through many of the same signaling pathways that are
important for learning and memory in the hippocampus and amygdala, and activating many of the
very same transcription factors and immediate early genes that are known to be regulated by
histone modification.
Acute and chronic drug exposures have different effects on gene expression and histone
modification. Acute exposure to drugs of abuse tends to result in short, transient changes in
chromatin modification and gene expression. The acute administration of cocaine (the most
commonly used drug in animal models of addiction, though substances like alcohol and
amphetamines are also well-studied) briefly increases histone H4 acetylation in the nucleus
accumbens at the promoters of the plasticity-related immediate-early genes cFos and FosB
(Kumar et al., 2005). Chronic drug exposure results in correspondingly long-lasting changes in
gene expression and chromatin modification at a much larger scale, especially in the nucleus
accumbens. Chronic exposure to cocaine leads to persistent upregulation of a set of plasticityrelated genes including bdnf and cdk5 (Bibb et al., 2001; Grimm et al., 2003), and
hyperacetylation of histone H3 at the promoters of these genes persists in the nucleus
accumbens for as long as one week after repeated cocaine exposure (Kumar et al., 2005). Taken
together, the evidence indicates that cocaine exposure facilitates plasticity via histone
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hyperacetylation in the nucleus accumbens, possibly mediated by a different set of modifications
depending on the duration and frequency of drug exposure (Maze and Nestler, 2011).
Several HAT and HDAC enzymes are known to have roles in drug-induced histone
modification. CBP mutant mice with just one functional CBP allele and reduced CBP protein
levels are not as sensitive to chronic cocaine exposure as their wild-type counterparts, with
reduced locomotor response and fosb expression after cocaine injection (Levine et al., 2005).
Focal deletion of CBP in the nucleus accumbens achieves similar results. This manipulation leads
to decreased H3K14 and H2BK12 acetylation in response to acute and chronic cocaine
administration. It also reduces the locomotor response to cocaine and blocks the formation of a
preference for a cocaine-paired context (Malvaez et al., 2011). While the class I HDAC enzymes
were discussed earlier in the chapter in relation to memory, the class II HDACs seem to be
involved in drug response.

Viral overexpression of HDAC4 (Kumar et al., 2005) or HDAC5

(Renthal et al., 2007) decreases the rewarding effects of cocaine, as measure by conditioned
place preference. Conversely, knockout of HDAC5 does not alter naïve cocaine response, but
prior drug exposure sensitizes mutant animals to cocaine; they exhibit enhanced conditioned
place preference compared to wild-type mice after such treatment (Renthal et al., 2007). Chronic
(but not acute) exposure to cocaine actually induces phosphorylation of HDAC5 and its
subsequent export from the nucleus (Renthal et al., 2007), and this loss of repression by HDAC5
may contribute to the increased acetylation, gene expression, and behavioral sensitization that
accompanies chronic drug administration (Renthal and Nestler, 2009; Maze and Nestler, 2011).
In addition to acetylation, histone phosphorylation and methylation have been associated
with addiction and the response to drug exposure. In the striatum, histone H3 phosphorylation
and phospho-acetylation are induced rapidly and transiently by cocaine administration (BramiCherrier et al., 2005; Kumar et al., 2005). Co-administration of cocaine and the HDAC inhibitor
NaB significantly increases striatal H3 phospho-acetylation, and also potentiates the locomotor
response to cocaine, linking histone phosphorylation to the behavioral response to drug exposure
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(Kumar et al., 2005). Cocaine-induced histone H3 phosphorylation can be been attributed to the
histone kinase MSK1, as the cocaine-induced phosphorylation of histone H3S10 was not
observed in MSK1 knockout mice (Brami-Cherrier et al., 2005). In mutant animals, the cocaineinduced phosphorylation of histone H3S10 was not observed. The loss of MSK1 also prevented
the drug-induced expression of c-fos and blocked the locomotor sensitization that occurs with
chronic cocaine administration (Brami-Cherrier et al., 2005). Genome-wide promoter analysis of
the nucleus accumbens after chronic cocaine administration found altered patterns of histone
H3K9 dimethylation (Renthal et al., 2009). Maze et al. (Maze et al., 2010) found that 24 hours
after repeated exposure to cocaine the level of H3K9 dimethylation was downregulated in the
nucleus accumbens, as was the expression of the histone methyltransferase enzymes G9a and
GLP. G9a protein levels were also reduced, and the investigators linked the cocaine-induced
repression of G9a to sensitized transcriptional response to cocaine in the nucleus accumbens
due to the loss of repressive methylation by the enzyme (Maze et al., 2010).
Administration of the HDAC inhibitors TSA, NaB, and SAHA can promote behavioral
sensitivity to drug exposure, determined by an increase in conditioned place preference following
cocaine exposure (Kumar et al., 2005; Renthal et al., 2007).

Although

HDAC

inhibiting

agents can facilitate addiction by enhancing neuronal plasticity, they may also offer a way to
enhance the extinction of drug-seeking and other addiction-related behavior. Consistent with the
enhancements in extinction that have been observed in hippocampus-dependent memory (Lattal
et al., 2007), HDAC inhibitor treatment also facilitates extinction of cocaine-induced conditioned
place preference (Malvaez et al., 2011). These findings suggest that pharmacological
manipulation of histone proteins may provide an opportunity for therapies to break the addiction
cycle.
1.7.4. Schizophrenia . Schizophrenia is a very prevalent disorder, affecting an estimated 1.1% of
the adult population of the United States (Sawa and Snyder, 2002). The disorder is characterized
by a number of classic symptoms, usually divided into three categories (positive, negative, and
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cognitive) based on their manifestation. Positive symptoms include auditory and visual
hallucinations, delusions, and movement disorders, and are the signs most usually associated
with schizophrenia. Negative symptoms are more difficult to identify, and present very similarly to
the symptoms of depression. The cognitive symptoms of schizophrenia, such as deficits in
attention and working memory, and can make the day-to-day functioning of schizophrenia
patients very difficult (Roth et al., 2009).
The root causes of schizophrenia are still not well-understood, but it is thought that the
disorder is the result of a combination of genetic and environmental factors. Investigation of
epigenetic mechanisms could be vital to our understanding of the changes in gene expression
that are found in schizophrenia and how they are influenced by the environment and experience.
Analysis of post-mortem human brain tissue has found changes in both facilitative and repressive
histone methyl modifications. Researchers have found significantly increased methylation of
histone H3R17 in post-mortem cortical tissue samples from a subgroup of schizophrenic
patients(Akbarian et al., 2005). The increase they observed in histone H3R17 methylation was
associated with decreased expression of four metabolic gene

in the identified subgroup

(Akbarian et al., 2005). While these changes in gene expression do not seem to be
representative of schizophrenia in general, this study was the first to demonstrate gene regulation
by histone modifications in schizophrenia.
In schizophrenia, cortical and hippocampal dysfunction is hypothesized to involve the
disruption of GABAergic neurotransmission (Akbarian and Huang, 2006). GAD67, encoded by the
gene GAD1, is an isofrom of glutamic acid decarboxylase, critical for the synthesis of the
neurotransmitter GABA. Over the course of normal development in humans, expression of GAD1
increases, a change that it is accompanied by increasing H3K4 methylation

at the GAD1

transcription start site (Huang et al., 2007a). Furthermore, the histone methyltransferase MLL1,
which catalyzes H3K4 methylation (Gupta et al., 2010), is expressed in GABAergic cortical
neurons in both humans and mice, and was occupies the GAD1 promoter in mice. Genetically
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modified mice with lower Mll1 levels have decreased H3K4 methylation at the promoters of
GAD1, Sst, and Npy, all GABAergic genes, demonstating a causal link between MLL1 and GABA
production proteins.
Decreases in the level of cortical GAD67 mRNA are commonly reported in patients with
schizophrenia, and dysregulation of GAD67 expression has been attributed to multiple causes
(Akbarian and Huang, 2006). Recently, changes in histone methylation have been linked to the
decreased expression of GAD67 in schizophrenic patients. The antipsychotic drug clozapine,
used to treat schizophrenia, increases MLL1 promoter occupancy and H3K4 methylation at Gad1.
In the human tissue samples, the researchers found that female schizophrenic patients exhibited
decreased GAD1 expression and H3K4 trimethylation. Further, a subset of schizophrenic patients
with polymorphisms in GAD1 had lower GAD1 expression, and a shift from H3K4 trimethylation to
the repressive H3K27 trimethyl mark (Huang et al., 2007a). While the connection in human
patients between H3K4 methylation deficits and changes in MLL1 activity is not firm, this research
demonstrates a link between GAD1 expression and histone modification mediated by MLL1. It
provides an interesting model of GAD1 dysregulation in schizophrenia; decreased H3K4
methylation and GAD1 expression could result from the loss of MLL1 at the GAD1 promoter
during development (Huang et al., 2007a; Akbarian and Huang, 2009) (Fig. 1.6C).
Histone acetylation may also be involved in schizophrenia. An analysis of microarray data
from the National Brain Databank, compared the expression levels of different histone
deacetylase enzymes in the prefrontal cortices of schizophrenic, bipolar, and control subjects
(Sharma et al., 2008). Expression of GAD1 was found to be negatively correlated with expression
of HDAC1, HDAC3, and HDAC4, all of which were more highly expressed in schizophrenic
patients than in matched controls. Perhaps in part because of these findings, treatment of
schizophrenia with HDAC inhibitors has received some renewed consideration. However, the
results of such studies have been controversial and at times conflicting. In animal models of
schizophrenia, HDAC inhibition seems to have the potential for relief. Researchers employing a
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methionine-induced mouse model of schizophrenia have used valproate (valproic acid, VPA) to
rescue the physiological (promoter hypermethylation and downregulation of reelin) and behavioral
(prepulse inhibition and social interaction deficits) schizophrenia-like phenotypes of the mice,
indicating that HDAC inhibitors could be useful in treating at least some of the known symptoms
of schizophrenia in human patients (Tremolizzo et al., 2005).
In the clinical realm, the HDAC inhibitor valproic acid has seen use as a supplemental
medication, along with a regimen of more established antipsychotic medications, in severely
affected patients (Citrome, 2009), and may serve to accelerate the antipsychotic actions of
established schizophrenia-treatment drugs (Casey et al., 2003). However, treatment with VPA
has not been as successful in controlled, randomized trials (Casey et al., 2003; Citrome, 2009),
and it may be the case that HDAC inhibitor treatment is best suited for individuals with very
severe cases of schizophrenia who do not respond to traditional medications (Grayson et al.,
2010).
Histone methyltransferase inhibitors and histone demethylase inhibitors have only been
described in the literature within the past decade, but they hold great potential because of the
reports linking histone methylation changes and downregulation of GABA synthesis genes
(Akbarian and Huang, 2006). The effects of HMT inhibitors in living animals are mostly unknown,
but inhibition of the repressive HMT enzymes GLP and G9a has been found to enhance or to
impair memory, in a region-specific fashion (Gupta-Agarwal et al., 2012). Inhibition of HDM
enzymes is able blocks the demethylation of trimethyl H3K4, a mark associated with open
chromatin (Huang et al., 2007b), which could be useful in facilitating the expression of GAD1.
Monoamine oxidase inhibitors administered as antidepressants also have inhibitory effects on
HDM enzymes, and combined treatment with particular monoamine oxidase inhibitors and
traditional antipsychotic medications can relieve negative schizophrenic symptoms (Gavin and
Akbarian, 2012). While some of these treatments may be promising, we still know very little about
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differential histone modification in schizophrenia and how histone modifications may affect the
onset and progression of the disease.
1.7.5. Depression. Major depressive disorder, also known as major depression or unipolar
depression, is a debilitating mental disorder in which extreme feelings of sadness, anger, and
frustration persist chronically and interfere with the ability to lead one’s life. Depression is often
predicated by chronic stress in susceptible individuals. The incidence of major depression is
significant, with an estimated 16% of the population suffering from depression at least once at
some point in their lives and 6% of the population dealing with it every year, according to the
NIMH. People with depression are at elevated risk for suicide and often suffer disproportionately
from other illnesses and physical health problems, making it a serious issue for public health.
The effects of depression in the central nervous system are widespread, implicating the
nucleus accumbens, the limbic system and the hippocampus, and the frontal cortex. It is
hypothesized that depression involves coordinated changes in the regulation of a number of
genes, leading to large-scale alterations in gene expression patterns. The bdnf gene encoding
brain-derived neurotrophic factor (BDNF) is of particular interest. Chronic stress, a precursor of
depression and a common paradigm used in animal models of depression, downregulates BDNF
levels, but this change is prevented by the administration of antidepressant drugs (Shirayama et
al., 2002). Hippocampal BDNF infusion can also relieve depression-like behaviors (Shirayama et
al., 2002), and animals lacking the bdnf gene are not responsive to treatment with
antidepressants (Monteggia et al., 2004). These results provide an important potential link
between depression and histone modification, as the promoter regions of bdnf are known to be
regulated by histone acetylation and expression of the various BDNF isoforms are sensitive to
HDAC inhibitor treatment. Initial work on the role of histone modifications in depression focused
on the regulation of hippocampal bdnf (Tsankova et al., 2006) in an animal model of depression,
the chronic social defeat stress paradigm. The behavioral effects that resulted from chronic stress
were accompanied by downregulation of bdnf transcription from the p3 and p4 promoters of the
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gene, while treatment with the antidepressant drug imipramine rescued these behavioral effects
and reversed the bdnf expression deficits. Chronically stressed animals also had large increases
in repressive H3K27 dimethylation at the p3 and p4 promoters of bdnf, but imipramine treatment
did not exert its effects by reversing these repressive marks. Instead, it induced hyperacetylation
of histone H3 at these same promoters and simultaneously reduced expression of HDAC5, a
class II histone deacetylase enzyme, apparently counteracting the repression of bdnf transcription
attributed to H3K27 histone methylation.
HDAC inhibitors are being considered as drugs for the treatment of depression because
of this promising research, but some doubts about their efficacy linger. These agents may not be
effective when administered alone. For example, in an experiment that found significant effects of
NaB on reducing immobility in the tail-suspension test, the effects of HDAC inhibition were not
found to extend to the other aspects of the behavioral despair battery employed by the
researchers (Schroeder et al., 2007). Some investigators have shown that increasing histone
acetylation on its own may not be enough to relieve depression-like behaviors, as assayed by the
forced-swim test and novelty-induced hypophagia (Gundersen and Blendy, 2009). Neither chronic
nor acute NaB treatment reduced immobility in the the forced swim test, and in acute doses
HDAC inhibition tended to lead to more severe symptoms, perhaps attributable to the neuronal
plasticity induced by NaB administration. Instead, HDAC inhibitors may need to accompany other,
more traditional antidepressant medications in order to reveal their effects (Gundersen and
Blendy, 2009).
Chronic social defeat, another model of depression, produced time-dependent alterations
in acetylation of H3K14 in the nucleus accumbens: decreased at 60 minutes after the final defeat,
but elevated at 24 hours and even as far out as 10 days. This unusual finding was bolstered by
the discovery that H3K14 acetylation was highly enriched in post-mortem nuclceus accumbens
tissue samples from depressed patients compared to matched control individuals. It is a different
story in the hippocampus, where decreased H3K14 acetylation was observed at 10 days after the

37

final defeat, indicating that different histone modification mechanisms are involved in mediating
the hippocampal and amygdalar responses to stress (Covington et al., 2011).
Some of these issues have been addressed by the use of more potent and specific
HDAC inhibitors. Recently, investigators have reported some success with the use of the class Ispecific HDAC inhibitor MS-275, finding it to reduce depression-like behaviors when administered
in both the nucleus accumbens (Covington et al., 2009) and the hippocampus (Covington et al.,
2011). HDAC2 protein levels are decreased both in the nucleus accumbens of chronicallydefeated mice and in post-mortem tissue from depressed patients (Covington et al., 2009), an
observation which could account for the long-term increase in H3K14 acetylation induced by
chronic-defeat stress. Chronic infusion of the HDAC inhibitors SAHA or MS-275 has
antidepressant-like effects in socially-defeated mice, and it even further increases H3K14
acetylation to levels higher than those found in untreated, stressed control mice. It is still unclear
how this hyperacetylation of H3K14 relieves depression-like symptoms, but it is possible that it
could be related to a reversal in gene expression profiles that were altered by the experience of
chronic social defeat (Covington et al., 2009).
The role of histone modifications in stress and depression is complicated, but the
research is promising. Although reports have provided some conflicting data on efficacy of certain
manipulations, it is very clear that histone modification operates on a large scale in the
symptomology of depression. Techniques to manipulate these histone modifications could
provide represent great leaps in the therapeutic treatment of the underlying mechanisms of
depression.
1.7.6. Bipolar Disorder. Bipolar disorder is one of the major mood disorders that threaten public
health and mental well-being, along with major depressive disorder. According to the NIMH, it is
estimated that 2.6% of the adult U.S. population has bipolar disorder. Patients suffering from
bipolar disorder experience alternating swings between periods of mania and depression, with
differing degrees of severity in the intensity of these mood changes. Like schizophrenia, the onset
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of bipolar disorder most often occurs in late adolescence or early adulthood, but it affects both
sexes equally often. Bipolar disorder is difficult to diagnose early, and those who have bipolar
disorder may suffer for years before receiving an appropriate diagnosis and treatment.
The triggers and risk factors for bipolar disorder remain mostly unknown, but there may
be some genetic contribution as those diagnosed with bipolar disorder are more likely to have a
relative with the same diagnosis. Like schizophrenia, bipolar disorder has been associated with
patterns of altered gene expression in the prefrontal cortex and the hippocampus that may be
connected to the psychosis that is frequently present in both disorders. Expression of the genes
RELN and GAD1is downregulated in the prefrontal cortex in both schizophrenia and bipolar
disorder patients (Guidotti et al., 2000), while decreased expression of GAD67 and GAD65 is also
found in the hippocampus of bipolar patients (Heckers et al., 2002). It is unclear what changes in
histone modification, if any, are associated with these gene expression changes in bipolar
disorder. However, similar gene expression patterns in schizophrenia have been connected to
altered histone methylation (Huang and Akbarian, 2007; Huang et al., 2007a). Given the
similarities described here, it is plausible that some of the same mechanisms proposed to operate
in schizophrenia are at work in GABAergic downregulation in bipolar disorder (see Fig. 1.6C).
Microarray analysis of frontal cortex samples from bipolar patients has also shown a trend
(although not a significant one) towards increased HDAC1 expression (Sharma et al., 2008). The
analysis of peripheral white blood cells from bipolar disorder patients found that compared to
control subjects the expression of HDAC4 was upregulated when patients were in a remissive
state, while HDAC6 and HDAC8 expression was lower in both depressive and remissive states
(Hobara et al., 2010).
This is possibly related to the successful use of mood-stabilizing drugs to treat bipolar
disorder, as one of the principle medications employed is valproate (Phiel et al., 2001), or valproic
acid, a broad-spectrum HDAC inhibitor (Bolden et al., 2006). While the success of an HDAC
inhibitor in the treatment of bipolar provides another potential link to histone modification (Gavin
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and Akbarian, 2012), it is important to consider an alternative interpretation that HDAC inhibitors
exert these effects via acetylation of non-histone proteins (Yeh et al., 2004).
1.7.7. Aging. A general decline in memory and cognitive function accompanies aging (Gallagher
and Rapp, 1997; Bach et al., 1999; Burke and Barnes, 2006). Memory recall is especially
susceptible to age-related deterioration, and this loss of cognitive ability has been linked to
altered gene expression in the hippocampus and the prefrontal cortex (Burke and Barnes, 2006;
Schimanski and Barnes, 2010), structures highly involved in the formation, storage, and
recollection of declarative memories.

Earlier sections of this chapter described the robust

evidence that links histone modification to gene expression in normal processes of memory and
synaptic plasticity. It is quite plausible that some of the epigenetic mechanisms that control
learning and memory are also involved in aging-related cognitive decline.
Because of the connections that have been established between histone modifications
and memory, Peleg and colleagues (Peleg et al., 2010) hypothesized that disruption in these
mechanisms may have some part in cognitive aging. The researchers found that aged (16 monthold) mice had significant impairment in hippocampus-dependent memory, in both contextual fear
conditioning and the Morris water maze task, compared to young mice. The observed memory
deficits could not be attributed to basal changes in HAT or HDAC levels. Instead, the differences
were caused by dysregulation in activity-dependent histone H4 acetylation at K12 in the coding
regions of memory-associated genes and an associated failure to initiate hippocampal gene
transcription

programs

associated

with

memory

consolidation

(Peleg

et

al.,

2010).

Intrahippocampal infusion of the HDAC inhibitor SAHA rescued memory and the learning-induced
acetylation of H4K12. Other forms of memory are impaired by aging; deficits in long-term memory
for novel object recognition were observed in 24-month old rats compared to 3-month old
controls, and this memory impairment was rescued by systemic administration of NaB
immediately after training (Reolon et al., 2011).
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Aging also impairs hippocampal synaptic plasticity (Zeng et al., 2011). In rats, significant
impairment in the late maintenance phase of LTP was found in hippocampal slices from old
animals compared to young controls, and this deficit in plasticity was rescued by pre-treating the
slices with the HDAC inhibitor TSA. Unlike the aged mice examined by Peleg et al. (Peleg et al.,
2010), old rats did exhibit some differences in their histone acetylation enzymes. The expression
of HDAC2 was increased and the expression of CBP was decreased in the hippocampi of aged
rats, indicating that a major shift in the balance of histone acetylation could occur in the aged
brain. Reduced acetylation of H3K9 and H4K12 was observed at all nine promoters of the bdnf
gene in the aged rats, with a corresponding decrease in the level of BDNF protein (Zeng et al.,
2011). The downregulation of BDNF was accompanied by reduced levels of phosphorylated,
active CaMKII and ERK, two kinases activated by BDNF signaling and important for memory
formation (Minichiello, 2009). HDAC inhibitor treatment, which had rescued the LTP deficits in the
old rats, also increased histone H3 and H4 acetylation at bdnf promoters and reversed the deficits
in CaMKII and ERK phosphorylation, evidence that aging-related histone acetylation deficits alter
hippocampal BDNF signaling, possibly impairing synaptic plasticity and memory.
While our understanding of the changes in histone modification that underlie agingrelated cognitive decline is still mostly incomplete, but the work that has been done so far is
promising. Histone hypoacetylation has been implicated (Peleg et al., 2010; Zeng et al., 2011),
and may relate to dysregulation of transcriptional elongation (Peleg et al., 2010; Stilling and
Fischer, 2011). Histone modifications regulating the neurotrophic factor bdnf may also be
involved, which could lead to reduced BDNF signaling and disruption in memory-related
transcriptional programs (Alonso et al., 2002; Tyler et al., 2002). As in many of the other disorders
discussed in this chapter, treatment with HDAC inhibitors has shown some potential for relieving
age-related memory deficits (Peleg et al., 2010; Reolon et al., 2011; Zeng et al., 2011). However,
there are other histone modifications involved in memory and plasticity that have not yet been
investigated in the context of the aging brain, and future research into the histone language could
have major ramifications for maintaining the cognitive health of an aging population.
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1.8. Upstream and Downstream Effectors of Epigenetic Regulation
So far, we have reviewed the variety of post-translational histone modifications that have
been shown to exhibit some role in neuronal function, with an emphasis on memory formation
and synaptic plasticity as well as neuropsychiatric and neurodevelopmental disorders. However,
these epigenetic histone marks and their “writers,” “readers,” and “erasers” (Borrelli et al., 2008)
are themselves not the entire story. While the evidence indicates that they exert large effects on
gene expression and in transcription-dependent of memory and plasticity, it is critical that they be
understood in a larger context. It is important that we look both upstream and downstream of
these modifications, to understand how they are triggered and how they exert their effects (Fig.
1.7). How are they targeted or recruited to their regulatory targets? Once that targeting has been
accomplished, what genes and resultant proteins are truly important for the behavioral and
synaptic phenotypes that have been observed?
These are important questions both for our understanding of long-term potentiation and
long-term memory, and for our ability to control and exploit these mechanisms in the laboratory
as well as in the clinic. Epigenetic mechanisms like chromatin modification offer attractive targets
for pharmacological interventions that could alter or enhance neuronal function. As discussed
above, many drugs are now available that can alter the function of histone-modifying enzymes,
and their use in the laboratory in the study of basic mechanisms has encouraged hope in them as
agents that could find therapeutic use in the amelioration of cognitive and functional deficits (Abel
and Zukin, 2008; Fischer et al., 2010; Peixoto and Abel, 2013; Abel and Poplawski, 2014). Such
translational applications can be frustrated by our relatively poor understanding of the
mechanisms by which HDAC inhibitors – and other similar drugs – actually lead to enhanced
memory and synaptic potentiation.
1.8.1. Recruitment of Histone Modifiers by Co-Repressor Complexes. Epigenetic chromatinmodifying enzymes are recruited as members of large, multi-protein co-activator and co-repressor
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complexes, coordinated by a central scaffolding protein (Schoch and Abel, 2014); for example,
HDAC1 and HDAC2 can be found in complexes coordinated by SIN3A, NuRD, and CoREST,
while HDAC3 is recruited by NCOR (Hakimi et al., 2002; Ishizuka and Lazar, 2005; Silverstein
and Ekwall, 2005; Allen et al., 2013). Such histone-modifying enzymes like these Class I HDACs
generally lack intrinsic DNA-binding or chromatin-binding capabilities, and these co-repressor
complexes usually contain factors that can bind chromatin, DNA, and DNA-binding transcription
factors, facilitating their dynamic recruitment in response to activity-induced signaling cascades
(Silverstein and Ekwall, 2005; Allen et al., 2013). Most of what we know about the function of corepressor complexes comes from research in non-neuronal systems, where they have been
implicated in functions including embryonic development, signal transduction, and cell
morphology (Kumar et al., 2005; McDonel et al., 2009; Kato et al., 2011; Lai and Wade, 2014).
Currently, little is known about the function of epigenetic co-repressor complexes in the brain;
however, it is becoming apparent that these co-repressors not only play important roles in
neurodevelopment but could also be involved in other neuron-specific functions and regulation of
activity-dependent neuronal gene expression (Youn and Liu, 2000; Chen et al., 2003; Potts et al.,
2011; Ebert et al., 2013; Vogel-Ciernia et al., 2013; Schoch and Abel, 2014), as well as the
regulation of memory formation and learning-induced transcription (McQuown et al., 2011). In
Chapter 2, the role of the co-repressor SIN3A in hippocampus-dependent memory consolidation
and long-term potentiation is investigated, and potential synaptic mechanisms by which
SIN3A/HDAC-regulated genes contribute to neuronal plasticity is examined.
1.8.2. Downstream Effectors of HDC Inhibitor Treatment. As discussed above, investigators
have identified many genes that are putative targets of HDAC and HAT enzymes or have altered
patterns of expression following treatment with HDAC inhibiting drugs. These include many
immediate-early genes, like c-Fos, and CREB-regulated genes, such as Bdnf (Fass et al., 2003;
Guan et al., 2009). Experiments investigating the enhancement of hippocampal long-term
memory and long-term potentiation by the HDAC inhibitor trichostatin A have identified another
promising group of acetylation-regulated target genes in the Nr4a sub-family of nuclear receptor
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transcription factors (Vecsey et al., 2007). The Nr4a genes encode three orphan nuclear receptor
proteins, which have been implicated in hippocampus-dependent memory and plasticity
(McQuown et al., 2011; Hawk et al., 2012; Bridi and Abel, 2013b)(Colón-Cesario et al., 2006;
Rojas et al., 2007; McNulty et al., 2012). These genes are regulated by CREB (Lemberger et al.,
2008), and their expression is increased after learning and further augmented by HDAC inhibitor
treatment (Malkani and Rosen, 2000; von Hertzen and Giese, 2005; Vecsey et al., 2007; Hawk et
al., 2012). Interestingly, it has been demonstrated that disrupting NR4A function blocks the ability
of HDAC inhibitor administration to enhanced contextual fear memory (Hawk et al., 2012) and
Schaffer collateral LTP (Bridi and Abel, 2013b), which makes the Nr4a sub-family a prime
candidate for exploring the mechanisms downstream of HAT and HDAC activity in neuronal
plasticity. In Chapter 3, the importance of NR4A function in long-lasting forms of hippocampal
synaptic potentiation and LTP enhancement by inhibition of HDAC enzymes is tested. In Chapter
4 the regulation of Nr4a gene expression and promoter acetylation by the HAT and co-activator
CBP is examined, and the possibility of enhancing LTP by pharmacological manipulation of the
NR4A proteins is tested.

1.9. Summary
An organism’s survival depends on its ability to perceive and interact with a constantly
changing environment. The brain must form and store associations and act on them accordingly;
it must update these connections as new information becomes available and conditions change.
Within the hippocampus, changes in patterns of gene expression ultimately enable the
stabilization of changes in synaptic strength and the consolidation and storage of memory. These
plastic processes require activity-dependent transcription; neuronal gene expression is in large
part regulated by an epigenetic histone code, a stable but reversible and highly modifiable
language that enables the fine control of long-lasting changes in gene expression. In this chapter,
I covered the best-characterized roles and mechanisms of histone modification in memory and
plasticity, as well as in neuronal dysfunction. It should be clear that histone modification provides
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both plasticity and stability to the transcriptional mechanisms that facilitate neuronal plasticity. It
should also be clear that, despite much study and experimentation, our understanding of how
manipulating the histone code ultimately leads to changes in memory and plasticity is far from
complete. In Chapter 2, we show that the SIN3A/HDAC complex negatively regulates
hippocampal memory and plasticity. In Chapter 3 and Chapter 4, we show that the Nr4a nuclear
receptors are regulated by histone modification, are critical for long-term potentiation, and
represent a novel pathway for enhancing neuronal plasticity. These investigations further our
understanding of the epigenetic mechanisms supporting and regulating synaptic plasticity and
function, and provide us with new targets for basic and translational research on neuronal
function and cognition.

Acknowledgements. We would like to thank Shane Poplawski, Lucia Peixoto, Marcel Estévez,
and Michelle Bridi for contributing their discussion and comments. This publication was made
possible by the support of predoctoral NRSA training grant NS079019 (to M. Bridi) and R01MH087463 (to T. Abel).

Author Contributions. The chapter was written by M. Bridi, with suggestions from T. Abel.

Portions of this chapter were previously published as:
Bridi, M.S. & Abel, T. (2013). Histone Modifications in the Nervous System and
Neuropsychiatric Disorders. In Sweatt, J.D., Meaney, M.J., Nestler, E.J., &
Akbarian, S. (Eds.), Epigenetic Regulation in the Nervous System (pp. 35 - 67).
Amsterdam, Netherlands: Elsevier

45

CHAPTER 1 FIGURE LEGENDS
Figure 1.1. Hippocampus-dependent memory. (A) The hippocampus is a structure in the
medial temporal lobe (indicated in pink in the left panel) that is crucial for the formation and the
short- and medium-term storage of spatial and episodic memory. The right panel shows a
transverse hippocampal slice, demonstrating the anatomy of the hippocampal trisynaptic circuit.
In the perforant path, neurons from the entorhinal cortex (EC) synapse onto neurons in the
dentate gyrus (DG). At the mossy fiber synapses, DG neurons send projections to area CA3. CA3
axons connect with neurons in area CA1 at the Schaffer collateral synapses. CA1 neurons send
projections back to the EC. (B) A schematic detailing contextual fear conditioning, a
hippocampus-dependent form of memory. A naïve mouse is removed from its home environment
and placed in a novel context, which is paired with a noxious stimulus – a footshock delivered
through the floor of the chamber, which begins the process of memory acquisition. The mouse is
returned to its home cage, and the newly formed context-shock association becomes stable
during a period of consolidation, which requires kinase activity, gene expression and protein
synthesis. When the mouse is placed back in the shock/training context, the consolidated
memory is retrieved and expressed as freezing behavior, and is once again temporarily labile.
Figure 1.2. Synaptic plasticity in the hippocampus. (A) Hippocampal plasticity is often studied
using the Schaffer collateral CA3-CA1 synapses in ex vivo hippocampal slices. In a typical LTP
experiment, a bipolar stimulating electrode placed in stratum radiatum of CA1 elicits activity in
CA3 axons; a glass microelectrode, also in stratum radiatum of CA1, is used to record the
excitatory postsynaptic field potential (fEPSP) elicited by axonal stimulation. (B) Weakly-induced
early-LTP (E-LTP) and strongly-induced late-LTP (L-LTP) at the hippocampal Schaffer collateral
synapses. In E-LTP, a single weak stimulus (1 sec, 100 Hz) induces synaptic potentiation, which
returns to baseline levels over the next several hours; the fEPSP trace in red shows an example
of a response recorded three hours after stimulation. Delivering four of these stimuli in succession
induces long-lasting L-LTP, which persists for many hours and requires both transcription and
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translation; the fEPSP trace in blue shows the change in synaptic response three hours after
stimulation compared to baseline in black.

Figure 1.3. Post-translational histone modifications. (A) Histone marks are added and
removed by particular classes of enzymes. Histone methylation occurs on lysine and arginine
residues. Methyl groups are added by histone methyltransferase enzymes, and are removed by
histone demethylase enzymes. Acetyl groups are added to lysine residues by the histone
acetyltransferase enzymes; histone deacetylase enzymes remove them. Histone kinases
phosphorylate serine, tyrosine, and threonine residues; histone phosphatase enzymes erase
these marks (Berger, 2007, 2010; Kouzarides, 2007; Bannister and Kouzarides, 2011). (B)
Multiple histone modifications of different types can occur together on the same histone protein.
(Gardner et al., 2011)

Figure 1.4. The variety of epigenetic mechanisms at work in the central nervous system.
(A) Epigenetic modifications that directly affect DNA and chromatin include post-translational
modification of histones (Borrelli et al., 2008), DNA modification by the addition of methyl groups
(Sultan and Day, 2011), deposition of variant histone proteins (Kamakaka and Biggins, 2005),
and ATP-dependent chromatin remodeling (Kundu and Peterson, 2009). (B) Non-coding RNA
and micro RNA have been implicated in the regulation of memory formation and neural plasticity.
Non-coding RNA mediate post-transcriptional gene expression silencing by regulating the
degradation, stability, editing , and translation of target mRNA in an activity-dependent manner
(Mercer et al., 2008; Bredy et al., 2011). (C) In some systems, the maintenance of long-term
changes in synaptic strength associated with memory is supported by self-propagating
conformational changes in proteins like neuronal CPEB, which form amyloid-like oligomers at the
synapse. (Si et al., 2003, 2010; Majumdar et al., 2012)

Figure 1.5. Central nervous system functions known to be associated with histone
modifications in different brain areas. The epigenetic regulation of histone modification occurs
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in a number of different brain regions, and is involved in a wide array of different central nervous
system functions. Some of the known roles of histone modification are shown, along with the
brain areas where they have been observed. Adapted with permission from (Sultan and Day,
2011).

Figure 1.6. Disorders and dysregulation of histone modification in the brain.
(A) A model of a potential cause of ATR-X syndrome. ATRX is recruited to heterochromatin by
binding to trimethylated H3K9, where it associates with repressive proteins like HP1α and
MeCP2. Mutation of the ADDATRX domain prevents this localization of ATRX, and could lead to
destabilization of heterochromatin structure (Iwase et al., 2011). (B) Rubinstein-Taybi syndrome
(RTS) is thought to be caused by the mutation and loss of function of the transcriptional coactivator and histone acetyltransferase CBP. CBP binds phosphorylated CREB, and the loss of
CBP activity and histone acetylation at cre-mediated genes leads to impairment in memory and
plasticity (Oike et al., 1999; Alarcón et al., 2004; Korzus et al., 2004; Wood et al., 2005, 2006a;
Barrett et al., 2011). (C) Reduced H3K4 methylation and GAD1 expression have been observed
in patients with schizophrenia, and the loss of the histone methyltransferase MLL1 from the
GAD1 promoter may be involved in these changes. (Huang et al., 2007a; Akbarian and Huang,
2009)

Figure 1.7. Histone acetylation regulates activity-dependent gene expression. A simple
model of the regulation of transcription-dependent memory formation and synaptic potentiation by
changes in histone acetylation, including upstream regulators and downstream effectors. (A) At
baseline, activity-regulated genes may be kept in a repressed state by the presence of HDAC
enzymes at their promoters; memory and plasticity can be facilitated by HDAC inhibitor treatment.
The HDACs lack intrinsic DNA- or histone-binding ability, and are recruited as members of corepressor complexes like that coordinated by SIN3A. What are the roles of these co-repressor
proteins in hippocampal plasticity? (B) Neuronal activity, induced by learning or by synaptic
stimulation, initiates signaling cascades that lead to the loss of repressive complexes and the
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recruitment of transcription factors like CREB and co-activators with HAT activity such as CBP,
and the expression of acetylation-regulated, plasticity-related genes. Our lab has identified the
genes of the Nr4a family of nuclear receptors as potential candidates for mediating the
enhancement of memory and plasticity by HDAC inhibition.
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CHAPTER 1 FIGURES

Figure 1.1. Hippocampus-dependent memory.
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Figure 1.2. Synaptic plasticity in the hippocampus.
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Figure 1.3. Post-translational histone modifications.
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Figure 1.4. The variety of epigenetic mechanisms at work in the central nervous system.
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Figure 1.5. Central nervous system functions known to be associated with histone
modifications in different brain areas.
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Figure 1.6. Dysregulation of histone modification in the brain.
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Figure 1.7. Histone acetylation regulates activity-dependent gene expression.
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CHAPTER 2: THE TRANSCRIPTIONAL CO-REPRESSOR SIN3A REGULATES
HIPPOCAMPAL SYNAPTIC PLASTICITY VIA HOMER1/MGLUR5 SIGNALING

Abstract. Long-term memory depends on the control of activity-dependent neuronal gene
expression, which is regulated by epigenetic modifications.

The epigenetic modification of

histones is orchestrated by the opposing activities of two classes of regulatory complexes:
permissive co-activators and silencing co-repressors. Much work has focused on co-activator
complexes, but little is known about the co-repressor complexes that suppress the expression of
plasticity-related genes. Here, we define a critical role for the co-repressor SIN3A in memory and
synaptic plasticity showing that post-natal neuronal deletion of Sin3a enhances hippocampal
long-term potentiation and long-term contextual fear memory. SIN3A regulates the expression of
a specific set of genes encoding proteins in the post-synaptic density. Loss of SIN3A increases
expression of the synaptic scaffold Homer1, alters the mGluR1α- and mGluR5-dependence of
long-term potentiation, and increases activation of extracellular signal regulated kinase (ERK) in
the hippocampus after learning. Our studies define a critical role for co-repressors in modulating
neural plasticity and memory consolidation and reveal that Homer1/mGluR signaling pathways
are central molecular mechanisms for memory enhancement.
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2.1. INTRODUCTION
Long-term memory consolidation and hippocampal long-term potentiation depend on
activity-dependent neuronal gene expression, which is in turn regulated by epigenetic
mechanisms such as post-translational histone modification (Fischer et al., 2010; Peixoto and
Abel, 2013). Histone acetylation is associated with transcriptional activation, and both histone
acetylation and expression of acetylation-regulated genes are increased during memory
consolidation (Levenson et al., 2004; Mahan et al., 2012; Maze, Noh, & Allis, 2013; Peixoto &
Abel, 2013). Acetylation levels are determined by the activity of histone acetyltransferase (HAT)
and histone deacetylase (HDAC) enzymes, which are recruited to chromatin by association with
co-activator and co-repressor proteins (Vecsey et al., 2007; Guan et al., 2009; McQuown et al.,
2011). For example, HATs such as CBP and p300 are recruited by the transcription factor and
co-activator protein CREB in response to signaling cascades triggered by synaptic activity (Vo
and Goodman, 2001). The CREB-CBP/p300 complex can regulate transcription through HAT
activity as well as association with other plasticity-related transcription factors , and genetic
studies have demonstrated critical roles for CREB, CBP, and p300 in memory and synaptic
plasticity (Alarcón et al., 2004; Oliveira et al., 2007; Vecsey et al., 2007). On the other hand,
HDACs and other histone-modifying effector enzymes are recruited by co-repressor proteins such
as NCoR, SIN3A, MI-2 (NuRD), and CoREST (Schoch & Abel, 2014). In neurons, co-repressors
have been linked to dynamic and activity-dependent regulation of gene expression and neuronspecific components of co-repressor complexes have also been described (Schoch & Abel,
2014), suggesting that these proteins may play a large role in regulating transcription-dependent
plasticity. However, few studies have directly addressed the function of the co-repressor proteins
in memory and plasticity.
SIN3A is a highly-conserved co-repressor protein that is expressed throughout the brain,
both in neuronal and in non-neuronal cells. Through its histone-interacting domain (HID), SIN3A
recruits a core complex that includes the histone binding proteins RBAP46/48, stabilizing proteins
SAP18/20 and SDS3, and the Class I HDAC enzymes HDAC1 and HDAC2 (Silverstein and
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Ekwall, 2005; Grzenda et al., 2009). Four paired-amphipathic helix (PAH) domains mediate the
binding of the SIN3A-HDAC complex to numerous transcription factors, DNA binding factors, and
other co-repressor proteins, facilitating the dynamic recruitment of SIN3A to chromatin
(Silverstein and Ekwall, 2005; Grzenda et al., 2009). The binding partners of the SIN3A-HDAC
complex include several factors linked to neuronal function and cognition, including MEF2,
MECP2, NCoR, REST, and CoREST (Silverstein and Ekwall, 2005; Schoch and Abel, 2014).
Members of the core SIN3A complex, especially HDAC2, have also been shown to regulate
memory and plasticity (Guan et al., 2009; Bahari-Javan et al., 2012). These findings suggest that
the SIN3A co-repressor complex is in a position to act as a critical regulator of neuronal function
and cognition, but this co-repressor and its function in the mature nervous system have not been
studied.
Pharmacological inhibition of HDAC enzymes has been shown to facilitate robust
enhancements in long-term memory as well as in long-term potentiation (Alarcón et al., 2004;
Levenson et al., 2004; Vecsey et al., 2007). Although a number of acetylation-regulated genes
have been identified in these studies, it remains to be defined what downstream mechanisms
mediate the enhancement of LTP and memory at the level of synaptic function. Similarly, while
HDAC2 has been identified as a negative regulator of memory and plasticity in the hippocampus
(Guan et al., 2009), the mechanisms by which it is recruited to its regulatory targets and ultimately
leads to changes in synaptic function has received little attention. Interestingly, blocking the
HDAC binding site on the co-repressor NCOR recapitulates the effect of HDAC inhibitor drugs on
object memory, highlighting the critical role for co-repressors in bringing epigenetic regulators to
gene loci (McQuown et al., 2011). Here, we address the function of co-repressors in memory
storage and synaptic plasticity by conditionally deleting the co-repressor SIN3A in excitatory
neurons, demonstrating a role for the SIN3A-HDAC co-repressor complex as a negative regulator
of memory and plasticity that exerts its downstream effects through the synaptic scaffold protein
Homer1 and the Group I metabotropic glutamate receptors.
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2.2. METHODS
Mice
Mutant mice with a forebrain-specific deletion of Sin3a were generated by crossing mice
L/L

homozygous for a loxP-flanked exon 4 of the Sin3a gene (Sin3a )(Dannenberg et al., 2005) with
mice carrying the CaMKIIα-Cre transgene (L7ag#13) (Dragatsis and Zeitlin, 2000) and
+/L

heterozygous for a loxP-flanked exon 4 of Sin3a (CaMKIIα-Cre; Sin3a ) to produce CaMKIIαCre; Sin3a

L/L

(Sin3aNH) mice and control littermates. Deletion and premature stop codons were

confirmed in cDNA from Sin3aNH hippocampus by PCR across the deletion site using the
following primers- Exon 2 F: CAGCAGTTTCAGAGGCTCAAG and Exon 6 R:
GGGCATACACCTCTTGCTCA. Amplified products were separated by gel electrophoresis,
purified, and sequenced. In Sin3aNH, a full length Sin3a product and a single recombined Sin3a
product were identified (data not shown). All genotypes produced from this mating were
examined in fear conditioning. No differences were observed among genotypes with the
exception of Sin3aNH mice, so all other genotypes were grouped for controls in the presented
data. Experimenters were blind to the genotypes of the mice during collection of behavioral and
electrophysiological data. CaMKIIα-Cre line L7ag#13 expresses Cre recombinase throughout the
forebrain including the hippocampus, cortex, and amygdala with the majority of recombination
occurring postnatally(Dragatsis and Zeitlin, 2000). These Sin3aNH mice were produced after
more than 6 generations of backcrossing of the loxP-flanked Sin3a allele and more than 9
generations of backcrossing the CaMKIIα-Cre transgene into C57BL/6J.
Genotyping was performed using PCR with allele-specific primers. To identify mice
bearing floxed alleles of the Sin3a gene, PCR was performed with the following primers: 3A-4 5’AGC CAG CCC TGA GAC TAG TGA TAA AC-3’, 3A-6: 5’-GGG GGA ATG CTG TGT TTT AGG
TAT G-3’. PCR reactions were performed using RedExtract-N-Amp (Sigma, R4775) with the
following thermal cycles parameters: 94° C for 15 min, [94° C for 30 s, 55° C for 30 s, 72° C for
30 s] x 50 cycles, 72° C for 10 min. For CaMKII-Cre genotyping, PCR was performed with the
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following primers: Cre1 5’-CTG CCA CGA CCA AGT GAC AGC-3’, Cre2 5’-CTT CTC TAC ACC
TGC GGT GCT-3’, Bglob1 5’-CCA ATC TCC TCA CAC AGG ATA GAG AGG GCA GG-3’,
Bglob2 5’-CCT TGA GGC TGT CCA AGT GAT TCA GGC CAT CG-3’. Thermal cycling
parameters were as follows: 94° C for 3 min, [94° C for 45 s, 61° C for 45 s, 72° C for 60 s] x 30
cycles, 72° C for 10 min.
Mice were maintained under standard conditions consistent with National Institute of
Health guidelines for animal care and use, and were approved by the Institutional Animal Care
and Use Committee of the University of Pennsylvania. Mice were maintained on a 12 hr lightdark cycle and provided with food and water in their home cages ad libitum. Animals were group
housed in cages of 2-5 littermates except for fear conditioning experiments. For fear
conditioning, animals were moved from group housing to single housing 1 week prior to training.
Behavioral testing, tissue collection, and electrophysiology were conducted on 2-6 month old
male and female animals during the light portion of the cycle.
Immunoblots
Hippocampal lysation and immunoblotting were conducted as previously described
(Hawk et al., 2012). Mice were cervically dislocated, and hippocampi were quickly dissected and
flash frozen on dry ice. Hippocampi were homogenized at 4° C in 500 µL of cell lysis solution (10
mM HEPES pH 7.9, 1 mM EDTA, 1.5 mM MgCl2, 10 mM KCl, 1% protease inhibitor cocktail
(Sigma), 1 mM DTT), and nuclei were pelleted by 20 min centrifugation at 1000 x g at 4° C.
Nuclear pellets were resuspended in 100 µL of nuclear lysis buffer (20 mM HEPES pH 7.9, 0.2
mM EDTA, 1.5 mM MgCl2, 400 mM KCl, 25% glycerol, 1% protease inhibitor cocktail (Sigma),
1mM DTT). After 30 min incubation on ice, samples were centrifuged at 4° C for 20 min at 1000 x
g. Protein concentrations of the supernatants were quantified by the Bradford method (Biorad).
Nuclear protein samples were prepared using 20 µg fractionated protein combined with NuPage
LDS sample buffer and 2-mercaptoethanol (Invitrogen) and incubated for 5 min at 100° C.
Proteins were separated on a 3-8% Bis-Tris gel (Novex, Life Technologies) for 1 hr and
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transferred to a PVDF membrane for immunoblotting.

Membrane was blocked with 5%

milk/PBST for 2 hrs at room temperature (RT), and incubated with anti-SIN3A (Sigma,S6695)
1:500 in 2% milk/PBST at 4° C overnight. Membrane was washed three times in PBST for 10
min and incubated with anti-rabbit HRP conjugated secondary antibody (sc-2004, Santa Cruz
Biotechnology) 1:1000 in 2% milk/PBST for 2 hr at RT. After three 10 min washes in PBST, the
membrane was incubated for 1 min in ECL Western Blotting Detection Reagent (GE Healthcare)
and developed on film. For detection of β tubulin control band, antibody was removed from the
blot using Restore Western Blot Stripping Buffer (Thermo Scientific) according to the
manufacturer’s instructions. The membrane was re-blocked and re-probed with anti- β tubulin
antibody (Sigma, T4026) using the same blotting protocol.
Gene expression
Hippocampal RNA was purified and cDNA was prepared as previously described (Hawk
et al., 2012). Following contextual conditioning, hippocampal dissections were performed on ice,
and tissue stored in RNA Later (Qiagen) at -80° C until RNA extraction. RNA was isolated by
Trizol extraction and purified using an RNeasy kit (Qiagen) according to the manufacturer’s
instructions.

RNA concentration was measured using a NanoDrop spectrophotometer

(ThermoFisher Scientific).

Template cDNA was synthesized from 1 μg total RNA using the

RETROscript kit (Ambion). Reactions were conducted at 44° C for 1 hr, heat inactivated at 100°
C for 10min, and the final products were diluted in water to a final concentration of 2 ng/μL. Real
time qPCR was performed on the Viia7 Real Time PCR platform (Applied Biosystems) in 5uL
reactions consisting of 4.5 ng cDNA, 2.5 μL Fast SYBR Green master mix (Applied Biosystems),
and 250nM forward and reverse primers. Samples that did not amplify were excluded from
analysis. Values were normalized to three housekeeper genes (Gapdh, ActB, ActG), and relative
quantification was calculated using a ΔΔCt method as described previously (Vecsey et al., 2007).
Relative gene expression is reported as the fold difference in mean values for distinct biological
replicates.
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Behavior
Fear conditioning was conducted as previously described (Hawk et al., 2012).

For

contextual conditioning, naïve 2- to 6-month old male and female Sin3a NH (CaMKIIα-Cre;
L/L

Sin3a

) and control (CaMKIIα-Cre; Sin3a

L/+

, and Sin3a

L/L

) mice were placed in a novel training

chamber for 180 s and a single 2 s, 0.75 mA foot shock was administered after 148 s. Contextual
fear testing was conducted 1 hr or 24 hrs after training, by re-exposing the animals to the trained
context for 5 min. Cued fear conditioning was conducted using a similar training procedure as
contextual fear, with the addition of a 30 s tone presentation starting at 120 s. Cued fear testing
was conducted in a novel conditioning chamber with altered floor covering, odor, and dimensions.
Mice were exposed to the novel context for 3 min, followed immediately by 3 min of tone
presentation. Freezing behavior during contextual and cued testing was scored by computer
using FreezeScan software (Clever Systems). Freezing levels for all groups was examined for
normality using Shapiro-Wilk test. Normally distributed data sets were compared using two-way
ANOVA, with significance levels of p < 0.05.

Non-parametric data were compared using

independent samples Kruskal-Wallis test, with p value significance level of 0.05.

For all

conditioning experiments, animals with responses two standard deviations above or below the
group mean were excluded from the analysis as outliers. Mice were tested in the elevated zero
maze with a single 5 min exposure in which the animals were allowed to freely explore the maze.
Time spent in open and closed quadrants of the maze were scored manually by a trained
observer blind to the genotypes of the animals. A two-tailed independent samples t-test was
used to compare genotypes for open and closed areas. For all behavioral tasks, testing order was
designed so that mice of different sexes were not in the testing room at the same time. Testing
chambers were thoroughly cleaned between each session to minimize odor cues.
Immunohistochemistry
Transcardial perfusions and immunohistochemical stainings were conducted as
previously described (Havekes et al., 2012). Sections incubated rabbit anti-phopsho-ERK1/2 (Cell
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Signaling, AB9101). Phosphatase inhibitors were included in the fixative and all buffers (Havekes
et al., 2012). Cell counts were conducted as described (Havekes et al., 2012) by a trained
observer blind to grouping. Groups were compared using a one-tailed independent samples ttest.
Electrophysiology
Recordings: To assess the effects of conditional Sin3a mutation on LTP, 2- to 6-month old male
and female Sin3a NH (CaMKIIα-Cre; Sin3a

L/L

) and control (Sin3a

L/L

) mice we killed by cervical

dislocation and their hippocampi quickly dissected out into ice-cold oxygenated artificial CSF
(aCSF;124 mM NaCl, 4.4 mM KCl, 1.3 mM MgSO4•7H2O, 1 mM NaH2PO4•H2O, 26.2 mM
NaHCO3, 2.5 mM CaCl2•2H2O, 10 mM D-glucose). Transverse hippocampal slices were cut
400µm thick using a tissue chopper (Stoelting Co., Wood Dale, IL), placed in an interface
chamber, and perfused with oxygenated aCSF at 28.0°C at a flow rate of 1 mL/min. Slices were
allowed to recover for at least 2 hours before beginning electrophysiological recordings. Singlepathway recordings were made using a single bipolar stimulating electrode made from nichrome
wire (A-M Systems, Sequim, WA) placed in the stratum radiatum and used to elicit action
potentials in the axons of CA3 pyramidal neurons. Field potentials (fEPSPs) were recorded using
an aCSF-filled glass microelectrode (A-M Systems) with a resistance between 1 and 5 MΩ placed
in the stratum radiatum region of CA1.

Data collection was handled by Clampex software

(Molecular Devices, Palo Alto, CA) and was analyzed using Clampfit software (Molecular
Devices). The peak fEPSP amplitude induced by the stimulating electrode was required to be at
least 5 mV, and stimulus intensity during the recording was set to produce a response of 40% of
the maximum fEPSP amplitude. Test stimulation occurred once every minute. Baseline
responses were recorded for 20 minutes before LTP induction or drug application. To examine
early-phase LTP (E-LTP) one 1-second, 100 Hz train of stimuli was applied through the
stimulating electrode. To examine late-phase LTP (L-LTP) four 1-second, 100 Hz trains of stimuli
were delivered 5 min apart. Recordings continued for at least 160 min after LTP induction. The
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initial slope of the recorded fEPSPs were normalized to the average of the 20 baseline traces and
expressed as percentages of this baseline value.
Drugs: All drugs used in the electrophysiology experiments were mixed as stock solutions and
stored as individual aliquots at -20° C. The HDAC inhibitor Trichostatin A (TSA; AG Scientific)
was mixed as a 16.5 mM stock solution in 50% ethanol (Vecsey et al., 2007), and diluted to a
final concentration of 1.65 µM in aCSF. The mGluR5 antagonist MPEP and the mGluR1α
antagonist LY367385 were purchased from AbCam. MPEP was mixed as a 5 mM stock solution
in ddH2O and diluted to a final concentration of 40 µM in aCSF. LY367385 was mixed as a 50
mM stock solution in equimolar NaOH, and diluted to a final concentration of 100 µM in aCSF.
The RNA synthesis inhibitor actinomycin D was dissolved in DMSO at a stock concentration of 50
mM, and was diluted to a final concentration of 25 µM in aCSF(Vecsey et al., 2007). Drug
application was initiated 20 min prior to induction and lasted for 10 min (mGLuR antagonists) or
for the duration of the recording (TSA and Actinomycin-D).

Statistical analyses: Initial slope of the fEPSP was used to quantify synaptic potentiation,
normalized to the averaged value of the 20-minute baseline. Only one slice per animal was
included in any treatment condition. Within each LTP experiment, recordings were made from
multiple slices from each mouse whenever possible to reduce the number of animals used. The
order of treatment was determined randomly on each day of recording. Sample sizes were not
predetermined using statistical methods, but the sample sizes in our experiments are similar to
those reported in similar previously published research from our lab and others(Havekes et al.,
2012; Vecsey et al., 2007). To evaluate potential differences in paired-pulse facilitation a
repeated measures ANOVA was used with genotype and inter-stimulus interval as factors and
the facilitation ratio as the dependent variable. For evaluation of input–output characteristics, an
independent samples t-test was performed comparing the average linear regression slopes for
control mice and Sin3aNH mice. Potential differences in the maximum fEPSP slope were
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evaluated using an independent samples t-test. Between-group differences in LTP maintenance
were determined using a repeated measures ANOVA on the final 20 minutes of the recordings,
followed by Tukey’s post-hoc test when appropriate(Vecsey et al., 2007). Normality and variance
of LTP data were checked to determine suitability for analysis by ANOVA. Normality of the data
was evaluated by Shapiro-Wilk tests and examination of normal probability plots of the residuals.
Variance was evaluated by examination of residual plots of observed versus fitted values. All
statistical analyses were performed using STATISTICA software (StatSoft Inc.; Tulsa, OK).
Significance for all tests was set at p < 0.05. In all related figures, significance is indicated by *p <
0.05, **p < 0.01, and ***p < 0.001.
2.3. RESULTS
2.3.1. Deletion of Sin3a from forebrain excitatory neurons enhances long-term potentiation
To explore the role of SIN3A in synaptic plasticity and memory consolidation, we used
the Cre-loxP system to conditionally delete the Sin3a gene in forebrain excitatory neurons (Fig.
2.1A). SIN3A protein levels are reduced by approximately 50% in the hippocampus of Sin3a
neuronal hypomorphs (Sin3aNH) relative to control animals (ANOVA: F (1,10)= 32.74, p < 0.001)
(Fig. 2.1B,C). SIN3A binds HDAC1 and HDAC2, and mediates transcriptional repression through
interactions with multiple transcription factors and epigenetic regulatory proteins that have been
linked

to

both

positive

and

negative

regulation

of

gene

transcription

(Fig.

2.1D).

HDAC inhibition enhances hippocampal long-term potentiation (LTP), transforming shortterm LTP into long-lasting, transcription-dependent LTP (Levenson et al., 2004; McQuown et al.,
2011). Because SIN3A is a scaffold protein that recruits both HDAC1 and HDAC2 to sites of
transcriptional regulation, we hypothesized that reduced neuronal Sin3a would mimic the effects
of HDAC inhibition and enhance hippocampal LTP. Initially, we tested basal synaptic properties,
paired-pulse facilitation, and synaptic stability at the Schaffer collateral synapses of area CA1.
We found that these electrophysiological properties were unchanged in the Sin3aNH mice,
indicating that synaptic transmission and the stability and health of slices are not affected by
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reduced neuronal Sin3a (Fig. 2.2). In hippocampal slices from wild-type control mice, a single
tetanus (1 sec, 100 Hz) induces short-lasting LTP that typically returns to baseline levels within
one or two hours after stimulation(Havekes et al., 2012; Vecsey et al., 2007). In slices from
Sin3aNH mice, the same weak stimulus produces sustained potentiation that is significantly
higher than in controls (controls, n = 6, avg. of fEPSP slope over final 20 min = 101.25 ± 2.03 %;
Sin3aNH, n = 6, avg. of fEPSP slope over final 20 min = 151.72 ± 10.88 %; repeated measures
ANOVA: genotype, F(1,10) = 7.713, p = 0.0195; Fig. 2.3A). Further, this LTP enhancement in
Sin3aNH slices is blocked by the transcription inhibitor Actinomycin D (Fig. 2.4). Given the
enhancement in hippocampal LTP by Sin3a deletion, we next investigated the ability of an HDAC
inhibitor to further enhance LTP in Sin3aNH mice. As has been demonstrated previously(Vecsey
et al., 2007), the combination of a single tetanus and administration of the HDAC inhibitor
Trichostatin A (TSA) enhances LTP in wild-type control slices (controls + veh, n = 4, avg. fEPSP
slope = 99.71 ± 7.24%; controls + TSA, n = 6, avg. fEPSP slope = 155.01 ± 9.47%; repeated
measures ANOVA: genotype, F(1,16) = 10.604, p = 0.005; treatment, F(1,16) = 5.111, p = 0.038;
genotype × treatment interaction, F(1,16) = 5.151, p = 0.037; Tukey’s post-hoc, controls + veh vs.
controls + TSA, p = 0.026; Fig. 2.3B). However, in Sin3aNH mice, TSA administration did not
enhance LTP compared to vehicle-treated slices (Sin3aNH + veh, n = 4, avg. fEPSP slope =
168.82 ± 2.05%; Sin3aNH + TSA, n = 6, avg. fEPSP slope = 169.34 ± 17.4%; Tukey’s post-hoc,
Sin3aNH + veh vs. Sin3aNH + TSA, p = 0.999; Fig. 2.3C). Further, LTP in Sin3aNH slices was
significantly greater than in vehicle-treated control slices but was similar to TSA-treated control
slices (repeated measures ANOVA with Tukey’s post-hoc test: control + veh vs. Sin3aNH + veh,
p = 0.012; control + veh vs. Sin3aNH + TSA, p = 0.006; control + TSA vs. Sin3aNH + veh, p =
0.894; control + TSA vs. Sin3aNH + TSA, p = 0.862; Fig. 2.3D). The occlusion of the effects of
TSA on LTP in Sin3aNH mice and the similarity of LTP enhancement by Sin3a deletion to LTP
enhancement by HDAC inhibitor treatment suggest that the changes we observe here in synaptic
plasticity are a phenocopy of HDAC inhibition, and that the enhanced LTP phenotypes share a
common underlying mechanism.
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2.3.2. Reduced Sin3a in forebrain excitatory neurons enhances hippocampal long-term
memory
To determine whether reduction of neuronal Sin3a impacts memory consolidation, we
tested associative memory in Sin3aNH animals using the contextual fear conditioning paradigm.
First, we tested long-term memory in Sin3aNH and wild type control animals in the foreground
contextual fear paradigm, a cognitive task that engages the hippocampus(Maren and Fanselow,
1997; Trifilieff et al., 2006). Sin3aNH animals show enhanced long-term memory compared to
controls when tested 24 hrs after conditioning (independent samples Kruskal-Wallis, effect of
genotype: pre-shock, p < 0.13; 24 hr test, p < 0.008; Fig. 2.5A). Consolidation of long-term (24
hr) hippocampal fear memory requires transcriptional activation and translation of new proteins,
but 1 hr short-term memory does not (Bourtchouladze et al., 1998; Igaz et al., 2002). When we
tested a second naïve cohort of animals for short-term contextual fear memory 1 hr after training,
we found no differences in the freezing responses of Sin3aNH and control animals to the training
context (two-way ANOVA; genotype F(1,44) = 0.05, p < 0.83; phase F(1,44) = 94.1, p < 0.001; Fig.
2.5B). Previous studies of fear learning circuitry suggest that associative fear conditioning to a
tone cue is dependent on the amygdala, but not on the hippocampus (Phillips and LeDoux, 1992;
Maren, 2005). When we conditioned a third cohort of Sin3aNH animals in the tone cued fear task,
no differences were seen in either baseline freezing pre-CS, or during CS tone presentation (twoway ANOVA: genotype F(1,22) = 0.1, p < 0.77; phase F(1,22) = 21.0, p < 0.001); Fig. 2.5C). This
finding suggests that the memory enhancements observed are specifically due to changes in
hippocampal function. As a next step, we examined mice for anxiety-related behaviors in the
elevated zero maze. Sin3aNH mice show increased time spent in the open sections (independent
samples t-test, p < 0.01) compared to controls, a result suggestive of decreased anxiety in the
Sin3aNH animals (Fig. 2.5D). The low levels of anxiety-like behaviors in the Sin3aNH mice
together with the absence of changes in both 1hr contextual and cued fear responses strongly
argue against general fear abnormalities in these animals. Rather, these results indicate that
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reducing the function of the SIN3A co-repressor in excitatory neurons enhances hippocampal
long-term memory.
2.3.3. Reduction of neuronal SIN3A changes memory-related gene expression and
synaptic signaling.
The effects of SIN3A depletion on transcription-dependent forms of long-term memory
and synaptic plasticity support a role for the SIN3A-HDAC complex in regulating the expression of
genes involved in neuronal plasticity. We focused our studies on specific gene loci linked to
memory and synaptic plasticity that were shown by others to be regulated by both HDAC2 and
SIN3A (NHGRI ENCODE) (Guan et al., 2009; Kundaje et al., 2012). To investigate whether
expression of these candidate target genes is altered in Sin3aNH mice, we collected hippocampal
tissue from Sin3aNH and control animals 1 hr after contextual fear conditioning and measured
mRNA transcript levels by quantitative RT-PCR.

Neuronal depletion of SIN3A alters mRNA

expression of a subset of HDAC2-regulated synaptic genes, increasing levels of transcripts
encoding synaptic scaffold Homer1 and cyclin-dependent kinase Cdk5 (Student’s t-test: Homer1,
p < 0.001; Cdk5, p < 0.02; Gria1, p < 0.26; Grin2a, p < 0.61; Grin2b, p < 0.02; CaMKIIα, p <
0.34; Fig. 2.6A). Homer1 and Cdk5 are implicated in memory consolidation and both proteins
function in a common pathway regulating the localization and function of type I mGluRs, so we
further investigated the role of HOMER1 and mGluR signaling in the Sin3aNH animals (Orlando
et al., 2009; Mahan et al., 2012). Two classes of HOMER1 isoforms modulate mGluR signaling at
the synapse (Shiraishi-Yamaguchi and Furuichi, 2007). Long Homer1 isoforms promote mGluR
signaling and recruit mGluRs to the post-synaptic density (Mao et al., 2005; Tu et al., 1999; Xiao
et al., 1998). Short isoforms of Homer1 act in a dominant negative manner to uncouple mGluRs
from the post-synaptic density and from downstream effector molecules (Bottai et al., 2002;
Kammermeier and Worley, 2007). A more detailed examination of Homer1 mRNA expression in
Sin3aNH animals revealed an increase in expression across the Homer1 locus, including regions
specific to both short isoforms (Homer1a-specific UTR following exon 5, and Ania-3 specific exon
A) and long isoforms (exon 10) (Student’s t test: exon 1, p < 0.02; Homer1a, p < 0.01; Ania-3, p <
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0.08; exon10, p < 0.01; Fig. 2.6B and Fig. 2.7C & D). These data provide evidence of synaptic
changes that accompany Sin3a deletion, and suggested a mechanism that could support the
memory and plasticity phenotype observed in Sin3aNH mice through changes in Group I mGluR
function.
The Group I mGluRs (mGluR1α and mGluR5), have been shown to play important roles
in several forms of memory and synaptic plasticity (Jia et al., 1998; Manahan-Vaughan and
Braunewell, 2005; Neyman and Manahan-Vaughan, 2008; Ménard and Quirion, 2012a), and are
upstream of a number of signaling pathways that contribute to plastic processes (Fig. 2.8A),
including intracellular Ca

2+

release, IP3/DAG signaling and PKC activation, ultimately leading to

the phosphorylation and activation of ERK1/2 (Anwyl, 2009; Piers et al., 2012). Compounds that
facilitate activation of mGluR5 enhance performance in rodent learning paradigms (Balschun et
al., 2006; Ayala et al., 2009; Uslaner et al., 2009). Because the reduction of forebrain SIN3A was
accompanied by the enhancement of long-term memory and long-term potentiation, as well as
the upregulation of both Homer1 and Cdk5 mRNA levels, we hypothesized that the observed
memory and LTP enhancements could be attributed to increased function of synaptic Type 1
mGluRs. We chose to assay levels of ERK1/2 phosphorylation after contextual fear conditioning
as an initial test of the memory-related signaling cascades downstream of the Group I mGluRs.
ERK phosphorylation is essential for memory formation and synaptic plasticity (Thomas and
Huganir, 2004; Trifilieff et al., 2006), is regulated by mGluR1α/5 activity (Mao et al., 2005), and is
necessary for Homer1/mGluR-mediated enhancement of LTP (O’Riordan et al., 2014). We
measured activation of ERK signaling pathways in hippocampal neurons one hour after
contextual fear conditioning using immunostaining for phosphorylated ERK1/2 in sections from
both Sin3aNH and control mice (Fig. 2.6C and Fig. 2.9). Quantification of the immunostained
cells revealed a higher number of phospho-ERK1/2 positive cells in area CA1, but not in area
CA3 or in the dentate gyrus (DG), of Sin3aNH mice compared to control littermates (n =10 for
each group; CA1 t-test, p = 0.0296; CA3 t-test, p = 0.46; DG, t-test, p = 0.0864; Fig. 2.6 D).
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These results suggest that a reduction in neuronal Sin3a leads to elevated expression of the
mGluR scaffold Homer1, and increased activity in mGluR signaling pathways.
2.3.4. Reduction of neuronal Sin3a changes mGluR contributions to long term potentiation
Changes in Homer1 expression have been linked to changes in synaptic plasticity, and
previous studies have shown that increasing the expression of long-form Homer1 alters signaling
through mGluR1α/mGluR5 in long-lasting forms of synaptic plasticity (Gerstein, O’Riordan,
Osting, Schwarz, & Burger, 2012; Klugmann et al., 2005). Late phase LTP in wild-type
hippocampal slices requires activity of both mGluR1 and mGluR5, but slices expressing long
isoform Homer1c exhibited a form of LTP that did not require mGluR1 signaling (Gerstein et al.,
2012). To investigate whether the changes we observed in Homer1 expression in the Sin3aNH
mice affect the contributions of mGluR1α and mGluR5 to synaptic plasticity, we induced L-LTP
using spaced 4-train stimulation in the presence of either the mGluR1α antagonist LY367385 or
the mGluR5 antagonist MPEP (Neyman and Manahan-Vaughan, 2008). When slices from wild
type control mice and Sin3aNH mice were stimulated with this protocol in the absence of drug
treatment no differences in LTP were observed, indicating L-LTP maintenance is not changed by
Sin3a depletion (Fig. 2.10). In slices from wild type control mice, antagonizing either of the Type I
mGluRs reduced LTP compared to vehicle-treated slices (controls + veh, n=6, avg. fEPSP slope
= 182.24 ± 4.67%; controls + LY367385, n = 5, avg. fEPSP slope = 121.82 ± 20.67%; controls +
MPEP, n = 5, avg. fEPSP slope = 120.96 ± 6.56%; repeated measures ANOVA: genotype, F(1,28)
= 17.894, p = 0.00023; treatment, F(2,28) = 20.453, p = 0.000003; genotype × treatment interaction,
F(2,28) = 7.924, p = 0.0019; Tukey’s post-hoc test, controls + vehicle vs. controls + MPEP, p =
0.018; controls + vehicle vs. controls + LY367385, p = 0.008; Fig. 2.11A). In slices from Sin3aNH
mice, the administration of MPEP significantly reduced LTP, while antagonism of mGluR1α with
LY367385 did not have a significant effect on potentiation (Sin3aNH + veh, n = 5, avg. fEPSP
slope = 192.29 ± 17.4%; Sin3aNH + LY367385, n = 6, avg. fEPSP slope = 213.12 ± 7.62%;
Sin3aNH + MPEP, n = 7, avg. fEPSP slope = 116.06 ± 10.94%; Tukey’s post-hoc test, Sin3aNH
+ vehicle vs. Sin3aNH + MPEP, p = 0.0002; Sin3aNH vehicle vs. Sin3aNH + LY367385, p =
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0.999; Sin3aNH + LY367385 vs. Sin3aNH + MPEP, p = 0.0002; Fig. 2.11B). These results
indicate that LTP in Sin3aNH mice is independent of mGluR1α but requires mGluR5, suggesting
that increased long Homer1 levels result in very specific changes in the function of the Group I
mGluRs at CA1 synapses.
2.4. DISCUSSION
Inhibition of HDAC activity enhances memory and facilitates neuronal plasticity (Peixoto
and Abel, 2013). However, the precise molecular mechanisms by which these manipulations
ultimately affect synaptic and neuronal function are not understood, and the identification of
functional effector genes targeted by HDAC inhibition has been challenging. Here, we targeted
the co-repressor SIN3A, a scaffolding protein that coordinates a multi-functional co-repressor
complex containing several histone-modifying enzymes including HDAC1 and HDAC2. Mice
carrying a conditional neuronal depletion of Sin3a have reduced levels of protein in the
hippocampus. We observed that chronic reduction of SIN3A is accompanied by enhanced
hippocampal synaptic plasticity and memory formation, mimicking the effects of acute HDAC
inhibitor administration. These enhancements in memory and plasticity are accompanied by
increased expression of several neuronal genes regulated by HDAC2 and SIN3A, including
Homer1 and Cdk5. We observed an increase in expression of constitutively expressed long
isoforms of Homer1, which organize group I mGluRs at the synapse, and increased
phosphorylation of ERK, a downstream target of group I mGluRs. Alterations in Homer1 and
mGluR functioning has profound effects on synaptic structure, plasticity, and cognition (Ayala et
al., 2009; Gerstein et al., 2012; Klugmann et al., 2005; Ménard & Quirion, 2012).
The upregulation of Homer1 and the observed shift in the requirements for Group I
mGluR signaling in Sin3aNH L-LTP indicate that the enhancements we observed in
hippocampus-dependent memory and hippocampal synaptic plasticity may be attributable to a
change in Homer1/mGluR5 signaling at the synapse, and suggest a model by which these
changes could occur. Long isoforms of Homer1 bind to the intracellular C-terminal tails of the
Group I mGluRs and linking them to the postsynaptic density in dendritic spines (Xiao et al.,
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1998; Tu et al., 1999). Under baseline conditions both mGluR1α and mGluR5 are linked to the
postsynaptic density through interactions with long Homer1b/c (Fig. 2.8A)., Group I mGluRs are
associated with several key signaling pathways associated with memory and plasticity (Mao et
al., 2005; Ayala et al., 2009; Ménard and Quirion, 2012a), and under baseline conditions the
activation of both mGluR1α and mGluR5 are necessary for long-term potentiation (Neyman and
Manahan-Vaughan, 2008) (Fig. 2.12). In Sin3aNH mice, higher levels of long-form Homer1b/c
may recruit more mGluR5 to the postsynaptic density (Fig. 2.8B). Such an increase in synaptic
mGluR5 could reduce the requirement for mGluR1α in LTP, and could also facilitate LTP
2+

enhancement via increases in [Ca ]i(Kotecha et al., 2003; Mao et al., 2005; Ayala et al., 2009),
downstream signaling through PKC and ERK (Kotecha et al., 2003; Mao et al., 2005; Ayala et al.,
2009), and even NMDA receptor potentiation through Src kinase (Kotecha et al., 2003) (Fig. 2.8).
Pharmacological inhibition of HDAC enzymes could be an important component of future
therapies for not only at improving cognition, but also treating cognitive and neurodegenerative
disorders(Abel and Zukin, 2008; Fischer et al., 2010). One of the major obstacles to developing
HDAC inhibitor drugs as neural therapeutic agents is a lack of understanding of basic molecular
mechanisms driving the synaptic and behavioral effects of these compounds. Here, we show that
neuronal depletion of the HDAC-coordinating co-repressor SIN3A alters the expression of HDACregulated genes as well as Group I mGluR function and downstream signaling through ERK, and
these effects on mGluR5/Homer1 signaling likely mediate the enhancements in memory and
plasticity observed in Sin3aNH mice. Indeed, it has recently been demonstrated that increasing
mGluR signaling via positive allosteric modulators enhances hippocampal long-term potentiation,
long-term depression, and long-term memory consolidation in rodents(Ayala et al., 2009), while
disruption of Group I mGluR function has been implicated in many cognitive and neurological
disorders that may also be influenced by histone acetylation (including anxiety disorder, Fragile X
syndrome, Parkinson’s disease, and schizophrenia) (Szumlinski et al., 2006; Nicoletti et al., 2011;
Piers et al., 2012). These findings provide evidence linking mGluR signaling at the synapse to
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epigenetic mechanisms regulating gene expression for the first time, paving the way for novel
therapeutics to treat cognitive deficits.
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CHAPTER 2 FIGURE LEGENDS
Figure 2.1. Sin3a neuronal hypomorphs have reduced levels of SIN3A in the hippocampus.
A. Structure of murine Sin3a locus with exon 4 highlighted.
promoter-driven Cre at one or more Sin3a

LoxP

Recombination via CaMKIIα

alleles results in deletion of exon 4 of Sin3a. B.

Sin3aNH mice have decreased SIN3A protein levels (arrows) in the hippocampus by immunoblot.
C. Quantification of optical density of SIN3A bands (arrows in panel C) normalized to β tubulin
loading control (controls n = 6, Sin3aNH n = 5, one way ANOVA, F (1,9) = 32.74, ***p < 0.001). D.
The HID domain and four PAH domains of SIN3A mediate interactions with co-factors, epigenetic
modifiers, and transcription factors. SIN3A-interacting factors have been linked to both activating
(green) and repressive (red) regulation of gene transcription.
Figure 2.2. Sin3aNH conditional mutation does not change basal synaptic properties at the
Schaffer collateral synapses. A. Paired-pulse facilitation was unchanged in hippocampal slices
from Sin3aNH mice (controls n = 18, Sin3aNH n = 16; repeated measures ANOVA: genotype,
F(1,32) = 0.364, p = 0.55; genotype × interval interaction, F(4,128) = 0.769, p = 0.547). B. Inputoutput relationships were not different in Sin3aNH mice compared to wild type controls (controls n
= 18, Sin3aNH n = 16; independent samples t-test on average of regression slopes, t(1,32) = 1.324,
p = 0.189). C. The maximum amplitude of fEPSP slopes recorded in slices from Sin3aNH mutant
mice and wild type control animals were not significantly different (controls n = 18, Sin3aNH n =
16; independent samples t-test, t(1,32) = 0.11, p = 0.913). D. Baseline synaptic response in the
absence of stimulation is not altered in Sin3aNH mutants when compared to wild type controls
(controls, n = 3, avg. fEPSP slope = 94.32 ± 7.78%; Sin3aNH, n = 3, avg. fEPSP slope = 95.12 ±
6.58%; repeated measures ANOVA: genotype, F(1,4) = 0.092, p = 0.777).
Figure 2.3. Neuronal deletion of SIN3A enhances hippocampal LTP. A. LTP was induced by
a single 100 Hz, 1 s duration stimuli (indicated by arrow). LTP maintenance was significantly
enhanced in Sin3aNH mice (controls, n = 6, avg. of fEPSP slope over final 20 min = 101.25 ±
2.03 %; Sin3aNH, n = 6, avg. of fEPSP slope over final 20 min = 151.72 ± 10.88 %; repeated
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measures ANOVA: genotype, F(1,10) = 7.713, *p = 0.0195). B. In control slices, perfusion with
1.65 µM TSA enhanced 1-train LTP compared to vehicle (controls+veh, n = 4, avg. fEPSP slope
= 99.71 ± 7.24%; controls+TSA, n = 6, avg. fEPSP slope = 155.01 ± 9.47%; repeated measures
ANOVA: genotype, F(1,16)=10.604, p = 0.005; treatment, F(1,16)= 5.111, p = 0.038;
genotype×treatment interaction, F(1,16)= 5.151, p = 0.037; Tukey’s post-hoc, controls+veh vs.
controls+TSA, *p = 0.026). C. In Sin3aNH slices, TSA administration did not enhance LTP
compared to vehicle (Sin3aNH+veh, n = 4, avg. fEPSP slope = 168.82±2.05%; Sin3aNH + TSA,
n = 6, avg. fEPSP slope = 169.34 ± 17.4%; Tukey’s post-hoc, Sin3aNH+veh vs. Sin3aNH+TSA, p
= 0.999). D. Average fEPSP slopes over final 20 minutes from all groups. No significant
difference was observed between control + TSA, Sin3aNH+veh, and Sin3a+TSA groups; these
groups all displayed higher potentiation than control+veh slices (repeated measures ANOVA,
Tukey’s post-hoc, control+veh vs. Sin3aNH+veh, *p = 0.012; control+veh vs. Sin3aNH+TSA, **p
= 0.006; control+TSA vs. Sin3aNH+veh, p = 0.894; control+TSA vs. Sin3aNH+TSA, p = 0.862).
Figure 2.4. Enhanced LTP in Sin3aNH slices is transcription-dependent. Following a 20
minute baseline recording, hippocampal slices from Sin3aNH mutant mice were perfused with the
RNA synthesis inhibitor Actinomycin-D (ActD, 25 μM) or vehicle (0.05 % DMSO) in aCSF for the
remainder of the recording period. A single 1 sec, 100 Hz tetanus was delivered at 40 minutes
(indicated by arrow). LTP in vehicle-treated Sin3aNH slices was significantly higher than in ActD
treated slices, indicating that transcription is necessary for the LTP enhancement observed in
Sin3aNH mutant mice (Sin3aNH + vehicle, n = 4, avg. fEPSP slope = 168.32 ± 17.74%; Sin3aNH
+ ActD, n = 4, avg. fEPSP slope = 110.55 ± 6.23%; repeated measures ANOVA: treatment, F (1,6)
= 9.430, *p = 0.022).
Figure 2.5. Sin3aNH mice have enhanced long-term memory. A. Sin3aNH animals have
enhanced 24 hr long-term memory for contextual fear conditioning (n = 34 control, n = 32
Sin3aNH, independent samples Kruskal-Wallis test, effect of genotype: pre-shock p < 0.13; 24 hr
test **p < 0.008). B. No effect of Sin3a reduction on 1 hr short-term memory for contextual fear
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conditioning (n = 10 control, n = 12 Sin3aNH; two-way ANOVA, genotype, F(1,44) = 0.05, p < 0.83;
phase, F(1,44) = 94.1, p < 0.001). C. Cued fear long-term memory is not altered in Sin3aNH
animals (n = 6 control, n = 7 Sin3aNH; two-way ANOVA: genotype, F(1,22) = 0.1; p < 0.77; phase,
F(1,22) = 21.0, p < 0.001). D. In the elevated zero maze, Sin3aNH mice spend more time in the
open arms (n =12 per group; independent samples t-test, t(1,22) = 3.342, **p < 0.01), and less time
in the closed arms (t-test, **p < 0.01) compared to wild-type control animals.
Figure 2.6. Reduction in SIN3A increases Homer1 expression and affects signaling
cascades downstream of mGluR. A. Expression of genes regulated by HDAC2 and SIN3A in
hippocampus of Sin3aNH mice 1hr after fear conditioning. Levels of Homer1 (unpaired t-test, n =
7 per group; t(1,12)= -6.448, ***p < 0.001) and Cdk5 (t(1,12) = -2.836, *p < 0.02) are increased
relative to controls, and the level of Grin2b is decreased (t(1,12) = 3.038, * p < 0.02). B.
Expression of Homer1 exons encoding both short (Homer1a) and long (containing exon 10)
isoforms is elevated in Sin3aNH mice (n = 7 control, n = 6 Sin3aNH; unpaired t-test, Exon 1 t(1,11)
= -2.877 *p < 0.02; Homer1a t(1,11) = -3.313, **p < 0.01; Ania-3 t(1,11) = -2.146, p < 0.08; Exon 10
t(1,11) = -3.251 **p < 0.01). C. Representative images of hippocampal area CA1 showing cells
stained for somatic ERK p42/44 in a Sin3aNH mouse and a control littermate one hour after
contextual fear conditioning. Scale bar = 0.1 mm. D. Quantification of pERK-positive neurons is
dorsal hippocampus following contextual fear conditioning shows a significantly higher number of
cells positive for ERK p42/44 in CA1, but not CA3 or DG, of Sin3aNH mice compared to control
littermates (n = 10 per group; t-test, CA1 *p = 0.0296; CA3 p = 0.46; DG p = 0.0864).
Figure 2.7. Expression of Homer1 exons and mGluR1/5 transcripts. A. mRNA expression of
individual exons of Homer1 in control and Sin3aNH mutant hippocampi 1 hr after training in
contextual fear (t-test, *p < 0.05, **p < 0.01). B. Expression of mGluR5 mRNA is reduced in
Sin3aNH mutants 1hr after contextual fear training (t-test, *p < 0.05). C. Exon structure of
Homer1 and neuronally expressed Homer1 mRNA transcripts. D. Gene structure of Homer1 in
RefSeq in UCSC genome browser (dark purple). ChIPseq analysis of SIN3A binding and histone
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H3K27 acetylation Homer1 locus in CH12 murine B cell lymphoma cell line and melanocyte cells
(MEL) from the TFBS ChIP-seq conducted by ENCODE/Stanford/Yale (NHGRI ENCODE data;
Kundaje et al., 2012). Called peaks are indicated in black and grey bars (significant enrichment
**p < 0.01 compared to input DNA control) above the signal (blue) for each cell line.
Figure 2.8. A model for enhanced synaptic plasticity and mGluR5 function with the
deletion of Sin3a. A. In wild type mice, both mGlur1α and mGluR5 are required for the
maintenance of hippocampal LTP. Group I mGluRs may be found clustered at glutamatergic
synapses by interactions with long-form Homer1 proteins, linking them to the post-synaptic
density and ionic glutamatergic receptors through other scaffolding proteins such as Shank,
GKAP, and PSD95. While there is debate over the exact mechanisms distinct to or shared by
mGluR1α and mGluR5 in CA1 pyramidal neurons, the Group I mGluRs are associated with
several downstream pathways and signaling mechanisms involved in both memory and LTP.
These include release of Ca

2+

2+

from internal stores and increase in [Ca ]i via IP3R signaling;

potentiation of NMDA receptor currents through Src kinase; and activation of PKC and the ERK
signaling cascade. B. A possible mechanism underlying memory and LTP enhancement in
Sin3aNH mutant mice: Neuronal deletion of Sin3a is accompanied by changes in expression of
several HDAC-regulated genes encoding synaptic proteins, including increased Homer1 and
Cdk5 expression. Increased levels of long-form Homer1b/c facilitate recruitment and clustering of
mGluR5 at the postsynaptic density, while increased Cdk5 leads to greater levels of
phosphorylation of the C-terminal tails of mGluRs, enhancing mGluR5/long-form Homer1
interaction and contributing further to localization of mGluR5 at the PSD. The increase in
2+

synaptically-located mGluR5 could contribute to enhanced LTP through increased [Ca ]i and
increased signaling via downstream pathways, and reduce the necessity of mGluR1α signaling at
the synapse.
Figure 2.9. Phospho-ERK immunostaining in hippocampal sections following contextual
fear conditioning. Representative images of hippocampal areas CA3 and DG in sections from
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control mice (A, C) and Sin3aNH (B, D) that were immunostained for phospho-ERK1/2. Scale
bars indicate 0.1 mm. Quantification of phospho-ERK positive cells in these regions found no
significant effect of genotype (n=10 for each group; CA3 t-test, p = 0.46; DG, t-test, p = 0.0864).
Figure 2.10. L-LTP is not affected by conditional neuronal Sin3a deletion. Four trains of
stimulation spaced five minutes apart (indicated by arrows) induces L-LTP of similar magnitude in
both wild type control slices and slices taken from Sin3aNH mice (controls, n = 5, avg. fEPSP
slope = 143.1 · 9.22%; Sin3aNH, n = 6, avg. fEPSP slope = 146.59 · 19.01%; repeated
measures ANOVA: genotype, F(1,9 )= 0.028, p = 0.879).
Figure 2.11. Reduction in SIN3A affects the role of mGluR signaling in hippocampal LTP.
A. In control animals, LTP induced by four spaced trains of stimulation is impaired by the
administration of the mGluR1α antagonist LY367385 or the mGluR5 antagonist (controls + veh, n
= 6, avg. fEPSP slope = 182.24 ± 4.67%; controls + LY367385, n = 5, avg. fEPSP slope = 121.82
± 20.67%; controls + MPEP, n = 5, avg. fEPSP slope = 120.96 ± 6.56%; repeated measures
ANOVA: genotype, F(1,28) = 17.894, p = 0.00023; treatment, F(2,28) = 20.453, p = 0.000003;
genotype × treatment interaction, F(2,28) = 7.924, p = 0.0019; Tukey’s post-hoc test, controls +
vehicle vs. controls + MPEP, *p = 0.018; controls + vehicle vs. controls + LY367385, **p = 0.008).
B. In Sin3aNH slices, application of an mGluR5 antagonist impairs spaced 4-train LTP, while
antagonizing mGluR1α has no effect (Sin3aNH + veh, n = 5, avg. fEPSP slope = 192.29 ± 17.4%;
Sin3aNH + LY367385, n=6, avg. fEPSP slope = 213.12 ± 7.62%; Sin3aNH + MPEP, n = 7, avg.
fEPSP slope = 116.06 ± 10.94%; Tukey’s post-hoc test, Sin3aNH+ vehicle vs. Sin3aNH + MPEP,
***p = 0.0002; Sin3aNH vehicle vs. Sin3aNH + LY367385, p = 0.999; Sin3aNH + LY367385 vs.
Sin3aNH + MPEP, ***p = 0.0002).
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Figure 2.1. Sin3a neuronal hypomorphs have reduced levels of SIN3A in the hippocampus.
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Figure 2.2. Sin3aNH conditional mutation does not change basal synaptic properties at the
Schaffer collateral synapses.
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Figure 2.3. Neuronal deletion of SIN3A enhances hippocampal LTP.
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Figure 2.4. Enhanced LTP in Sin3aNH slices is transcription-dependent.
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Figure 2.5. Sin3aNH mice have enhanced long-term memory.
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Figure 2.6. Reduction in SIN3A increases Homer1 expression and affects signaling
cascades downstream of mGluR.
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Figure 2.7 Expression of Homer1 exons and mGluR1/5 transcripts.
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Figure 2.8. A model for enhanced synaptic plasticity and mGluR5 function with the
deletion of Sin3a.
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Figure 2.9. Phospho-ERK immunostaining in hippocampal sections following contextual
fear conditioning.
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Figure 2.10. L-LTP is not affected by conditional neuronal Sin3a deletion.
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Figure 2.11. Reduction in SIN3A affects the role of mGluR signaling in hippocampal LTP.
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CHAPTER 3: The NR4A orphan nuclear receptors mediate transcriptiondependent hippocampal synaptic plasticity

Abstract. Memory consolidation and long-term potentiation require activity-dependent gene
transcription, coordinated by an array of transcription factors. Many members of the nuclear
receptor superfamily of transcription factors are expressed in the hippocampus immediately after
learning, including the Nr4a family of orphan receptors. These activity-dependent transcription
factors are critical for hippocampus-dependent contextual fear and object recognition memory,
but their role in hippocampal synaptic function is unknown. In this study, we hypothesized that
Nr4a transcription factor function is also necessary for hippocampal long-term potentiation. We
used a strain of mice expressing a dominant-negative Nr4a transgene. Hippocampal slices from
Nr4aDN mutant mice exhibited impairments in transcription-dependent long-term potentiation and
were not sensitive to LTP enhancement by the HDAC inhibitor TSA. These results demonstrate
that NR4A transcription factor function mediates mechanisms of synaptic plasticity in the
hippocampus.
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3.1. INTRODUCTION
In the hippocampus, the consolidation of long-term memory (LTM) and the maintenance
of long-term potentiation (LTP) both depend on cAMP signaling, PKA activity, gene transcription,
and de novo protein synthesis (Abel et al., 1997; Huang & Kandel, 1994; Igaz et al., 2002;
Nguyen, Abel, & Kandel et al., 1994; Pittenger et al., 2002). A number of transcription factors are
known to support activity-driven transcription in neurons, including well-characterized proteins
such as cAMP response element-binding protein (CREB) and the immediate early genes C/EBP
and Zif268 (see Alberini, 2009 for review). The large family of nuclear receptor transcription
factors is increasingly being investigated for its role in memory and plasticity, and the potential of
some nuclear receptors to serve as therapeutic targets in disorders of cognition (Hawk & Abel,
2011; Hawk et al., 2012). For example, agonists for the liver X receptor (LXR), retinoic acid
receptor (RAR), retinoid X receptor (RXR), and the peroxisome proliferator-activated receptor
gamma (PPARγ) have been found to improve memory and synaptic plasticity in mouse models of
disease, most notably in mouse models of Alzheimer’s disease (Cramer et al., 2012; Jiang et al.,
2008; Pedersen et al., 2006; Wesson et al., 2011).

Although most of the nuclear receptors are regulated by lipophilic ligands that readily
cross the nuclear membrane, some are considered “orphan” receptors. These proteins either
have no known endogenous ligand, or operate independently of ligand binding. One such group
of orphan receptors is the Nr4a subfamily, made up of three closely related members
(Nr4a1/Nur77/NGFI-B, Nr4a2/Nurr1/HZF-3, and Nr4a3/NOR-1/TEC) (Paulsen et al., 1992;
Wansa et al., 2003; Maxwell and Muscat, 2006; Hawk and Abel, 2011). The NR4A proteins are
involved in activity-dependent processes in numerous cell types, supporting such phenomena as
apoptosis, metabolism, dopaminergic development, and inflammatory response (for review see
Hawk & Abel, 2011). The Nr4a genes are immediate-early genes transcribed rapidly in response
to external stimuli (Peña de Ortiz and Jamieson, 1996). Mature NR4A proteins are capable of
both positively and negatively regulating the transcription of their downstream targets (Johnson et
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al., 2011), which include plasticity related genes such as Bdnf1 and Fosl2 (Hawk et al., 2012;
Volpicelli et al., 2007).

In many systems, Nr4a transcription is controlled by the cAMP/PKA/CREB signaling
pathway (Kovalovsky et al., 2002; Lemberger et al., 2008), which is a cascade vital to
transcription of other memory- and plasticity-related genes (Josselyn and Nguyen, 2005). In the
hippocampus, training on different behavioral tasks increases the expression of one or all of the
Nr4a genes in discrete anatomical regions (Hawk et al., 2012; McNulty et al., 2012; Peña de
Ortiz, Maldonado-Vlaar, & Carrasquillo, 2000). Memory enhancement by intrahippocampal
administration of the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) further increases
the expression of Nr4a1 and Nr4a2 (Vecsey et al., 2007), and knockdown of Nr4a2 attenuates
memory enhancement in mice lacking the histone deacetylase HDAC3 (McQuown et al., 2011).
Further, disrupting NR4A function by knockout (Rojas et al., 2007), siRNA knockdown (McNulty et
al., 2012), antisense oligonucleotides (Colón-Cesario et al., 2006), or expression of a dominantnegative protein (Hawk et al., 2012) impairs learning and long-term memory. To define the
importance of the Nr4a transcription factors in hippocampal synaptic function, we employed a
transgenic dominant-negative NR4A protein to inhibit NR4A function. We then measured synaptic
function and long-term potentiation at the Schaffer collateral-CA1 synapses. The results
presented here support an important role for the NR4A transcription factors in the maintenance of
long-term synaptic plasticity, consistent with their role in the consolidation of long-term
hippocampus-dependent memory.

3.2. METHODS
Subjects
Mice were maintained under standard conditions consistent with National Institute of
Health guidelines for animal care and use. All experimental procedures described here were
consistent with NIH guidelines and approved by the Institutional Animal Care and Use Committee
of the University of Pennsylvania. Mice were maintained on a 12:12 light:dark cycle with lights on
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at 7 AM. Food and water were provided in their home cages ad libitum. Tissue collection and
electrophysiological testing were conducted on male and female adult (2 to 6 months old) animals
during the light portion of the cycle, with animals being sacrificed at approximately 11 AM.
The Nr4aDN mice were generated as previously described (see Hawk et al, 2012).
Briefly, the transgenic Nr4aDN mice express a dominant-negative NR4A construct under the
control of the tetracycline operator (tetO). This strain was crossed with transgenic CaMKIItetracycline transactivator (CaMKII-tTA) mice (Mayford et al., 1996) to produce double-transgenic
mice that express the Nr4aDN construct postnatally in excitatory forebrain neurons. The
dominant-negative NR4A construct is a form of NR4A1 that contains the dimerization domain and
DNA-binding domain but lacks the transactivation domain, and instead contains an HA and an
YFP tag (Hawk et al., 2012; Robert, Martin, & Tremblay, 2006). Double-trasngeic (CaMKII-tTA +;
Nr4aDN +) males were bred to C57BL/6J females. From the resulting litters experimental
Nr4aDN mutant mice were double-transgenic (CaMKII-tTA +; Nr4aDN +), while non-transgenic
and single-transgenic littermates served as controls. Mice were raised in the absence of
doxycycline, but were placed on doxycycline chow after weaning to suppress transgene
expression as required for control experiments.
Electrophysiological recordings
To assess the effects of Nr4a dominant-negative transgene expression on hippocampal
LTP, mice were killed by cervical dislocation and their hippocampi were quickly dissected in icecold oxygenated artificial CSF (aCSF; 124 mM NaCl, 4.4 mM KCl, 1.3 mM MgSO4ˍ7H2O, 1
NaH2PO4ˍH2O, 26.2 mM NaHCO3, 2.5 mM CaCl2ˍ2H2O, 10 mM glucose). Transverse
hippocampal slices were cut 400µm thick using a Stoelting tissue chopper, placed in an interface
recording chamber, and perfused with oxygenated aCSF at 28.0°C. Slices were allowed to
recover for at least 2 hours before beginning electrophysiological recordings. Single-pathway
recordings were made using a single bipolar stimulating electrode made from nichrome wire (A-M
Systems) placed in the stratum radiatum of the CA1 subfield and used to elicit action potentials in
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the axons of CA3 pyramidal neurons. Field potentials (fEPSPs) were recorded using an aCSFfilled glass microelectrode (A-M Systems) with a resistance between 0.5 and 5 MΩ placed in the
stratum radiatum region of CA1. Data collection was handled by Clampex software (Molecular
Devices, Palo Alto, CA) and was analyzed using Clampfit (Molecular Devices). The peak fEPSP
amplitude induced by the stimulating electrode was required to be at least 5mV, and stimulus
intensity during the recording was set to produce a response of 40% of the maximum fEPSP
amplitude. Stimulations occurred once every minute. Baseline responses were recorded for 20
minutes before LTP induction or drug application. To examine early-phase LTP (E-LTP) one train
of stimuli at 100 Hz for 1s was applied through the stimulating electrode. To examine late-phase
LTP (L-LTP) four trains of stimuli at 100 Hz for 1s were delivered 5 min apart (spaced 4-train
HFS), or a theta-burst (TBS) protocol consisting of 15 pulses of 40 ms duration delivered at a rate
of 5Hz was used. Recordings continued for 160 minutes after LTP induction. The initial slopes of
the recorded fEPSPs were normalized to the averaged slope of the 20 baseline traces and
expressed as a percentage of this baseline. Input–output characteristics in area CA1 were
investigated by recording the fEPSPs elicited by stimuli of decreasing intensity. The initial fEPSP
slopes were plotted against the amplitudes of corresponding presynaptic fiber volleys and fit with
linear regressions. The maximum elicited fEPSP slope was also recorded as a measure of
synaptic strength. Paired-pulse facilitation, a short-term form of synaptic plasticity and a measure
of presynaptic function, was measured in slices from control and Nr4aDN mutant mice. Paired
stimuli were delivered with varying interpulse intervals (300, 200, 100, 50 and 25̳ms) and the
initial fEPSP slope from the second stimulus was plotted relative to the slope from the first
stimulus to give the facilitation ratio.
Drugs
The HDAC inhibitor Trichostatin A (TSA; AG Scientific) was dissolved at 32 mM in 100%
ethanol and diluted to a 16.5 mM stock solution in 50% ethanol. Aliquots of the TSA stock
solution were stored at -20°C. TSA was diluted to a final concentration of 1.65 uM in oxygenated
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aCSF and slices were perfused with drug or vehicle (0.005% ethanol in aCSF) for 20 minutes
prior to stimulation and throughout the remainder of the recording (Vecsey et al., 2007).
Statistical analysis
The initial slope of the recorded fEPSP was used to quantify synaptic potentiation,
normalized to the averaged 20-minute baseline value. Between-group differences in the
maintenance of LTP were analyzed by performing a repeated measures ANOVA on the final 20minute epoch of the recordings (Vecsey et al., 2007, 2009). When multiple comparisons were
made to a control group, a two-way repeated measures ANOVA with Dunnett’s post-hoc test was
used with genotype and doxycycline treatment as factors and fEPSP slope as the dependent
variable. To evaluate potential differences in paired-pulse facilitation a two-way repeated
measures ANOVA was used with genotype and inter-stimulus interval as factors and the
facilitation ratio as the dependent variable. For evaluation of input–output characteristics a t-test
was performed comparing the average linear regression slopes for control mice and Nr4aDN
mutants. Synaptic strength was analyzed with a t-test comparing the maximum elicited fEPSP
slopes in control and mutant mice. All statistical analyses were performed using STATISTICA 7
software (StatSoft Inc.; Tulsa, OK). Significance for all tests was set at p < 0.05.

3.3. RESULTS
3.3.1.

Nr4aDN

expression

does

not

change

basal

synaptic

properties

The Nr4a genes are transcribed as immediate-early genes in response to external stimuli
such as synaptic activation and in turn they regulate a number of genes, including some genes
involved in synaptic plasticity (Hawk & Abel, 2011). The dominant-negative form of Nr4a
expressed in mutant mice blocks transcriptional activation by the NR4A proteins, so we began by
examining basal synaptic properties to determine if this attenuation of NR4A-mediated
transcription caused any disturbances in normal synaptic function at the Schaffer collateral
synapses. Paired-pulse facilitation (Fig. 3.1A), a form of short-term plasticity and a measure of
presynaptic release mechanisms, was unchanged by Nr4aDN expression (p = 0.267). The input-
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output relationship (Fig. 3.1B) in the Nr4aDN mutants was not altered compared to control mice
(p = 0.573), indicating that the relationship between presynaptic release and postsynaptic
response was unchanged. Synaptic strength, measured as the maximum fEPSP slope induced
by stimulation (Fig. 3.1C), was comparable between genotypes (control = 9.25 · 0.91 –mV/ms,
Nr4aDN = 9.62 ± 0.6 –mV/ms; t-test,Gp = 0.791). Further, field recordings in the absence of LTPinducing stimulation (Fig. 3.1D) did not significantly deviate from control baseline responses over
time (p = 0.256) indicating that transgene expression does not affect synaptic stability or the
health of hippocampal slices.
3.3.2. Expression of the dominant-negative Nr4a transgene impairs transcriptiondependent hippocampal LTP
Previously, our lab has found that Nr4aDN mutant mice have deficits in hippocampusdependent long-term contextual fear memory but not in short-term memory (Hawk et al, 2012).
Other labs have found that interfering with hippocampal Nr4a2 function by heterozygous deletion
(Rojas et al., 2007) or by antisense injection (Colón-Cesario et al., 2006) impairs some forms of
long-term memory, while siRNA knockdown of Nr4a1 or Nr4a2 impairs specific forms of object
memory (McNulty et al, 2012). Hippocampal synaptic LTP, which is defined as an activitydependent change in synaptic strength between neurons, is a long-lasting form of synaptic
plasticity that shares many of its underlying molecular mechanisms with long-term memory
(Huang et al., 1996; Martin, Grimwood, & Morris, 2000). LTP can be divided into two distinct
categories: transient early LTP (E-LTP) that only lasts for one to two hours and is independent of
transcription, and late LTP (L-LTP) which lasts for several hours and requires both transcription
and translation (Huang & Kandel, 1994; Nguyen et al., 1994).
To further explore the role of the Nr4a family in activity-dependent hippocampal function
and long-term changes in synaptic strength, we examined two forms of transcription-dependent
L-LTP in slices from Nr4aDN mutant mice (Fig. 3.2). In control animals, the delivery of four 1s,
100Hz stimuli spaced five minutes apart powerfully induces long-lasting long-term potentiation
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(Fig. 3.2A) (control, avg. of fEPSP slope over final 20 min. = 195.6 · 23.9%). In hippocampal
slices from Nr4aDN mutant animals the same stimulation protocol induced potentiation initially but
failed to produce maintained L-LTP (Fig. 3.2A) (Nr4aDN, avg. of fEPSP slope over final 20 min. =
112.5 · 10.5%), and the fEPSP slope returned to near-baseline levels that were significantly
lower than controls (p = 0.016). A more physiologically relevant stimulation protocol was also
tested. Theta-burst stimulation, which mimics the natural pattern of input from the axons of CA3
pyramidal neurons to the dendrites of CA1 neurons (Nguyen and Kandel, 1997), also elicited LLTP in WT control mice but not in Nr4aDN mutant littermates (Fig. 3.2B) (avg. of fEPSP slope
over final 20 minutes for controls = 184.4 · 11.6%, for Nr4aDN = 113.7% · 9.4%; control vs.
Nr4aDN, p = 0.002). These data suggest that transcription-dependent forms of plasticity in the
hippocampus depend on the normal activity of the NR4A transcription factors and their
downstream target genes.
3.3.3. LTP impairment in Nr4aDN mutant mice depends on transgene expression
The deficits in long-term contextual memory that were reported in Nr4aDN transgenic
mice were rescued by transgene suppression ( Hawk et al., 2012), indicating that observed
impairments were not due to development effects of blocking NR4A protein function. We sought
to address this issue at the synaptic level in Nr4aDN transgenic mice. Nr4aDN mice and
littermate controls were reared in the absence of doxycycline, and then placed on a doxycycline
diet from the time of weaning until they were 2 months old, a 4-week treatment that is sufficient to
suppress expression of the transgene and restore contextual fear memory in Nr4aDN mutant
mice (Hawk et al., 2012). Following this procedure, spaced 4-train stimulation protocol was
applied to slices from both the doxycycline-treated transgenic mice and doxycycline-treated
control animals and found to produce long-lasting LTP (Fig. 3.3) (avg. fEPSP slope over final 20
minutes in ON-DOX controls = 175.6 · 20.8%, in ON-DOX Nr4aDN = 187.7 · 15.4%). To
determine the effects of transgene suppression on LTP, we included our previously-collected offdoxycycline spaced 4-train LTP data (Fig. 3.2A) in our analyses. We compared on- and off-
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doxycycline LTP using a two-way ANOVA (factors: genotype, doxycycline treatment) and found
no significant main effects, but a significant interaction between genotype and doxycycline
treatment (p = 0.03). Post-hoc comparisons revealed that while Nr4aDN mutant L-LTP was
impaired with respect to controls (p = 0.02), this deficit was rescued by transgene suppression
with doxycycline (p = 0.984). In contrast, doxycycline did not affect L-LTP in control mice (p =
0.814). The rescue of LTP impairment by transgene suppression indicates that the loss of NR4Amediated transcription does not permanently alter synaptic function and demonstrates that the
observed deficits in L-LTP are due to transgene expression and not attributable to potential
insertional effects of the transgene.
3.3.4.

Nr4aDN

expression

blocks

LTP

enhancement

by

HDAC

inhibition

Long-term memory and LTP are both enhanced by the pharmacological inhibition of
histone deacetylase (HDAC) enzymes, which produces increases in histone acetylation
(Levenson et al., 2004; Vecsey et al., 2007). These enhancements are dependent on the
transcription factor CREB, and hippocampal administration of the HDAC inhibitor TSA increases
the expression of Nr4a1 and Nr4a2, both Cre-regulated genes (Vecsey et al., 2007). Conditional
knockout of the class I histone deacetylase HDAC3 in mice enhances memory and increases the
expression of Nr4a2, while siRNA knockdown of Nr4a2 abolished the memory enhancement
observed in HDAC3 mutant mice (McQuown et al., 2011). These results indicate that these NR4A
proteins are critical in mediating the memory-enhancing effects of HDAC inhibition. We explored
the possibility that NR4A proteins may also be critical for the LTP-enhancing effects of HDAC
inhibition by testing the ability of TSA to enhance 1-train E-LTP in Nr4aDN mutant mice. A single
1s, 100Hz tetanus induces short-lived E-LTP in both control mice (Fig.4A; WT VEH, avg. of
fEPSP slope over final 20 minutes = 112.6 · 10.5%) and Nr4aDN mutant mice (Fig. 3.4B;
Nr4aDN VEH avg. fEPSP slope over final 20 minutes = 109.9 · 4.5%). When acute slices from
control animals were exposed to 1.65 µM TSA, the same stimulus induces significantly enhanced
long-lasting L-LTP compared to vehicle-treated slices (Fig.3.4A; avg. fEPSP slope over final 20
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minutes = 175.7 · 16.8%, TSA vs. VEH within wild-type slices, p = 0.016). In slices from Nr4aDN
mutant animals, HDAC inhibitor treatment failed to enhance LTP (Fig. 3.4B; avg. fEPSP slope
over final 20 minutes = 109.9 · 4.5%, TSA vs. VEH within Nr4aDN slices, p = 0.11). Our results
support previous findings that blocking NR4A function prevents memory enhancement by acute
TSA treatment (Hawk et al, 2012), and indicate that the NR4A transcription factors are necessary
for mediating the effects of HDAC inhibition on synaptic plasticity.

3.4. DISCUSSION
The present study investigated the role of NR4A transcription factor function in LTP in the
hippocampus using a dominant-negative NR4A construct to block transactivation by native NR4A
proteins ( Hawk et al., 2012; Robert, Martin, & Tremblay, 2006). We found that transcriptiondependent LTP induced by either spaced high-frequency stimulation (HFS) or TBS was greatly
attenuated in the transgenic mice. However, Nr4aDN expression had no effect on the basal
properties of the Schaffer collateral synapses or synaptic stability. In addition, we demonstrated
that the enhancement of LTP by the HDAC inhibitor TSA (Vecsey et al., 2007) also requires
NR4A transcription factor function. Previous studies from our lab (Hawk et al., 2012; Vecsey et
al., 2007) and others (Peña de Ortiz et al., 2000; Colón-Cesario et al., 2006; Rojas et al., 2007;
McQuown et al., 2011; McNulty et al., 2012) have implicated the Nr4a family in the formation and
expression of memory of several types. Here, we have provided evidence that these transcription
factors are involved in mediating activity-dependent changes in synaptic strength, in processes
thought to underlie memory formation, supporting the NR4A proteins as important regulators of
plastic and cognitive processes.
We find that two forms of transcription-dependent L-LTP, one induced by spaced 4-train
HFS and the other induced by theta-burst stimulation, were both disrupted by Nr4aDN
expression. Mutant slices responded to stimulation with an initial potentiation, but were unable to
sustain that potentiation through the subsequent transcription- and translation-dependent phase
of LTP (Huang et al., 1996; Nguyen et al., 1994). The experience-dependent changes in synaptic
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strength that occur during LTP share many of the same pathways and mechanisms as long-term
memory formation, and some of these (for example, PKA signaling and the activation of CREB)
are known to initiate the transcription of the Nr4a genes (Lemberger et al., 2008). Contextual fear
conditioning is accompanied by increased hippocampal expression of all three Nr4a family genes
in the two hours following training (Hawk et al., 2012). Other groups have reported upregulation of
Nr4a1 in CA1 (von Hertzen and Giese, 2005) and Nr4a2 in both CA1 and CA3 (Peña de Ortiz et
al., 2000) after hippocampus-dependent memory tasks, while Colùn-Cesario et al. (2006)
demonstrated that the injection of antisense oligonucleotides directed against Nr4a2 attenuated
learning on a spatial discrimination task. Taken together with our results, these studies suggest
that the activity-dependent transcription of the Nr4a genes and subsequent changes in NR4Aregulated transcription are critical for memory consolidation and the underlying synaptic plasticity.
Acute administration of HDAC inhibitors has repeatedly been shown to enhance longterm memory (Haettig et al., 2011; Levenson et al., 2004; Stefanko et al., 2009; Vecsey et al.,
2007) and extinction (Lattal et al., 2007; Stafford et al., 2012) in vivo, and can transform shortterm E-LTP into transcription-dependent L-LTP in ex vivo hippocampal slices. Accumulated
research indicates that the Nr4a nuclear receptors are important regulators of HDAC inhibitormediated memory enhancement. Vecsey et al. (2007) reported that Nr4a1 and Nr4a2 mRNA
levels were increased during memory consolidation in mice administered TSA, while Hawk and
colleagues (2012) found that contextual fear memory in Nr4aDN mice was not enhanced by TSA
treatment. Knocking out HDAC3 enhances memory, mimicking the effects of HDAC inhibitor
treatment, and this effect is reversed by siRNA knockdown of Nr4a2 (McQuown et al., 2011).
Here, we replicated the finding that acute TSA treatment enhances LTP in hippocampal slices
from wild-type mice, and we further demonstrated that HDAC inhibition is unable to enhance LTP
in slices lacking NR4A activity. These data suggest that the NR4A transcription factors mediate
the memory- and plasticity- enhancing effects of HDAC inhibitors. As histone acetylationregulated and activity-dependent genes, the Nr4a family is rapidly transcribed in response to
neuronal activity (Peña de Ortiz and Jamieson, 1996; Maxwell and Muscat, 2006; Vecsey et al.,
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2007; McQuown et al., 2011). The putative gene targets of NR4A include Bdnf and Fosl2, both of
which are upregulated by HDAC inhibitor treatment (Hawk et al., 2012). Bdnf is of particular
interest as a candidate by which the Nr4a family influences neuronal plasticity and memory and
mediates the effects of histone deacetylase inhibition, because it is an acetylation-regulated gene
and its expression coincides with a later wave of transcription (Cunha et al., 2010) that could be
controlled by newly translated NR4A proteins.
Research into the pharmacological manipulation of nuclear receptors has shown that
altering the function of RXR, LXR, and PPAR can rescue memory and memory deficits in mouse
models of Alzheimer’s disease and neurodegeneration (Pedersen et al., 2006; Jiang et al., 2008;
Cramer et al., 2012). RXR is able to form transcriptionally active heterodimers with LXR and
PPAR, as well as the NR4A nuclear receptors; this partnering facilitates the transcription of the
gene targets of either partner and could link the function of these receptors in the brain
(Mangelsdorf and Evans, 1995; Maxwell and Muscat, 2006). Although the NR4A proteins are
orphan receptors and lack the canonical nuclear receptor ligand-binding domain (Wansa et al.,
2003), a number of small-molecule activators exist that target one or more of the NR4A
transcription factors (Dubois, Hengerer, & Mattes, 2006; Inamoto et al., 2008; Li, Lee, & Safe,
2012; Pearen & Muscat, 2010). Impairing the function of the NR4A nuclear receptors attenuates
memory, so could increasing their function enhance it? Such research would have important
practical applications in studies of human aging and neuropsychiatric illness. In some human
patients, Nr4a2 mutations have been identified and associated with schizophrenia (Buervenich et
al., 2000; Xing et al., 2006), while Nr4a2 +/- mutant mice display schizophrenia-like behaviors
(Rojas et al., 2007). In humans, decreased Nr4a2 gene expression has also been reported to
accompany aging (Chu et al., 2002). Pharmacological activation of NR4A could be used to
compensate for transcriptional deficiency caused by mutation or loss of these transcription factors
and could be utilized to counter the effects of age-related cognitive decline or NR4A dysfunction
in schizophrenia.
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CHAPTER 3 FIGURE LEGENDS
Figure 3.1. Basal transmission is unaffected by Nr4aDN transgene expression.
(A) Paired-pulse facilitation, a measure of presynaptic release, was not affected by Nr4aDN
expression (p = 0.267). (B) Input-output curves, plotted with fEPSP slope as function of the
presynaptic fiber volley, are not affected by Nr4aDN expression (p = 0.573). (C) The maximum
fEPSP slopes from Nr4aDN mutants and controls were not significantly different (p = 0.791). (D)
Baseline synaptic response in the absence of stimulation is not altered in Nr4aDN mutants when
compared to controls (p = 0.256).
Figure 3.2. L-LTP is impaired in Nr4aDN mutant mice. A, Four trains of stimulation spaced
five minutes apart (indicated by arrows) induces L-LTP in control slices but not slices taken from
Nr4aDN mutant mice (p=0.016). B, Theta-burst LTP (TBS; indicated by arrow) produced less
potentiation in the late maintenance phase in Nr4aDN mutant mice compared to control animals
(p=0.002).
Figure 3.3. The Nr4aDN LTP impairment can be rescued by transgene suppression. Offdoxycycline Nr4aDN and control data reproduced here from Fig. 2A for comparison. After four
weeks on doxycyline chow to suppress the tTA; Tet-O system, spaced 4-train stimulation
produces sustained L-LTP in the ON-DOX control and Nr4aDN mice that does not differ from
controls (Dunnett’s post-hoc, control vs. Nr4aDN ON-DOX, p = 0.984). Doxycycline did not affect
LTP in control mice (Dunnett’s post-hoc, control vs. control ON-DOX, p = 0.814). [*p < 0.05, twoway repeated measures ANOVA followed by Dunnett’s post hoc, control vs. Nr4aDN; p > 0.05 for
control vs. Nr4aDN ON-DOX and control vs. control ON-DOX]

Figure 3.4. Nr4aDN expression blocks LTP enhancement by the HDAC inhibitor TSA.

A,

Perfusion of control slices with the HDAC inhibitor TSA enhances potentiation following a single
1s, 100Hz train of stimulation (indicated by arrow) when compared to 1-train LTP induced in the
presence of vehicle (p = 0.016). B, In slices from Nr4aDN mutants a single train of stimulation
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(indicated by arrow) produces short-term E-LTP in the presence of both vehicle and 1.65 μM TSA
(p = 0.11). [Black bar indicates drug/vehicle treatment.]
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Figure 3.1. Basal transmission is unaffected by Nr4aDN transgene expression.
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Figure 3.2. L-LTP is impaired in Nr4aDN mutant mice.
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Figure 3.3. The Nr4aDN LTP impairment can be rescued by transgene suppression.
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Figure 3.4. Nr4aDN expression blocks LTP enhancement by the HDAC inhibitor TSA.
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CHAPTER 4: CREB/CBP Interaction Regulates Activity-Dependent Nr4a
Gene Expression and Promoter Acetylation and LTP Enhancement by
NR4A Activators

Abstract. Memory consolidation and the maintenance of long-term potentiation require gene
expression, and are enhanced by HDAC inhibitor treatment. Expression of the Nr4a nuclear
receptors is induced after learning and synaptic activity, and NR4A function is important for longlasting forms of hippocampal plasticity and memory. Nr4a expression is augmented by HDAC
inhibition, while disrupting NR4A function impairs memory and LTP and blocks their enhancement
by HDAC inhibition. We have found that the learning-induced expression of Nr4a is accompanied
by increased acetylation of histone H3 at the Nr4a2 promoter, and that upregulation of Nr4a2 and
Nr4a3 and the acetylation of the Nr4a2 promoter are mediated by CREB/CBP interaction.
Further, exogenous NR4A agonists have been described but have not been investigated in the
context of synaptic plasticity and memory. Because Nr4a disruption impairs memory and
plasticity, we hypothesized that activating the NR4A family would facilitate hippocampal LTP. We
found that para-phenyl substituted di-indolylmethane ”C-DIM” compounds enhanced hippocampal
long-term potentiation, while reduced Nr4a gene expression or NR4A function attenuated this
LTP enhancement.
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4.1. INTRODUCTION
The consolidation of long-term memory and the stabilization of long-term potentiation
both depend on gene expression. Over the past decade, research has shown that epigenetic
mechanisms such as the post-translational modification of histone proteins are important
regulators of transcription-dependent forms of long-term memory and long-term potentiation (Bridi
and Abel, 2013a; Peixoto and Abel, 2013). Epigenetic histone marks, such as acetylation,
methylation, and phosphorylation, are associated with learning and memory in multiple brain
regions including the hippocampus, cortex, and amygdala (Bridi and Abel, 2013a). Increased
histone acetylation is associated with active transcription (Hebbes and Thorne, 1988), and
pharmacological inhibitors of histone deacetylase (HDAC) enzymes have been shown to enhance
multiple forms of both long-term memory and synaptic plasticity (Levenson et al., 2004; Vecsey et
al., 2007; Guan et al., 2009; Peleg et al., 2010; Haettig et al., 2011). However, the critical
acetylation-regulated genes that facilitate the enhancement of memory and synaptic plasticity are
still largely unknown.
The Nr4a subfamily of nuclear receptor transcription factors is made up of three closelyrelated genes (Nr4a1/Nur77/HZF-3, Nr4a2/Nurr1/NGFI-B, and Nr4a3/NOR-1/TEC) (Maxwell and
Muscat, 2006). The Nr4a genes are activity-regulated immediate early genes (Peña de Ortiz and
Jamieson, 1996), and the NR4A proteins they encode are “orphan” nuclear receptors that
regulate transcription in a concentration-dependent fashion (Johnson et al., 2011). The Nr4a
genes are expressed throughout the forebrain, and it has previously been shown that disruption
of the function of one or more of the NR4A transcription factors impairs hippocampus-dependent
memory (Colón-Cesario et al., 2006; Hawk et al., 2012; McNulty et al., 2012) and synaptic
plasticity (Bridi and Abel, 2013b). Earlier research from our lab identified the Nr4a orphan nuclear
receptors as genes induced by learning and further upregulated by HDAC inhibition ( Hawk et al.,
2012; Vecsey et al., 2007), and whose function is critical for long-term memory consolidation and
long-term potentiation as well as their enhancement by the HDAC inhibitor trichostatin A (Bridi &
Abel, 2013; Hawk et al., 2012).
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While the NR4A subfamily remain orphan receptors, without any identified endogenous
ligands, pharmacological agents that activate NR4A nuclear receptors have been described in the
literature (Pearen and Muscat, 2010). These exogenous NR4A agonists include 6mercaptopurine (Ordentlich et al., 2003; Wansa et al., 2003), cytosporone B (Zhan et al., 2008),
and derivatives of benzimidazole (Dubois et al., 2006) and isoxazolopyridinone (Hintermann et
al., 2007). Recently, a class of putative NR4A-targeted activators, the para-phenyl substituted diindolylmethane analogs – also known as the “C-DIM” compounds – has been described, and
used as effective anti-tumor agents (Chintharlapalli et al., 2004; Cho et al., 2007; Inamoto et al.,
2008; Lei et al., 2008; Li et al., 2012). Importantly, these C-DIM compounds have been shown to
induce the activation of nuclear NR4A proteins and transcription from NR4A-regulated promoters;
they are also able to penetrate the blood-brain barrier following systemic administration, and
seem to be well-tolerated in vivo (Cho et al., 2007; De Miranda et al., 2013, 2015).
Not only are the Nr4a genes activity-induced and acetylation-regulated, they are also
targets of the plasticity-regulating cAMP-PKA-CREB signaling pathway (Kovalovsky et al., 2002;
Impey et al., 2004; Lemberger et al., 2008). One protein in this pathway, the CREB-binding
protein (CBP) is a transcriptional co-activator that possesses histone acetyltransferase (HAT)
activity. Mutant mouse models have demonstrated that mutation of CBP impairs long-term
memory formation (Alarcón et al., 2004; Korzus, Rosenfeld, & Mayford, 2004; Oike et al., 1999;
Wood et al., 2005; M. A. Wood, Attner, Oliveira, Brindle, & Abel, 2006). Of particular note, these
memory-disrupting CBP mutations include point mutations affecting the histone acetyltransferase
domain of CBP (Korzus et al., 2004), as well as the kinase-inducible CREB interaction (KIX)
domain of the co-activator (Wood et al., 2006).
Because of their regulation both by CREB and by changes in histone acetylation, as well
as their importance for the enhancement of plasticity by HDAC inhibitor treatment, we
hypothesized that the learning-induced expression of the genes of the Nr4a subfamily would be
regulated by CBP. In the present study, we used mutant mice with disrupted CBP/CREB
interaction to examine the role of CBP in regulating Nr4a gene expression and promoter
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acetylation following hippocampus-dependent contextual fear learning. We also explored the
potential of para-phenyl substituted di-indolylmethane “C-DIM” compounds, putative activators of
the NR4A proteins, to enhance long-term potentiation in hippocampal slices. We found that Nr4a
gene expression and promoter acetylation are attenuated by mutation of the KIX domain of the
co-activator CBP, and that the enhancement of LTP by the C-DIM compounds is impacted by
mutations that reduce Nr4a expression or function.

4.2. METHODS
Animals. Mice were maintained under standard conditions consistent with National Institute of
Health guidelines and approved by the Institutional Animal Care and Use Committee of the
University of Pennsylvania. Food and water were available ad libitum. Adult mice (2-6 months of
age) were used for all experiments. Mice were kept on a 12-hr light/12-hr dark cycle with all
behavioral, electrophysiological, and biochemical experiments performed during the light cycle.
kix/kix

CBP

mutant mice were produced as described in previous work (Kasper et al., 2002;

Wood et al., 2006). Mice heterozygous for the triple point mutation in CBP (Tyr650Ala,
Ala654Gln, and Tyr658Ala) were backcrossed on a C57BL/6J background for at least 10
generations. Heterozygous mutant mice (CBP
wt/wt

and wild-type (CBP

kix/wt

) crosses produced homozygous mutant mice

) littermates for experiments. PCR genotyping for the mutant CBP allele

was performed using PureTaq RTG beads (GE-Amersham) with the primers KIX-F and KIX-R
(Table 4.1) and the following thermal cycling parameters: 94º C for 3 min, [94º C for 30 s, 60º C
for 30 s, 72º C for 60 s] x 34 cycles, 72º C for 10 min.
Nr4aDN transgenic mutant mice were produced as described in previous work (Hawk et
al., 2012; Bridi & Abel, 2013). Briefly, Nr4aDN transgenic mice express a dominant-negative
NR4A construct under the control of the tetracycline operator (tetO). The tetO-Nr4aDN strain was
crossed with transgenic CaMKII-tetracycline transactivator (CaMKII-tTA) mice (Mayford et al.,
1996) to produce a double-transgenic line with postnatal expression of the Nr4aDN construct in
excitatory forebrain neurons. The dominant-negative NR4A construct is a form of NR4A1 that
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contains the dimerization domain and DNA-binding domain but lacks the transactivation domain,
and instead contains an HA and an YFP tag (Hawk et al., 2012; Robert et al., 2006). Doubletransgenic (CaMKII-tTA +; Nr4aDN +) males were bred to C57BL/6J females. From the resulting
litters experimental Nr4aDN mutant mice were double-transgenic (CaMKII-tTA +; Nr4aDN +),
while non-transgenic and single-transgenic littermates served as controls. Mice were raised in the
absence of doxycycline.
Behavior. Fear conditioning was performed as previously described (Vecsey et al., 2007) with
handling for 3 days prior to conditioning. Briefly, the conditioning protocol entailed a single 2-sec,
1.5 mA footshock terminating at 2.5 minutes after placement of the mouse in the novel chamber.
Conditioning was quantified by measuring freezing behavior, the absence of non-respiratory
movement (Fanselow, 1980; Maren and Quirk, 2004), using automated scoring software (Clever
Systems, Reston, VA).
RNA preparation. Hippocampal dissections were performed on ice after fear conditioning.
Conditioning and dissections alternated between control and experimental groups. RNA was
prepared using a modified Trizol RNA extraction followed by RNeasy (Qiagen) purification and
DNA-free (Ambion) DNase treatment. RNA concentration was determined using a NanoDrop
spectrophotometer (ThermoFisher Scientific).
cDNA synthesis. cDNA was produced using the RETROscript kit (Ambion). For each reaction, 1
µg of total RNA was added to a 20 µl total reaction volume composed of 50 mM Tris-HCl (pH
8.3), 75 mM KCl, 3 mM MgCl2, 5 mM dithiothreitol, 500 µM each dNTP, 5 µM random decamer,
10 units RNase inhibitor, and 100 units MMLV-RT. Control reactions were performed lacking
template or reverse transcriptase. Reactions were performed at 44°C for 1 hr, followed by heat
inactivation at 100°C for 10 min. Reactions were diluted to 2 ng/µl in water to 500 µl final volume.
Real-Time PCR. qPCR was performed on the ABI7500 Fast using three separate housekeeper
genes for normalization (Gapdh, Tuba4a, and Hprt). Relative quantification of gene expression
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was based on the ABI users’ bulletin using a ΔΔCt method and described previously (Vecsey et
al., 2007). Fold difference in mean value for biological replicates is presented, and each sample is
a distinct biological replicate.
Chromatin immunoprecipitation. ChIP assays were performed as previously described
(Vecsey et al., 2007). Briefly, finely chopped hippocampi were cross-linked in 2%
paraformaldehyde in PBS. Nuclei were prepared and cross-linked chromatin was extracted as
described (Vecsey et al., 2007). Chromatin isolated from nuclei was sonicated to between 200
and 1000 bp using the Bioruptor (Diagenode) with high power sonication for 30 minutes with a
1.5-min rest between 1-min pulses of sonication. Soluble chromatin quantity and fragmentation
size was assessed using agarose gel electrophoresis and Nanodrop (Wilmington, DE)
spectrophotometry. For each chromatin immunoprecipitation (ChIP) assay, 2 μg chromatin and 2
μg antibody (anti-acetyl histone H3, 1:1000, Millipore #06-599; anti-acetyl H4, 1:1000, Millipore
#06-866) were incubated overnight at 4°C. Mock immunoprecipitation with pre-immune IgG was
performed in parallel. Immunoprecipitation was performed with 100 μl protein G plus agarose
beads (Invitrogen) at 4°C for 2 hr. Beads were washed in low salt buffer, high salt buffer, LiCl
buffer, and TE buffers as described previously (Vecsey et al., 2007). Chromatin-antibody
conjugates were released from beads in 1% SDS, 100mM NaHCO3 elution buffer. Cross-linking
was reversed by overnight incubation at 65°C in the presence of 200 mM NaCl, followed by
proteinase K treatment for 1 hr at 55°C. DNA was isolated using MinElute spin columns (Qiagen).
Quantitative real-time PCR was performed with gene promoter-specific ChIP primers (Nr4a1-F,
Nr4a1-R, Nr4a2-F, Nr4a2-R, Nr4a3-F, Nr4a3-R, LINE1-F, and LINE1-R) as listed in Table 1.
Amplification detection was performed using PowerSYBR green mix (ABI) on the ABI7500 Fast
real-time PCR system using 7500 standard cycling parameters.

Electrophysiology. Electrophysiological recordings were performed as described in previous
work (Vecsey et al., 2007; Bridi and Abel, 2013b; Park et al., 2014) and in Chapters 2 and 3.
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Mice were killed by cervical dislocation and their hippocampi quickly removed and dissected in
ice-cold oxygenated artificial CSF (aCSF; 124 mM NaCl, 4.4 mM KCl, 1.3 mM MgSO 4ˍ7H2O, 1
NaH2PO4ˍH2O, 26.2 mM NaHCO3, 2.5 mM CaCl2ˍ2H2O, 10 mM glucose). Transverse
hippocampal slices 400 µm thick were cut with a Stoelting tissue chopper, transferred to an
interface recording chamber, and maintained in oxygenated aCSF at 28.0°C. Slices recovered for
at least 2 hours before recording. Single-pathway recordings were made using a single bipolar
stimulating electrode made from nichrome wire (A-M Systems) placed in the stratum radiatum of
CA1 and used to elicit action potentials in axons of CA3 pyramidal neurons. Field potentials
(fEPSPs) were recorded using an aCSF-filled glass microelectrode (A-M Systems) with a
resistance between 1 and 6 MΩ placed in stratum radiatum of area CA1. Data was collected with
Clampex software (Molecular Devices, Palo Alto, CA) and analyzed with Clampfit (Molecular
Devices). Peak fEPSP amplitude induced by stimulation was required to be at least 5 mV, and
stimulus intensity during the recording was set to produce a response of 40% of the maximum
amplitude. Probe stimulation occurred once per minute. Baseline responses were recorded for 20
minutes before drug application. Following the 20-minute baseline recording, one of the C-DIM
compounds or an equivalent volume of DMSO vehicle was administered for a period of 40
minutes. LTP was induced using a single 1 sec, 100 Hz train of stimuli, delivered 20 minutes into
the period of drug treatment. Recordings lasted for 3 hours after the beginning of drug treatment.
The initial slopes of the recorded fEPSPs were normalized to the averaged slope of the 20
baseline traces and expressed as a percentage of this baseline.
Drugs. DIM-C-pPhOCH3 was purchased from Sigma-Aldrich (D7946 SIGMA). DIM-C-pPhBr was
generously provided by Dr. Stephen Safe of Texas A&M University. Both of the C-DIM
compounds were dissolved in 100% DMSO to a stock concentration of 5 mM, aliquoted into
amber tubes, and stored at -20° C. C-DIM drugs were administered to hippocampal slices at a
final concentration of 2.5 μM in aCSF.
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Data analysis. Statistical analysis was performed in SPSS (version 17), STATISTICA (version
11), and JMP (version 5). For behavioral experiments, ANOVAs were performed followed by
Student-Newman-Keuls post hoc tests. Gene expression and ChIP statistical analysis was
performed with non-parametric Kruskall-Wallis ANOVAs. For electrophysiology data, analyses
were performed as described in Chapter 2 and Chapter 3. Repeated-measures ANOVAs were
used to compare the effects of vehicle vs. DIM-C-pPhOCH3 or vehicle vs. DIM-C-pPhBr in
controls and mutants from each genotype. Experimenters were blind to genotype, and genotypes
were confirmed after experiments were completed. Data are expressed as mean +/- SEM unless
otherwise noted.

4.3 RESULTS
4.3.1 The CREB interaction domain of CBP is required for Nr4a gene expression after
contextual fear learning. Because the genes encoding the Nr4a sub-family of nuclear receptors
are regulated by CREB (Impey et al., 2004; Lemberger et al., 2008), we examined whether the
recruitment of CBP to phosphorylated CREB by the KIX interaction domain is required for the
hippocampal expression of the Nr4a genes after contextual fear conditioning. We utilized mice
carrying homozygous knock-in mutations in the KIX domain of CBP (CBP
al., 2002). Previously, our lab has used the CBP

kix/kix

kix/kix

mice) (Kasper et

mutant mice to show that disruption of

CREB/CBP interaction blocks the enhancement of Schaffer collateral LTP by the administration
of the HDAC inhibitor trichostatin A (Vecsey et al., 2007), and that mutation of the KIX domain
impairs long-term contextual fear memory (Wood et al., 2006).
We first examined Nr4a1, Nr4a2, and Nr4a3 gene expression under basal homecage
conditions in CBP

kix/kix

mutant mice and CBP

wt/wt

controls. We did not detect any differences in

Nr4a mRNA levels between genotypes (Nr4a1, p = 0.970; Nr4a2, p = 0.496; Nr4a3, p = 0.910),
indicating that the disruption of CREB/CBP interaction does not affect Nr4a transcription under
baseline conditions (Fig. 4.1A). We have seen previously that hippocampal expression of the
Nr4a genes is upregulated rapidly after learning (Hawk et al., 2012), so we assayed Nr4a mRNA
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levels at two time points after single-trial contextual fear conditioning, at 30 minutes and at 60
minutes post-training.
At 30 minutes post-fear conditioning, Nr4a2 mRNA levels were significantly reduced in
kix/kix

CBP

mutant mice compared to CBP

wt/wt

controls (p = 0.028) (Fig. 4.1B). At this same time

point, no deficits were found in the mRNA levels of either Nr4a1 (p = 0.999) or Nr4a3 (p = 0.583)
(Fig. 4.1B). When we performed the same analyses in tissue collected 60 minutes after fear
conditioning, we observed significant deficits in the level of both Nr4a2 (p = 0.013) and Nr4a3 (p =
0.036) mRNA in CBP

kix/kix

mice compared to controls (Fig. 4.1C). A non-significant trend towards

a deficit in in the expression of Nr4a1 was also found (p = 0.072) (Fig. 4.1C). These results
suggest that disrupting the interaction of CREB and CBP selectively inhibits the activitydependent upregulation of Nr4a2 and Nr4a3 expression.

4.3.2 Increased histone acetylation at Nr4a gene promoters after fear conditioning
depends on CREB-CBP interaction. All three members of the Nr4a nuclear receptor subfamily
are CREB-regulated genes, and CREB mutation attenuates the expression of Nr4a1 and Nr4a2
in the hippocampus induced by seizure activity (Impey et al., 2004; Lemberger et al., 2008).
Further, the increased expression of Nr4a1 and Nr4a2 after contextual fear conditioning is
augmented by the administration of the HDAC inhibitor trichostatin A (Vecsey et al., 2007).
Therefore, it was somewhat unexpected that expression of Nr4a2 and Nr4a3, but not Nr4a1
expression, was affected the mutation of the CREB interaction domain of CBP (Fig. 4.1B-C). One
scenario that could explain these results is that the promoters of Nr4a2 and Nr4a3, but not of
Nr4a1, are regulated by CBP-dependent histone acetylation.
To investigate the relationship between chromatin acetylation and learning-induced Nr4a
gene expression, we examined histone acetylation both at baseline and 30 minutes after
contextual fear conditioning using chromatin immunoprecipitation (ChIP) with antibodies specific
to acetylated histone H3 and acetylated histone H4. We found that, 30 minutes after contextual
fear conditioning, histone H3 acetylation was significantly increased at the Nr4a2 promoter (p =
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0.049) relative to baseline (Fig. 4.2A). We did not observe any change in H3 acetylation at the
Nr4a1 promoter (p = 0.827), although the data indicated a non-significant trend towards
increased acetylation at the promoter of Nr4a3 (p = 0.127) (Fig. 4.2A). We also examined
acetylation of histone H4 at the same 30-minute time point, but we did not find that acetylation of
histone H4 was significantly affected by contextual fear conditioning at any of the Nr4a gene
promoters (Nr4a1, p = 0.141; Nr4a2, p = 0.330; Nr4a3, p = 0.349) (Fig. 4.2B).
Next, we used the CBP

kix/kix

mutant mice to investigate whether CREB-CBP interaction is

an important component of histone acetylation and regulation of the Nr4a genes. Because of the
kix/kix

differences we observed in the expression of Nr4a2 and Nr4a3 in CBP

mice, and the

increased acetylation of histone H3 we found in C57BL/6J animals after training, we hypothesized
kix/kix

that CBP

mutants would also exhibit reduced histone acetylation at the Nr4a2 promoter.

Indeed, compared to control, the CBP

kix/kix

mutant mice showed lower levels of histone H3

acetylation at the Nr4a2 promoter (p = 0.049), but not at the promoters of Nr4a1 (p = 0.772) or
Nr4a3 (p = 0.309) (Fig. 4.3A). No differences were found in the levels of histone H4 acetylation
(Nr4a1, p = 0.605; Nr4a2, p = 0.434; Nr4a3, p = 0.539) (Fig. 4.3B). Taken together, the results of
these experiments indicate that the rapid, learning-induced expression of Nr4a2 is regulated by
activity-dependent histone acetylation mediated by CBP.

4.3.3 Enhancement of hippocampal Schaffer collateral LTP by C-DIM compounds in an
NR4A-dependent fashion. Our lab has previously demonstrated that NR4A transcription factor
function is important for both long-term memory consolidation (Hawk et al., 2012) and the
stabilization of long-lasting LTP in hippocampal slices (Bridi & Abel, 2013).

It is clear that

perturbation of NR4A function disrupts both normal memory and synaptic plasticity, but it has not
been investigated whether targeted activation of the NR4A transcription factors could enhance
hippocampal plasticity or cognition.
Because of the impairments we observed in hippocampal long-term potentiation after
disruption of NR4A transcription factor function (Bridi and Abel, 2013b), we hypothesized that the
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administration of NR4A-activating C-DIM compounds would enhance synaptic potentiation
induced by stimulation normally below the threshold for the induction of long-lasting LTP. We
investigated the effects of the C-DIM compounds on long-term potentiation in mutant mice
expressing a dominant-negative NR4A construct (Nr4aDN), which blocks NR4A transcription
factor function (Bridi & Abel, 2013; Hawk et al., 2012). Both control mice and Nr4aDN transgenic
mice exhibit short-lived LTP in the presence of vehicle when a weak LTP-inducing stimulus was
applied (control + veh, n = 4, 104.2 ± 10.0%; Nr4aDN + veh, n = 4, 100.8 ± 13.6%; Tukey’s posthoc, p = 0.998) (Fig. 4.4A). Slices from wild-type control mice exhibited enhanced long-term
potentiation with the application of 2.5 μM DIM-C-pPhOCH3 around the time of LTP induction
(control + pPhOCH3, n = 5, 205.9 ± 12.4%; Tukey’s post-hoc, control + pPhOCH3 vs. control +
veh, p = 0.00082) or of 2.5 μM DIM-C-pPhBr (control + pPhBr, n = 5, 209.7 ± 19.3%; Tukey’s
post-hoc, control + pPhBr vs. control + veh, p = 0.0008) (Fig. 4.4B & C). However, the
expression of the Nr4a-dominant negative construct blocked the enhancement of LTP by DIM-CpPhOCH3 (Nr4aDN + pPhOCH3, n = 6, 122.4 ± 6.8%; Tukey’s post-hoc, Nr4aDN + pPhOCH3 vs.
Nr4aDN + veh, p = 0.488) (Fig. 4.4B) as well as by DIM-C-pPhBr (Nr4aDN + pPhBr, n = 6, 124.6
± 8.7%; Tukey’s post-hoc, Nr4aDN + pPhBr vs. Nr4aDN + veh, p = 0.525) (Fig. 4.4C & D).
In hippocampal slices from CBP

wt/wt

control and CBP

kix/kix

induced short-lived potentiation in the presence of vehicle (CBP
kix/kix

CBP

mutant mice, a single tetanus

wt/wt

+ veh, n = 7, 99.8 ± 7.6%;
wt/wt

+ veh, n = 7, 108.0 ± 12.0%; Tukey’s post-hoc, p = 0.968) (Fig. 4.5A). In CBP
wt/wt

controls, perfusion with either DIM-C-pPhOCH3 (CBP
wt/wt

Tukey’s post-hoc, CBP

wt/wt

+ pPhOCH3 vs. CBP

+ pPhOCH3, n = 5, 205.8 ± 15.3%;
wt/wt

+ veh, p = 0.0002) or DIM-C-pPhBr (CBP
wt/wt

+ pPhBr, n = 5, 224.2 ± 11.7%; Tukey’s post-hoc, CBP

+ pPhBr vs. CBP

wt/wt

+ veh, p =

0.0002) around the time of LTP induction led to long-lasting potentiation compared to vehiclekix/kix

treated slices (Fig. 4.5B-D). In hippocampal slices from CBP

mutant mice, the application of

DIM-C-pPhOCH3 enhanced LTP compared to vehicle-treated slices, but potentiation was still
significantly lower than in CBP
kix/kix

post-hoc, CBP

wt/wt

controls (CBP
kix/kix

+ pPhOCH3 vs. CBP

kix/kix

+ pPhOCH3, n = 5, 154.4 ± 9.5%; Tukey’s
kix/kix

+ veh, p = 0.0197; CBP
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wt/wt

+ pPhOCH3 vs. CBP

+ pPhOCH3, p = 0.047) (Fig. 4.5B&D). In DIM-C-pPhBr-treated CBP

kix/kix

slices (CBP

kix/kix

+

pPhBr, n = 7, 149.3 ± 19.9%), potentiation was not enhanced compared to vehicle-treated
kix/kix

CBP

mice although a trend was observed (CBP

kix/kix

+ veh vs. CBP

kix/kix

+ pPhBr, Tukey’s

post-hoc, p = 0.0767), while it was significantly lower than in C-DIM-pPhBr-treated slices from
wt/wt

CBP

controls (CBP

wt/wt

+ pPhBr vs. CBP

kix/kix

+ pPhBr, Tukey’s post-hoc, p = 0.0032) (Fig.

4.5C&D). These data indicate that administration of the C-DIM compounds enhances Schaffercollateral long-term potentiation in hippocampal slices, in a manner consistent with the activation
of the NR4A nuclear receptor transcription factors.

4.3 DISCUSSION
Histone acetylation regulates both long-term memory and LTP in the hippocampus.
Increasing histone acetylation through HDAC inhibition enhances plastic processes, and
upregulates the expression of many genes; however, it is still not clear which acetylationregulated genes are critical for mediating these effects on memory and plasticity. In past work,
our lab has identified the Nr4a nuclear receptors as candidate effectors, critical for memory
formation and stabilization of LTP and their enhancement by HDAC inhibition. In the present
study, we found that the activity-dependent hippocampal expression of Nr4a2 and Nr4a3
following contextual fear conditioning is attenuated by mutation of the CREB-interacting KIX
domain of CBP. We also found that after training, the upregulation of Nr4a mRNA coincides with
a rapid increase in acetylation of histone H3 at the Nr4a2 promoter, which is blocked by
disruption of CREB/CBP interaction. Further, we probed the NR4A transcription factors as targets
for the enhancement of synaptic plasticity, and found that two related, putative activators of NR4A
(DIM-C-pPhOCH3 and DIM-C-pPhBr) were able to enhance long-term potentiation when
administered to hippocampal slices from wild-type mice. This LTP enhancement was reduced by
mutations that lead to diminished Nr4a expression or function, consistent with the mediation of
the plasticity-enhancing effects of C-DIM treatment by the NR4A nuclear receptors.
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The three members of the Nr4a subfamily of nuclear receptor transcription factors are
upregulated following hippocampus-dependent learning (Hawk et al., 2012; Poplawski et al.,
2014). Our lab has identified the Nr4a orphan nuclear receptors as critical mediators of long-term
memory consolidation and long-term potentiation, as well as their enhancement by
pharmacological HDAC inhibition (Vecsey et al 2007; Hawk et al 2012; Bridi & Abel 2013). The
increased acetylation of the Nr4a gene promoters that we observed after fear conditioning is
consistent with their apparent role as mediators of the effects of HDAC inhibition on memory and
LTP (Bridi & Abel, 2013; Hawk et al., 2012), as well as their further upregulation after HDAC
inhibitor treatment (Vecsey et al 2007). Both Nr4a1 and Nr4a2 have been identified as CREBregulated genes, and Trichostatin A treatment after fear conditioning increases expression of both
Nr4a1 and Nr4a2 (Vecsey et al 2007; Impey et al., 2004; Lemberger et al 2008). It is therefore
somewhat surprising that differential expression and promoter acetylation of Nr4a2 was found,
but not of Nr4a1. One caveat here is that our gene expression and promoter ChIP data were
collected at timepoints relatively soon after training – 30 minutes and 60 minutes – while changes
in Nr4a expression after HDAC inhibitor administration can occur 2 hours after training (Vecsey et
al 2007). Nr4a1 expression rapidly increases after fear conditioning, and this upregulation
persists for at least an hour (Hawk et al., 2012); it is possible that the rapid expression of Nr4a1 is
not dependent on histone acetylation, but that differences in H3 acetylation would still be seen at
later timepoints.
The Nr4a nuclear receptors hold potential as novel pharmacological targets for the
manipulation of neuronal function, in both basic and translational neuroscience research. In
recent years several of the nuclear receptors – liver X receptor (LXR), retinoid X receptor (RXR),
and PPARű, for example – have received attention as possible therapeutic targets in
neurocognitive disorders, in particular for the amelioration of AD-related cognitive dysfunction
(Pedersen et al., 2006; Jiang et al., 2008; Wesson et al., 2011; Cramer et al., 2012). However,
further development of these agents for cognitive enhancement has not produced promising
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results. In contrast, previous work with the C-DIM compounds as anti-tumor agents has shown
them to be well-tolerated in rodents, and two recent reports have found that C-DIMs are able to
penetrate the blood-brain barrier following systemic administration and that they are effective in
preventing neuronal loss in an MPTP-induced mouse model of Parkinson’s disease (Inamoto et
al., 2008; De Miranda et al., 2013, 2015). In light of this research, our results in hippocampal slice
LTP suggest that the C-DIM compounds could also be used in vivo to enhance long-term memory
consolidation.
Some progress has been made in identifying the specific Nr4a genes involved in different
forms on memory (Colón-Cesario et al., 2006; Hawk et al., 2012; McNulty et al., 2012; Poplawski
et al., 2014), and Bdnf and Fosl2 have identified as potential targets of NR4A regulation after
hippocampus-dependent learning (Hawk et al., 2012). However, the identities of the plasticityrelated genes downstream of NR4A activity and the time-course by which the NR4A proteins
mediate gene expression after learning remain elusive. It is imperative that future studies identify
the downstream target genes that are regulated by the NR4A transcription factors during memory
consolidation and the stabilization of synaptic potentiation. Successful identification of these
effectors will improve our mechanistic understanding of plasticity and its regulation by epigenetic
processes, and will provide valuable information necessary to validate the effects of these NR4Aactivating drugs and to inform future research on their use as tools in basic research as well as in
animal models of disease.
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Chapter 4 Figure Legends

Figure 4.1. Activity-dependent hippocampal Nr4a gene expression is impaired by mutation
of the CBP-CREB interaction domain. Nr4a family transcript levels were examined in wild-type
wt/wt

(CBP

) and CBP-KIX domain mutant mice (CBP

kix/kix

) at three time points with respect to

contextual fear training. (A) Without training (homecage), no significant differences were detected
kix/kix

in CBP

mice in comparison to littermate controls (CBP

wt/wt

, n = 5; CBP

kix/kix

, n = 5; Nr4a1, p =

0.970; Nr4a2, p = 0.496; Nr4a3, p = 0.910). (B) At 30 minutes after training, a defect emerges in
Nr4a2 gene expression (CBP

wt/wt

kix/kix

, n = 5; CBP

, n = 5; Nr4a1, p = 0.999; Nr4a2, p = 0.028;

Nr4a3, p = 0.583). (C) At 60 minutes after training, significant deficits were observed in
wt/wt

expression of both Nr4a2 and Nr4a3 in comparison to littermate controls (CBP

, n = 4;

kix/kix

CBP

, n = 5; Nr4a1, p = 0.072; Nr4a2, p = 0.013; Nr4a3, p = 0.036). (*p < 0.05)

Figure 4.2. Nr4a promoter histone acetylation increases after contextual fear learning. (A)
Acetylation of histone H3 is elevated at the Nr4a2 promoter 30 minutes after contextual fear
training (homecage, n = 3; FC+30 min, n = 3; Nr4a1, p = 0.827; Nr4a2, p = 0.049; Nr4a3, p =
0.127). (B) No significant differences were identified in histone H4 acetylation at the Nr4a
promoters 30 minutes after contextual fear training (homecage, n = 3; FC+30 min, n = 3; Nr4a1, p
= 0.141; Nr4a2, p = 0.330; Nr4a3, p = 0.349). Data are expressed as a ratio of acetylation relative
to the LINE-1 retrotransposon. (*p < 0.05)
Figure 4.3. Nr4a promoter histone acetylation depends on CBP-CREB interaction domain.
(A) At 30 minutes after training, CBP

kix/kix

mice have significantly reduced levels of histone H3

acetylation at the Nr4a2 gene promoter (Nr4a1: CBP
wt/wt

CBP

n = 8, CBP

kix/kix

wt/wt

n = 8, CBP

wt/wt

n = 9, CBP

n = 8, p = 0.049; Nr4a3: CBP

kix/kix

, n = 9, p = 0.772; Nr4a2:

kix/kix

n = 8, p = 0.309). (B) No
wt/wt

n

wt/wt

n

deficit was observed for acetylation of histone H4 at the Nr4a family promoters (Nr4a1: CBP
kix/kix

= 8, CBP

wt/wt

n = 8, p = 0.605; Nr4a2: CBP

n = 9, CBP
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kix/kix

n = 9, p = 0.434; Nr4a3: CBP

= 9, CBP

kix/kix

n = 8, p = 0.539). Data are expressed as a ratio of acetylation relative to the LINE-1

retrotransposon. (*p < 0.05)

Figure 4.4. Reduction of NR4A function by a dominant-negative NR4A construct attenuates
LTP enhancement by C-DIM compound administration. (A) A single 1 sec, 100 Hz tetanus
induces short-lived LTP in Nr4aDN transgenic mice and WT littermate controls. (B) Administration
of 2.5 µM DIM-C-pPhOCH3 around the time of LTP induction enhances LTP in control slices
relative to vehicle treatment, but not in Nr4aDN mutants (repeated measures ANOVA: genotype
(Nr4aDN vs. control), F=16.7, p = 0.0098; treatment (veh vs. DIM-C-pPhOCH3), F=33.8, p =
0.00034; genotype × treatment, F=14.4, p = 0.0017. Tukey’s post-hoc: control + pPhOCH3 vs.
Nr4aDN + pPhOCH3, p = 0.000292; control + veh vs. control + pPhOCH3, p = 0.00214; Nr4aDN +
veh vs. control + pPhOCH3, p = 0.000205; other comparisons, p > 0.4). (C) Administration of 2.5
µM DIM-C-pPhBr around the time of LTP induction enhances LTP in control slices relative to
vehicle treatment, but not in Nr4aDN mutants (repeated measures ANOVA: genotype (Nr4aDN
vs. control), F=8.7, p = 0.01; treatment (veh vs. DIM-C-pPhBr), F=21.7, p = 0.00031; genotype ×
treatment, F=7.5, p = 0.015. Tukey’s post-hoc: control + pPhBr vs. Nr4aDN + pPhBr, p =
0.00291; control + veh vs. control + pPhBr, p = 0.000788; Nr4aDN + veh vs. control + pPhBr, p =
0.000642; other comparisons, p > 0.5). (D) fEPSP slope averaged over the last 20 minutes for
each experimental group (*p < 0.05, **p < 0.01, ***p < 0.001, arrows indicates LTP induction,
black bars indicate drug or vehicle treatment).

Figure 4.5. Disruption of the CREB-CBP interaction domain reduces the enhancement of
hippocampal LTP by C-DIM substituted compounds. (A) A single 1 sec, 100 Hz train induces
short-lived LTP in both CBP

kix/kix

wt/wt

and CBP

mice in the presence of DMSO vehicle. (B)

Administration of 2.5 µM DIM-C-pPhOCH3 around the time of LTP induction enhanced LTP in
kix/kix

both CBP

and CBP-wt/wt mice relative to vehicle-treated slices, but potentiation in CBP

kix/kix

mice was still significantly lower than in wild-type control slices (repeated measures ANOVA:
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genotype (CBP

wt/wt

vs. CBP

kix/kix

), F=3.7, p = 0.069; treatment (veh vs. DIM-C-pPhOCH3), F=42.4,

p = 0.000002; genotype × treatment, F=6.3, p = 0.021. Tukey’s post-hoc: CBP
vs. CBP

kix/kix

kix/kix

CBP

wt/wt

+ pPhOCH3, p = 0.0408; CBP

+ veh vs. CBP

wt/wt

+ veh vs. CBP

wt/wt

kix/kix

+ pPhOCH3, p = 0.000207; CBP

wt/wt

+ pPhOCH3

+ pPhOCH3, p = 0.000187;
kix/kix

+ veh vs. CBP

+ pPhOCH3,

p = 0.0197; other comparisons, p > 0.9). (C) Administration of 2.5 µM DIM-C-pPhBr around the
time of LTP induction enhances LTP in both CBP

kix/kix

wt/wt

and CBP

mice. Potentiation in CBP

mice was significantly lower than wt/wt mice (repeated measures ANOVA: genotype (CBP

kix/kix

wt/wt

vs.

kix/kix

CBP

), F=7.2, p = 0.0133; treatment (veh vs. DIM-C-pPhBr), F=42.1, p = 0.000002; genotype
wt/wt

× treatment, F=10.4, p = 0.00388. Tukey’s post-hoc: CBP
wt/wt

0.0032; CBP

wt/wt

+ veh vs. CBP

kix/kix

+ pPhBr vs. CBP
kix/kix

+ pPhBr, p = 0.000167; CBP

+ veh vs. CBP

+ pPhBr, p =

wt/wt

+ pPhBr, p

= 0.000169; other comparisons, p > 0.07). (D) fEPSP slope averaged over the last 20 minutes for
each experimental group (*p < 0.05, **p < 0.01, ***p < 0.001, arrow indicates LTP induction, black
bars indicate drug or vehicle treatment).
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CHAPTER 4 FIGURES

Figure 4.1. Activity-dependent hippocampal Nr4a gene expression is impaired by mutation
of the CBP-CREB interaction domain.
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Figure 4.2. Nr4a promoter histone acetylation increases after contextual fear learning.
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Figure 4.3. Nr4a promoter histone acetylation depends on CBP-CREB interaction domain.
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Figure 4.4. Reduction of NR4A function by a dominant-negative NR4A construct attenuates
LTP enhancement by C-DIM compound administration.
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Figure 4.5. Disruption of the CREB-CBP interaction domain reduces the enhancement of
hippocampal LTP by C-DIM substituted compounds.
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CHAPTER 4 TABLES
Name
TCRA-F
TCRA-R
tTA-F
tTA-R

Purpose
tTA genotyping
tTA genotyping
tTA genotyping
tTA genotyping

Sequence
5'-CAA ATG TTG CTT GTC TGG TG-3'
5'- GTC AGT CGA GTG CAC AGT TT-3'
5'-CGC TGT GGG GCA TTT TAC TTT AG -3'
5'-CAT GTC CAG ATC GAA ATC GTC-3'

EGFP-F
EGFP-R
Actb-F
Actb-R

Nr4aDN genotyping
Nr4aDN genotyping
Nr4aDN genotyping
Nr4aDN genotyping

5'-CCT ACG GCG TGC AGT GCT TCA GC-3'
5'-CGG CGA GCT GCA CGC TGC GTC CTC-3'
5’-GAT GAC GAT ATC GCT GCG CTG GTC G-3’
5’-GCC TGT GGT ACG ACC AGA GGC ATA C-3’

KIX-F
KIX-R

CBP-kix genotyping
CBP-kix genotyping

5’-TAG TTC CCT TGT GCC ACC TT-3’
5’-TCC CAG TGA TAC CAG CAT ACC-3’

Nr4a1-F
Nr4a1-R
Nr4a2-F
Nr4a2-R
Nr4a3-F
Nr4a2-R
LINE1-F
LINE1-R

ChIP primer
ChIP primer
ChIP primer
ChIP primer
ChIP primer
ChIP primer
ChIP primer
ChIP primer

5’-CCC TTG TAT GGC CAA AGC TC-3’
5’-CTC CGC AGT CCT TCT AGC AC-3’
5’-CCG TTC CCA CCT TAA AAT CA-3’
5’-CTG CCA ACA TGC ACC TAA AG-3’
5’-GAG GGA GGA GGA GGG TGA CGT A-3’
5’-CAT AGA GTG CCT GGA ATG CGA GA-3’
5’-AAA CGA GGA GTT GGT TCT TTG AG-3'
5’-TTT GTC CCT GTG CCC TTT AGT GA-3’

Table 4.1. Primer sequences for genotyping and gene-specific Nr4a promoter chromatin
immunoprecipitation.
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS
5.1. Overview. The focus of my thesis work has been the investigation of how factors both
upstream and downstream of histone acetylation, an epigenetic modification involved in activityregulated transcription, mediate long-term memory and synaptic plasticity in the hippocampus
(Fig. 5.1). In Chapter 2, we found that the co-repressor and scaffold SIN3A negatively regulates
transcription, memory, and plasticity, and that reduction of neuronal SIN3A levels enhances
plasticity though a mechanism that may involve HOMER1 and mGluR5 signaling. In Chapter 3, I
showed that the function of the NR4A transcription factors is crucial for long-lasting forms of LTP,
as well as LTP enhancement by HDAC inhibitor administration. In Chapter 4, we found that
Nr4a2 promoter acetylation and expression after learning is regulated by CREB/CBP interaction;
we also found that two NR4A-activating C-DIM compounds can enhance hippocampal LTP in a
manner sensitive to Nr4a disruption. Here, I will review the primary findings from my dissertation
research, discuss their implications, share some additional preliminary data, and suggest future
directions.

5.2. The Transcriptional Co-Repressor SIN3A Regulates Memory Formation and
Synaptic Plasticity in the Hippocampus. The class I histone deacetylase enzyme HDAC2
has a major role in hippocampal plasticity and memory (Guan et al., 2009), and can participate in
the co-repressor complexes coordinated by NCoR, NuRD, CoREST, and SIN3A (Schoch and
Abel, 2014). In Chapter 2, we identified SIN3A as a negative regulator of hippocampal memory
and synaptic plasticity and as a repressor of several plasticity-related genes. Sin3a neuronal
hypomorph (Sin3aNH) mutant mice exhibited enhanced long-term memory and a transcriptiondependent enhancement in long-term potentiation. Memory enhancement was accompanied by
increased expression of the synaptic kinase Cdk5 and

both long and short isoforms of the

synaptic scaffold Homer1, all of which are involved in regulation of the Group I metabotropic
glutamate receptors – mGluR1 and mGluR5 – at the postsynaptic density (Xiao et al., 1998;
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Kammermeier and Worley, 2007; Orlando et al., 2009; Guan et al., 2011; Gerstein et al., 2012;
O’Riordan et al., 2014). We saw elevated ERK1/2 phosphorylation in area CA1 after fear
conditioning, consistent with increased mGluR5/Homer1 signaling (Mao et al., 2005), and
observed changes in the requirement for mGluR5 and mGluR1 in late-phase LTP similar to those
seen after long-form Homer1c overexpression (Gerstein et al., 2012; O’Riordan et al., 2014).
These data suggest that increased Homer1/mGluR5 signaling may underlie the enhancement of
synaptic plasticity in Sin3aNH mice. I carried out preliminary studies to test this possibility (see
Section 5.3 and Appendix Section 6.2).

5.3. Investigating Enhanced Synaptic Plasticity in Sin3aNH mice. In CA1 pyramidal
neurons, mGluR1 and mGluR5 activation can induce PLC signaling and release of calcium form
intracellular stores, activation of PKC and ERK, activation of local dendritic translation, and
NMDA receptor potentiation (Mannaioni et al., 2001; Kotecha et al., 2003; Rae and Irving, 2004;
Mao et al., 2005; Ferraguti et al., 2008; Anwyl, 2009; Ménard and Quirion, 2012b; Piers et al.,
2012). One way to distinguish between these receptors is by measuring the conversion of the
medium afterhyperpolarization, or AHP, that follows a burst of spikes into an afterdepolarization,
or ADP (Park et al., 2010; Park and Spruston, 2012).This AHP-to-ADP conversion is almost
entirely mediated by mGluR5, and requires G-protein signaling, the release of intracellular
calcium, PLC activation, and the activation of CaV2.3 R-type voltage-gated calcium channels (Park
et al., 2010). In the next section, I will describe some preliminary data I collected from
experiments based on this work that may help us identify intracellular effectors linked to mGluR5
activation.
5.3.1. Enhanced mGluR5 signaling in CA1 pyramidal neurons of Sin3aNH mutant mice.
I used whole-cell current-clamp recording from CA1 pyramidal neurons in acute
hippocampal slices to measure the post-burst membrane potential, as a readout of mGluR5
function (see Appendix 6.2). I first extended the earlier findings of the Spruston lab, which were
performed mostly in rats (Park et al., 2010), using slices from C57BL/6J mice. I found that
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perfusion of the mGluR1/5 agonist DHPG converted the medium AHP to an ADP in CA1 neurons,
significantly changing the post-burst membrane potential (B6 + vehicle, n=4 cells, ΔV = -0.41 ±
0.47 mV; B6 + DHPG, n=5 cells, ΔV = 3.26 ± 1.14 mV; t-test, p = 0.0298, at 15 minutes;
Appendix Fig. 6.3). CA1 pyramidal neurons in Sin3aNH wild-type controls exhibited a similar,
moderate post-burst medium ADP in response to DHPG administration, while in Sin3aNH
mutants the change in post-burst potential was significantly greater than in controls (controls +
DHPG, n=7 cells, ΔV = 2.43 ± 0.66 mV; Sin3aNH +DHPG, n=5 cells, ΔV = 7.49 ± 0.84 mV; t-test,
p < 0.001 at 15 min.; Appendix Fig. 6.4A). Co-application of DHPG and 10 µM MPEP – a
specific inhibitor of mGluR5 – almost completely blocked the post-burst ADP in both controls (p <
0.01) and Sin3aNH mutants (p < 0.001) (Appendix Fig. 6.4B). The enhanced effects of DHPG in
CA1 neurons from Sin3aNH mice, as well as the attenuation of this ADP by MPEP, supports the
hypothesis discussed in Chapter 2 that upregulated expression of Homer1 and Cdk5 increases
signaling through mGluR5. The AHP-ADP conversion modulates neuronal excitability and
facilitates postsynaptic spiking (Park et al., 2010), which could in turn support enhanced memory
and LTP in the Sin3aNH mice (Metz et al., 2005).
Coincident pre- and post-synaptic bursting activity can also induce the AHP-to-ADP
conversion (Park et al., 2010), while AHP amplitude is reduced after learning (Zhang and Linden,
2003; Disterhoft et al., 2004). These additional changes in the AHP could also be investigated in
Sin3aNH mice to further confirm the enhancement of mGluR5 signaling in this mutant strain.
Additionally, mechanisms downstream of mGluR5 signaling could also be investigated, including
Gq-coupled signaling, PLC activation, and R-type voltage-gated calcium channel activity, all of
which are involved in the AHP-ADP conversion (Park et al., 2010).

5.3.2. Other Future Studies of Plasticity in Sin3aNH Mutant Mice.

Several additional

experiments would help to define changes in plasticity in Sin3aNH mice. If increased signaling
through long-form Homer1b/c and mGluR5 facilitates the enhanced memory and plasticity that we
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observed in Sin3aNH mutants, specific inhibition of mGluR5 would be expected block the 1-train
LTP enhancement (Chapter 2, Fig. 2.3), much as inhibition of mGluR5, but not of mGluR1,
blocked L-LTP in Sin3aNH mice (Chapter 2, Fig. 2.11). Loss of SIN3A could also have an effect
on mGluR5-dependent long-term synaptic depression; this should be tested with LTD induced by
PP-LFS stimulation, rather than induced by the mGluR1/5 agonist DHPG, which our lab has
found to be unreliable in adult animals. Finally, another possible contributor to enhanced plasticity
is the potentiation of NMDA receptor currents by mGluR5, which could involve a number of
mechanisms (Kotecha et al., 2003); EPSC frequency and amplitude, as well as NMDA/AMPA
current ratios, should be investigated in CA1 pyramidal neurons of Sin3aNH mice using wholecell voltage-clamp recordings.

5.4. The NR4A Nuclear Receptors Support Hippocampal Long-term Potentiation.
Our laboratory has identified the three Nr4a nuclear receptor transcription factors as important
mediators of hippocampal plasticity and memory, and of their enhancement by HDAC inhibitor
treatment (Bridi & Abel, 2013; Hawk et al., 2012). In Chapter 3, I showed that expression of a
dominant-negative NR4A protein, which blocks endogenous NR4A transcription factor function
(Hawk et al, 2012), impaired long-lasting forms of LTP and blocked LTP enhancement by the
HDAC inhibitor Trichostatin A. In Chapter 4, we found that the rapid induction of Nr4a2 promoter
acetylation and gene expression after contextual fear conditioning are regulated by CREB/CBP
interaction. We also found that C-DIM drugs, which are putative NR4A activators, enhanced
hippocampal LTP in a manner sensitive to reduced Nr4a expression and NR4A function. These
findings support a critical role for the NR4A nuclear receptors in normal hippocampal plasticity, as
well as its enhancement by HDAC inhibition.
5.4.1. Pharmacological Manipulation of the NR4A Nuclear Receptors. The NR4A nuclear
receptors are orphans, lacking any known endogenous ligands (Hawk & Abel, 2011; Maxwell &
Muscat, 2006). Synthetic and exogenous NR4A activators have been described, but none so far
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been examined in the context of memory and cognition (Pearen and Muscat, 2010). The
laboratory of Dr. Stephen Safe, at Texas A&M University, has developed a number of related
para-phenyl substituted di-indolylmethane, or “C-DIM,” compounds that have been used as NR4A
activators and as anti-tumor agents both in vitro and in vivo (Chintharlapalli et al., 2005; Cho et
al., 2007; Inamoto et al., 2008). C-DIM administration has also shown neuroprotective effects in a
rodent model of Parkinson’s disease (De Miranda et al., 2013, 2015). In Chapter 4, we found that
administration of two of these C-DIM compounds – DIM-C-pPhOCH3 and DIM-C-pPhBr –
enhanced hippocampal LTP in wild-type mice. These results are the first demonstration of an
enhancement in neuronal plasticity by targeting the NR4A nuclear receptors, and are very
promising for future studies of the NR4A family in plasticity and memory. NR4A dysfunction has
been associated with a list of disorders, including schizophrenia, Parkinson’s disease,
Alzheimer’s disease, and age-related cognitive decline, so the C-DIM compounds also offer
therapeutic potential in translational research. Signaling cascades involved in neuronal plasticity
often converge and overlap, sometimes with processes not involved in plasticity; intervening at a
point further downstream in the cAMP-PKA-CREB pathway, such as the NR4A proteins, would
allow for specific enhancement in plastic processes while avoiding other undesired or nonspecific effects.
LTP enhancement by C-DIM treatment was attenuated by mutations that block NR4A
kix/kix

function (Nr4aDN mice) or reduce Nr4a expression (CBP

mice), suggesting that the drug

effect was indeed mediated by NR4A. To further confirm this finding, inhibitors of transcription
and translation should be tested with C-DIM-enhanced LTP; one would expect that both will be
found necessary if the LTP enhancement involves NR4A-mediated transcription. Furthermore,
the ability of C-DIM compounds to enhance long-term memory formation could also be tested.
Systemically-administered C-DIMs can penetrate the blood-brain barrier (De Miranda et al., 2013,
2015), so it should be straightforward to investigate enhanced contextual fear conditioning or
spatial object recognition memory using intraperitoneal C-DIM administration. In addition, it is still
unknown which NR4A nuclear receptor (or receptors) is required for LTP enhancement, and
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which NR4A target genes mediate the enhancement. Biochemical and genetic studies such as
ChIP-qPCR and knockout or knockdown of individual Nr4a genes could narrow down the exact
mechanisms of NR4A-mediated enhancement of LTP.

There are several other C-DIM

compounds that I have not yet tested for the ability to enhance hippocampal LTP, such as DIM-CpPhCF3, DIM-C-pPhCn, and DIM-C-pPhCO2ME; I would predict similar LTP-enhancing effects
from these other C-DIMs. Investigating these compounds would be worthwhile, as it will provide a
larger number of efficacious candidate drugs for eventual use in translational studies and even
clinical trials, such that the compound with the highest efficacy and best safety profile can be
used. Finally, while my results so far have been promising, some potential caveats regarding the
use of the C-DIM compounds should be kept in mind. While something is known about their
interaction with the NR4A proteins, which may involved binding to the LBD of the NR4A proteins,
their precise mode of action is not well understood, and off-target or other undesired effects are
not fully characterized. Similarly, their specificity for individual NR4A proteins is not clear, and
they have been observed to act as NR4A agonists and antagonists in different tissue types (Lee
et al., 2014).

5.4.2. Targets Further Downstream of NR4A. Progress has been made in understanding the
involvement of the individual Nr4a genes in different forms of memory. For example, novel object
recognition and spatial object recognition tasks induce different patterns of Nr4a1 and Nr4a2
gene expression in hippocampus and cortex (McNulty et al., 2012), contextual fear conditioning
and spatial object recognition both induce expression of Nr4a1, Nr4a2, and Nr4a3 in the
hippocampus (Hawk et al., 2012; Poplawski et al., 2014), and specific disruption of Nr4a2 impairs
spatial memory (Colón-Cesario et al., 2006). However, these findings do not reveal the NR4Aregulated target genes that ultimately support memory formation and synaptic potentiation. The
identification of these genes is essential for future studies of NR4A in memory and plasticity,
histone acetylation, the effects of C-DIM drug treatment, and even CNS dysfunction and cognitive
disorders. A handful of candidate targets have been identified, but it is clear that the NR4A
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nuclear receptors can regulate a broad network of gene expression (Johnson et al., 2011). This
merits an unbiased approach like ChIP-seq for the identification of those NR4A-regulated genes
critical for memory and plasticity, and the Nr4aDN mice used in previous research from our lab
(Hawk et al., 2012; Bridi & Abel, 2013), and described in Chapter 3 and Chapter 4, provide an
ideal tool. The dominant-negative NR4A construct is both YFP- and HA-tagged (Hawk et al.,
2012), facilitating its use in chromatin immunoprecipitation, and the genes bound by the construct
are likely to be relevant to the function of NR4A in neuronal plasticity and memory consolidation.
HA-tag ChIP could be performed on microdissected CA1 collected from Nr4aDN mice after fear
conditioning or spatial object recognition training at both early and late time points, to capture the
targets of NR4A regulation during both the first and second windows of transcription during
consolidation.

5.5. The SIN3A-NR4A Pathway. The available data – both published and unpublished –
suggests that the dynamic recruitment of the SIN3A/HDAC complex and the downstream actions
of the NR4A nuclear receptors are two parts of the same pathway. For example, MEF2, a
transcription factor known to interact with SIN3A (Grzenda et al., 2009; Schoch and Abel, 2014),
regulates Nr4a expression (Youn and Liu, 2000), while unpublished data from our lab shows
increased Nr4a2 expression in our Sin3aNH mutant mice as well as HDAC2 occupancy at the
Nr4a2 promoter (Hawk, 2011). There is some indication that NR4A and SIN3A can interact, and
are capable of regulating the same genes; while this complicates any model of this mechanism, it
suggests that the Nr4a family is not only acetylation-regulated, but also involved in the regulation
other epigenetically-regulated genes (Jacobs et al., 2009a, 2009b; Katunar et al., 2009; van
Heesbeen et al., 2013). This is not surprising, since NR4A proteins not only activate transcription,
but can also repress transcription (Glass and Saijo, 2010), and may alternate between
transrepression and transactivation through post-translational modification or the dynamic
interaction with co-factors such as Pitx3, p300, PCAF, PSF, SMRT, NCoR, and Foxa2 (Wansa et
al., 2003; Jacobs et al., 2009b; Hawk and Abel, 2011; van Heesbeen et al., 2013; Yi et al., 2014) .
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Linking these upstream and downstream mechanisms draws a line from synaptic activation to
nuclear activity and gene expression regulated by SIN3A and NR4A; to complete the loop and
connect these mechanisms back to the synapse, we must identify those NR4A target genes that
support both normal memory and plasticity and the effects of boosting histone acetylation by
HDAC inhibition.

5.6. Concluding Remarks. Post-translational histone modifications – like acetylation,
methylation, and phosphorylation – are involved in the activity-induced neuronal gene expression
that is essential for consolidation of long-term memory and the stabilization of long-lasting
synaptic potentiation. Disorders of the nervous system – neurodevelopmental syndromes,
neurological diseases, and even some forms of disordered behavior – are often associated with
dysregulation of epigenetic histone modification (see Chapter 1 for review), and recent genomewide association studies even suggest links between de novo mutations in histone-modifying
enzymes and autism spectrum disorders (De Rubeis et al., 2014). Previous studies using genetic
and pharmacological manipulations have helped to elucidate the mechanisms by which histone
acetylation enhances plastic processes, and thereby provide insight into how the modulation of
histone modification may eventually be used to treat neurocognitive disorders (Abel and Zukin,
2008; Fischer et al., 2010; Peixoto and Abel, 2013; Abel and Poplawski, 2014). However, our
mechanistic understanding of how histone modification in the CNS is controlled, and ultimately
exerts its effects on neurons and circuits, remains incomplete. Here, I presented research on the
regulation of hippocampal synaptic plasticity by a factor upstream of histone acetylation – the corepressor protein SIN3A, which regulates transcription by recruiting a complex of HDACs and
other histone modifiers – and a factor downstream of histone acetylation – the Nr4a nuclear
receptor family, acetylation-regulated immediate-early genes that are important for both normal
memory and plasticity and with connections to neuronal dysfunction (Fig. 5.1).
Continued study of these processes will further expand our knowledge of how histone
acetylation and other histone modifications are mediated in neurons, and will improve our
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understanding of the mechanisms by which manipulating histone acetylation facilitates memory.
Further investigation of these mechanisms will also help us to develop the NR4A nuclear
receptors as novel targets for the experimental modulation of memory and neuronal plasticity in
basic research, and as possible therapeutic targets for translational research on neurocognitive
disorders.

CHAPTER 5 FIGURE LEGEND

Figure 5.1. Regulation of plasticity upstream of acetylation by the co-repressor SIN3A, and
downstream by the NR4A transcription factors. (A) Similar to the model shown in Chapter 1
(Fig. 1.7), under “normal” baseline conditions plasticity-related genes are repressed by the
SIN3A/HDAC co-repressor complex. Synaptic activity leads to the exchange of co-repressors for
transcriptional activators and HATs like CREB and CBP, increasing histone acetylation and gene
expression. The induction of the Nr4a genes facilitates further transcriptional activation via the
NR4A nuclear receptor proteins, and the expression of synaptic plasticity. Critical NR4A target
genes remain to be identified.

(B) Reducing levels of SIN3A in the hippocampus increases

expression of plasticity-related synaptic genes and enhances long-term memory and LTP (see
Chapter 2). Changes in mGluR5 signaling are also seen, which could contribute to enhanced
plasticity in Sin3aNH mutant mice by increasing neuronal excitability. (C) Expression of a
dominant-negative NR4A construct (Nr4aDN) impairs memory formation (Hawk et al., 2012), and
here was shown to attenuate long-lasting LTP and LTP enhancement by HDAC inhibition (see
Chapter 3, Fig. 3.2-3.4). Nr4aDN expression reduces learning-induced expression of Bdnf and
Fosl2, which could be important for the observed LTP phenotype. (D) Treatment of hippocampal
slices with NR4A-activating “C-DIM” compounds enhanced long-term potentiation (see Chapter
4, Fig. 4.4 and Fig. 4.5). Further study will be necessary to determine changes in NR4Aregulated gene expression that mediate this enhancement, what mechanisms it involves, and any
potential overlap with enhancement of plasticity by loss of SIN3A.
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CHAPTER 5 FIGURE

Figure 5.1. Regulation of plasticity upstream of acetylation by the co-repressor SIN3A, and
downstream by the NR4A transcription factors.
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APPENDIX

In addition to the work presented in the above chapters, I have also been engaged in
several other projects that have generated data that, while interesting, have not yet found a
home, are still in the preliminary stage, or are awaiting future experiments that will extend them
into a publishable form. In this final section of my dissertation, I will present these findings along
with a brief background, and will discuss their relevance to current and future research.

6.1. The HDAC Inhibitor MS-275 Enhances Schaffer Collateral LTP
The pharmacological inhibition of HDAC enzymes has been used to enhance memory
formation, memory extinction, and synaptic plasticity of numerous forms (Bridi and Abel, 2013a;
Peixoto and Abel, 2013). Often, the drugs used in these experiments – such as Trichostatin A,
SAHA, and sodium butyrate – inhibit HDAC enzymes of both Class I and Class II ( Hawk, Florian,
& Abel, 2011). Genetic studies have identified the Class I histone deacetylase HDAC2 as
perhaps the most functionally important target of HDAC inhibition in learning and plasticity (Guan
et al., 2009). MS-275 is an HDAC-inhibiting drug specific to the Class I HDACs, with highest
affinity for HDAC2 in particular, and could be useful for minimizing off-target effects in studies of
histone acetylation in neuronal function. Our lab has shown previously that hippocampal infusion
of MS-275 enhances long-term spatial object location memory (Hawk, Florian, & Abel, 2011).
I tested the ability of MS-275 administration to enhance hippocampal long-term
potentiation, as well as the potential impact of MS-275 on basal synaptic transmission. I used a
single 1 sec, 100 Hz train of stimuli to induce LTP in hippocampal slices from wild-type C57BL/6J
mice. I found that perfusion of 0.1 µM MS-275 significantly enhanced LTP versus vehicle-treated
slices (vehicle, n=3, 111.6 ± 7.7%; MS-275, n=4, 180.0 ± 11.8%; p = 0.000524; Fig. 6.1).
Administration of MS-275 did not have a significant effect on any measure of basal synaptic
transmission. Paired pulse facilitation (vehicle, n=3; MS-275, n=3; p > 0.05; Fig. 6.2A), the inputoutput relationship (vehicle, n=3; MS-275, n=3; t-test, p = 0.699; Fig. 6.2B), and maximum
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synaptic response (vehicle, n=3, 8.7 ± 2.0 –mV/s; MS-275, n=3, 7.4 ± 0.8 –mV/s; t-test, p =
0.596; Fig. 6.2C) were all unaffected by drug treatment. Perfusion of MS-275 in the absence of
LTP induction did not lead to any significant change in synaptic strength relative to slices
administered only DMSO vehicle (vehicle, n =3, 91.2 ± 2.5%; MS-275, n =3, 97.7 ± 1.7%; p =
0.105; Fig. 6.2D). These results indicate that specific inhibition of the Class I HDAC enzymes,
most especially HDAC2, is able to enhance long-lasting synaptic potentiation.

Materials & Methods
Animals. Adult, wild-type, male C57BL/6J mice were used for all recordings, aged 2 to 6 months.
Mice were group housed, under standard conditions consistent with NIH guidelines for animal
care and use. All procedures described here were consistent with NIH guidelines and approved
by the Institutional Animal Care and Use Committee of the University of Pennsylvania. Mice were
maintained on a 12:12 light:dark cycle with lights on at 7 AM. Food and water were provided in
their home cages ad libitum.

Electrophysiology. Acute hippocampal slices were prepared and extracellular field recordings
were conducted as described in previous work (Vecsey et al., 2007; Bridi and Abel, 2013b) and in
Chapters 2, 3, and 4. The Class I-specific HDAC inhibitor MS-275 (Santa Cruz) was prepared as
a 100 µM solution in 100% DMSO, then diluted with water to a 1 µM stock solution in 1% DMSO;
this was diluted to a final concentration of 0.1 µM in aCSF. Drug or vehicle treatment began
following a stable 20-minute basline recording period, and continued for the duration of the
recording. LTP was induced with a single 1 sec, 100 Hz train of stimuli delivered 20 minutes after
drug application. Recordings lasted a total of 180 minutes.

Data Analysis. LTP and basal transmission data were analyzed as described in previous work
(Bridi and Abel, 2013b) and in Chapters 2, 3, and 4. All data are presented as mean ± s.e.m.
Significance is indicated in figures as *p < 0.05, **p < 0.01, and ***p < 0.001.
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6.2. Activation of Metabotropic Receptors in CA1 Pyramidal Neurons Converts a
Post-Burst Afterhyperpolarization into an Afterdepolarization
Using mice with a conditional deletion of Sin3a in excitatory forebrain neurons (Sin3aNH
mice), we saw that the loss of SIN3A enhances long-term memory and long-term potentiation and
occludes the effects of HDAC inhibitor administration on LTP. In search of a mechanism for the
observed phenotype of Sin3aNH mice, we found that the synaptic genes Homer1 and Cdk5 are
upregulated following contextual fear conditioning. Homer1 is a scaffold that interacts with Group
I mGluRs while the kinase Cdk5 regulates Homer1-mGluR interaction, and L-LTP experiments
with Group I mGluR inhibitors found that mGluR signaling is altered in Sin3aNH mice; mGluR5 is
still required, but LTP is mGLuR1-independent, consistent with the effects of long-form Homer1
upregulation on L-LTP. A number of possible models have been developed to explain these
observations (see Chapter 2), but biochemical approaches to probing differences in mGluR1 and
mGluR5 signaling are difficult to interpret due both to shared mechanisms and the issue of
cellular heterogeneity.
In CA1 pyramidal neurons mGluR1 and mGluR5 have been associated with intracellular
mechanisms such as PLC signaling and release of calcium form intracellular stores, activation of
PKC and ERK, activation of local dendritic translation, and NMDA receptor potentiation. However,
it is not clear whether mGluR1 and mGluR5 play distinct roles or share these functions. It has
been shown that Group I mGluR activation increases neuronal excitability after spiking, by the
conversion of the medium afterhyperpolarization, or AHP, that follows a burst of spikes into an
afterdepolarization or ADP, (Park et al., 2010; Park and Spruston, 2012). This AHP-to-ADP
conversion is almost entirely mediated by mGluR5, providing a clear functional differentiation
between the Group I mGluRs that we could test in Sin3aNH mice. Generously, Dr. Nelson
Spruston offered to host me in his lab at the HHMI Janelia Farm Research Campus while I
learned to conduct these experiments, and carried them out in our Sin3aNH mutant mice.
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I first replicated and extended the basic findings from the Spruston lab (Park et al., 2010;
Park and Spruston, 2012), originally performed in rats, using C57BL/6J mice, with whole-cell
current-clamp recording from CA1 pyramidal neurons in acute brain slices. I used 5 brief 2 ns,
2000 pA current injections delivered at 100 Hz to induce a burst of 5 somatic spikes followed by
an afterhyperpolarization. Consistent with the earlier work, perfusion of slices with DHPG for 15
minutes reversibly transformed the medium afterhyperpolarization that followed a burst of action
potentials into an afterdepolarization (B6 + vehicle, n=4 cells, ΔV = -0.41 ± 0.47 mV; B6 + DHPG,
n=5 cells, ΔV = 3.26 ± 1.14 mV; t-test, p = 0.0298, at 15 minutes; Fig. 6.2). One difference noted
was the amount of drug needed to achieve a reliable effect. In the earlier work performed in acute
slices from rats, only 2-4 µM DHPG was used to induce the AHP-to-ADP conversion. In mice a
higher concentration of DHPG, 12 µM, was required to reliably elicit this effect. This drug
concentration and the overall smaller amplitude of the change in membrane potential that I
observed are both in line with the limited data from mice reported in supplemental material from
Park and colleagues (Park et al., 2010).
In CA1 neurons from Sin3aNH control littermates, I also saw that DHPG induced a postburst afterdepolarization of moderate strength, similar to that seen in B6 mice (controls + DHPG,
n=7 cells, ΔV = 2.43 ± 0.66 mV). In Sin3aNH mutants, however, the response to DHPG was
significantly enhanced, and CA1 pyramidal neurons exhibited a larger-amplitude change in postburst potential (Sin3aNH +DHPG, n=5 cells, ΔV = 7.49 ± 0.84 mV; t-test, p < 0.001 at 15 min.;
Fig. 6.4A). Because of the large contribution of mGluR5 to the DHPG-induced afterdepolarization
(Park et al., 2010), I also tested the co-application of 10 µM MPEP – a specific inhibitor of
mGluR5 – with 12 µM DHPG. MPEP almost completely blocked the post-burst afterdepolarization
in both controls (p < 0.01) and Sin3aNH mutants (p < 0.001) (Fig. 6.4B).
It has also been shown that mGluRs and mAChRs have synergistic effects on the postburst afterdepolarization, and that activation of mAChRs with carbachol (CCh) induces an AHPto-ADP conversion similar to the effects of DHPG treatment (Park and Spruston, 2012). In wildtype C57BL/6J mice, I conducted a pilot study using a 10-minute CCh treatment with the same
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100 Hz burst of somatic spikes. I found that, similar to DHPG administration, perfusion with 8 µM
CCH induced a post-burst afterdepolarization (B6 + vehicle, n=4 cells, ΔV = -0.41 ± 0.47 mV; B6
+ CCh, n=6 cells, ΔV = 3.07 ± 0.87 mV; t-test, p = 0.00906, at 10 minutes) (Fig. 6.6).
I also compared input resistance and excitability of CA1 pyramidal neurons in Sin3aNH
mutants and controls. Input resistance in CA1 pyramidal neurons from Sin3aNH mice (205 ± 14
MΩ) and control littermates (201.8 ± 7.1 MΩ) was similar (controls, n = 23 cells; Sin3aNH, n = 24
cells; t-test, p = 0.838; Fig. 6.5A). During a 500 ms duration step current of +500 pA, Sin3aNH
neurons responded on average with 26.8 ± 1.2 spikes and controls with 24 ± 0.8 spikes, a
difference that trended towards significance (controls, n = 10 cells; Sin3aNH, n = 9 cells; t-test, p
= 0.068; Fig. 6.5B).
In summary, these results indicate that in CA1 pyramidal neurons of mice, as in rats,
activation of metabotropic glutamatergic and cholinergic receptors modulates excitability through
the conversion of the post-burst afterhyperpolarization into an afterdepolarization. Consistent with
an enhancement in mGluR5/Homer1 signaling, Sin3aNH mutant mice exhibited significantly
increased ADP amplitude in response to mGluR activation, which was blocked by inhibition of
mGluR5.

Acknowledgements. Thanks to Dr. Nelson Spruston, the entire Spruston lab, and the HHMI
Janelia Farm Research Center for providing animal care, training, material, and other resources
while I learned single-cell recording and carried out these experiments.

Materials & Methods
Animals. Mice were group-housed on a 12-hour/12-hour light/dark cycle, with ad libitum access
to food and water. All experimental procedures were conducted according to National Institute of
Health guidelines for animal research, and approved by the Institutional Animal Care and Use
Committee at the Janelia Farm Research Campus. Wild-type, male C57BL/6J mice were
acquired from Jackson Laboratories. Sin3aNH mutant mice and control littermates were
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generated and genotyped as described in Chapter 2. The experimenter was blind to the
genotype of all animals, and all experimental mice were re-genotyped after experiments were
completed.

Slices. Slices were prepared as previously described (Park et al., 2010; Park and Spruston,
2012). Briefly, near-horizontal slices (∼300 μm thick) were prepared from postnatal day 21–30
mice that were anaesthetized with isofluorane, using a vibrating tissue slicer (Microm HM 650 V
Vibration microtome, Thermo Scientific Inc., Waltham, MA). Animals were decapitated and their
brains were rapidly removed and placed in ice-cold sucrose slicing solution containing (in mM):
215 sucrose, 2.5 KCl, 1.25 NaH2PO4, 2.8 NaHCO3, 7 dextrose, 3 Na-Pyruvate, 1 Na-Ascorbate,
0.5 CaCl2, 7 MgCl2 (pH 7.4, oxygenated with 95% CO 2 and 5% O2). After sectioning, slices were
transferred to a warmed (35°C) incubation chamber for 30 minutes with bubbled artificial
cerebrospinal fluid (aCSF) consisting of (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3,
25 dextrose, 2 CaCl2, 1 MgCl2, 3 Na-Pyruvate, 1 Na-Ascorbate. Slices were then maintained in
bubbled aCSF at room temperature until transferred to the recording chamber.

Recordings. Whole-cell current-clamp recordings were conducted as previously described (Park
et al., 2010; Park and Spruston, 2012). Briefly, during recordings, slices were continuously
perfused with bubbled aCSF, maintained at a temperature of 32°C. Somatic whole-cell currentclamp recordings were made using patch-clamp electrodes pulled from borosilicate glass and
filled with intracellular solution containing (in mM): 115 K-gluconate, 20 KCl, 10 Na2phosphocreatine, 10 HEPES, 2 Mg-ATP, 0.3 Na-GTP. Electrode resistance in the bath was
between 4–9 MΩ, and series resistance was 10–25 MΩ. Appropriate capacitance compensation
and bridge balance were used. Recordings were made using a Dagan BVC-700A amplifier
(Dagan Corporation, Minneapolis, MN). Data were low-pass filtered and digitized using an ITC18
digital-analog converter (HEKA Instruments Inc., Bellmore, NY), and acquired under control of
custom macros programmed in IGOR Pro (Wavemetrics, Lake Oswego, OR). Patched cells were
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maintained at a potential of -65 mV with a holding current, when needed (no larger than ±50 pA).
A 100 Hz burst of 5 somatic spikes was induced by current injection (+ 2000 pA, 2 ns, × 5) once
every 20 seconds. Baseline responses were recorded for 3 minutes before beginning
drug/vehicle perfusion. Recordings lasted for 30 minutes after baseline. Drug perfusion lasted
either 15 minutes (DHPG) or 10 minutes (CCh).

Data Analysis. Electrophysiological data was analyzed using custom scripts written by Mark
Cembrowski in the Spruston lab for use with IGOR Pro software (WaveMetrics), to compare postburst membrane potential with the pre-spike baseline potential. Statistical analyses were
performed using STATISTICA 11 software and Prism 6 software (GraphPad, La Jolla, CA, USA).
Data from multiple cells was pooled and tested for statistically significant differences using
unpaired Student's t-tests or a one-way ANOVA with Tukey's post hoc comparisons. For all tests,
significance was defined as p < 0.05. All measurements are presented as mean ± SEM unless
otherwise indicated; significance is indicated as *p < 0.05, **p < 0.01, and ***p < 0.001.

6.3. Expression of a dominant-negative NR4A protein reduces spine density in
hippocampal area CA1 after fear conditioning.
Research from our lab and other groups has demonstrated that the Nr4a nuclear
receptors are important for memory formation and neuronal plasticity (McQuown et al., 2011;
Hawk et al., 2012; McNulty et al., 2012; Bridi and Abel, 2013b). While our lab has identified some
candidate NR4A-regulated genes such as Bdnf and Fosl2 (Hawk et al., 2012), we have yet to
identify any synaptic mechanisms by which NR4A disruption impairs neuronal plasticity. Chen
and colleagues (Chen et al., 2014) reported that chronically elevated activity, combined with
knockdown of Nr4a1, increased the density of spines at distal dendrites in area CA1.
These results suggested to us that the deficits in memory and plasticity we have
observed in our Nr4aDN mutant mice could involve dysregulation of dendritic spines in the
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hippocampus following neuronal activity. To investigate this possibility, I used Golgi staining to
analyze spine density in apical dendrites in area CA1 of the hippocampus, 24 hours after
contextual fear conditioning in Nr4aDN mutant mice and littermate controls. Representative
images from the distal apical dendrites of Golgi-stained neurons in control and Nr4aDN mutants
show some apparent morphological changes in spines (Fig. 6.7A). A small but significant
reduction in overall spine density on the apical dendrites was found in Nr4aDN mutants compared
to controls (controls, n = 6; Nr4aDN, n = 6; ~8% decrease; ANOVA, p < 0.05) (Fig. 6.7B).
Although an overall decrease in density was observed, no significant reduction was found in any
particular sub-type of dendritic spine in CA1, suggesting that this is a subtle change in overall
spine density (data not shown).
The overall decrease in spine density in Nr4aDN mutant mice is consistent with the
memory and LTP phenotypes that we have observed in these animals (Hawk et al., 2012; Bridi
and Abel, 2013b), but does not align with the results from the Sheng lab, who observed a marked
increase in spine density at the distal dendrites. This could be attributed to the differences in our
model systems. While Chen and colleagues (Chen et al., 2014) used specific knockdown of
Nr4a1 in cultured hippocampal slices, and stimulated for a protracted period of time using
picrotoxin, we used a dominant-negative approach to block NR4A function in excitatory neurons,
paired with single-trial learning in vivo, which activates a much smaller subset of neurons. The
decrease in spine density still begins to provide a mechanism for the Nr4aDN memory and
plasticity phenotype, and indicates that genes related to synapse formation and PSD function
could be important targets of the NR4A proteins.

Materials & Methods
Animals. Adult Nr4aDN mutant mice and control littermates were used, as described in Chapter
3 and in previous work from our laboratory (Hawk et al., 2012; Bridi and Abel, 2013).
Experimental animals were from 2 to 6 months of age, and were experimentally naïve.
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Behavior. Fear conditioning was conducted as previously described (Hawk et al., 2012). Naïve
2- to 6-month old male and female Nr4aDN mice and littermate controls mice were placed in a
novel training chamber for 180 s and a single 2 s, 1.5 mA foot shock was administered after 148
s. Mice were returned to their home cages for 24 hours before tissue collection.
Golgi staining. 24 hours after fear conditioning mice were sacrificed, their brains removes and
rinsed with PBS. Golgi impregnation was conducted using the FD Rapid GolgiStain kit (FD
Neurotechnologies, Columbia, MD, USA), following kit instructions.
After 3 days of impregnation in kit solution A/B, brains were placed in solution C twice for 48 hrs.
After, brains were frozen and 80 µm coronal sections were cut on a Leica cryostat. Sections
were mounted on gelatin coated slides and dried at room temperature for more than one week.
Slides were stained according to kit instructions, and coverslipped using Permount mounting
medium (Thermo-Fisher).
Data Analysis. Mounted slides were sent to Neurodigitech, LLC (San Diego, CA) for analysis.
Serial sections were analyzed using Neurolucida software (v. 10, Microbrightfield, VT), on a PC
workstation controlling a Zeiss Axioplan 2 microscope with an Optronics MicroFire CCD camera,
to conduct 3-D dendritic reconstruction and continuous counting of spines throughout the
dendritic tree.
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APPENDIX FIGURE LEGENDS

Figure 6.1. The Class I HDAC inhibitor MS-275 enhances 1-train LTP. In hippocampal slices
from wild-type mice, perfusion with the 0.1 µM MS-275 enhanced LTP induced by a single 1 sec,
100 Hz train of stimulus compared to slices that received on an equivalent volume of DMSO
vehicle (vehicle, n=3, 111.6 ± 7.7%; MS-275, n=4, 180.0 ± 11.8%; p = 0.000524). Drug/vehicle
treatment indicated by black bar, stimulation indicated by arrow.
Figure 6.2. The Class I HDAC inhibitor MS-275 does not affect basal synaptic transmission.
(A) Paired-pulse facilitation was not affected by exposure to MS-275 (vehicle, n=3; MS-275, n=3;
p > 0.05). (B) Input-output curves, plotted with fEPSP slope as function of the presynaptic fiber
volley, were not affected by MS-275 treatment (vehicle, n=3; MS-275, n=3; t-test, p = 0.699). (C)
The maximum fEPSP slopes were not significantly different in vehicle- versus MS-275 treated
slices (vehicle, n=3, 8.7 ± 2.0 –mV/s; MS-275, n=3, 7.4 ± 0.8 –mV/s; t-test, p = 0.596). (D)
Baseline synaptic response in the absence of stimulation is not altered in MS-275 treated slices
when compared to controls (vehicle, n =3, 91.2 ± 2.5%; MS-275, n =3, 97.7 ± 1.7%; p = 0.105).
Figure 6.3. The Group I mGluR agonist DHPG converts the medium post-burst
afterhyperpolarization into an afterdepolarization in C57BL/6J mice.
In wild-type B6 mice, perfusion of slices with DHPG (12 μM, black bar) for 15 minutes reversibly
transformed the medium afterhyperpolarization (AHP) that followed a burst of action potentials
into an afterdepolarization (ADP), significantly changing the post-burst membrane potential
compared to the vehicle treatment group (B6 + vehicle, n=4 cells, ΔV = -0.41 ± 0.47 mV; B6 +
DHPG, n=5 cells, ΔV = 3.26 ± 1.14 mV; t-test, p = 0.0298, at 15 minutes).
Figure 6.4. The DHPG-mediated post-burst afterdepolarization in CA1 pyramidal neurons
of Sin3aNH mice. (A) The DHPG-mediated medium AHP-to-ADP conversion is enhanced in
Sin3aNH mice relative to controls (controls + DHPG, n=7 cells, ΔV = 2.43 ± 0.66 mV; Sin3aNH
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+DHPG, n=5 cells, ΔV = 7.49 ± 0.84 mV; t-test, p < 0.001 at 15 min). (B) The mGluR5 inhibitor
MPEP (10 μM) blocks the AHP-to-ADP conversion in Sin3aNH mice when co-applied with 12 μM
DHPG (Sin3aNH +DHPG, n=5 cells, ΔV = 7.49 ± 0.84 mV; Sin3aNH + DHPG + MPEP, n = 5
cells, ΔV = 1.05 ± 0.52 mV; t-test, ***p < 0.001 at 15 min). Black bar indicates drug treatments (12
µM DHPG or 12 µM DHPG + 10 µM MPEP).
Figure 6.5. Input resistance and excitability in CA1 pyramidal neurons from Sin3aNH mice.
(A) Input resistance in CA1 pyramidal neurons from Sin3aNH mice (205 ± 14 MΩ) and control
littermates (201.8 ± 7.1 MΩ) was similar (controls, n = 23 cells; Sin3aNH, n = 24 cells; t-test, p =
0.838). (B) During a 500 ms duration step current of +500 pA, Sin3aNH neurons responded on
average with 26.8 ± 1.2 spikes and controls with 24 ± 0.8 spikes, a difference that trended
towards significance (controls, n = 10 cells; Sin3aNH, n = 9 cells; t-test, p = 0.068).
Figure 6.6. Administration of the mAChR agonist CCH converts the medium post-burst
afterhyperpolarization into an afterdepolarization in C57BL/6J mice. In wild-type B6 mice,
perfusion of slices with the muscarinic AChR agonist CCh for 10 minutes (8 μM, black bar)
reversibly transformed the medium afterhyperpolarization (AHP) that followed a burst of action
potentials into an afterdepolarization (ADP) (B6 + vehicle, n=4 cells, ΔV = -0.41 ± 0.47 mV; B6 +
CCh, n=6 cells, ΔV = 3.07 ± 0.87 mV; t-test, p = 0.00906, at 10 minutes).
Figure 6.7. Decreased spine density at apical dendrites in Nr4aDN mice after fear
conditioning.

(A) Representative images from an Nr4aDN mutant and a control littermate

showing a segment of Golgi-impregnated apical dendrite from a CA1 pyramidal neuron. Scale bar
= 5 µm. (B) Overall spine density on apical dendrites is lower in Nr4aDN mice than in controls,
24 hours after contextual fear conditioning (controls, n = 6; Nr4aDN, n = 6; 8% decrease;
ANOVA, p < 0.05).
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Figure 6.1. The Class-I HDAC inhibitor MS-275 enhances 1-train LTP.
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Figure 6.2. Administration of MS-275 does not affect basal synaptic transmission.
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Figure 6.3. The Group I mGluR agonist DHPG converts the medium post-burst
afterhyperpolarization into an afterdepolarization in B6 mice.
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Figure 6.4. A DHPG-mediated post-burst afterdepolarization in CA1 pyramidal neurons of
Sin3aNH mice.
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Figure 6.5. Membrane resistance and excitability in CA1 pyramidal neurons of Sin3aNH
mice.
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Figure 6.6. The AChR agonist CCH converts the medium post-burst afterhyperpolarization
into an afterdepolarization in B6 mice.
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Figure 6.7. Decreased spine density at apical dendrites in Nr4aDN mice after fear
conditioning.
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